<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/1999/REC-html401-19991224/loose.dtd">
<html><head><title>Report for na_neg 1441901072646 [GSEA]</title><link href='xtools.css' rel='stylesheet'><link href='http://www.broadinstitute.org/gsea/images/XBench.gif' rel='shortcut icon'></head><body><div class='richTable'><table cols='11' border='1'><th class='richTable'></th><th class='richTable'>GS<br> follow link to MSigDB</th><th class='richTable'>GS DETAILS</th><th class='richTable'>SIZE</th><th class='richTable'>ES</th><th class='richTable'>NES</th><th class='richTable'>NOM p-val</th><th class='richTable'>FDR q-val</th><th class='richTable'>FWER p-val</th><th class='richTable'>RANK AT MAX</th><th class='richTable'>LEADING EDGE</th><tr><td class='lessen'>1</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY'>DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY</a></td><td><a href='DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY.html'>Details ...</a></td><td>24</td><td>-0.74</td><td>-1.86</td><td>0.000</td><td>0.275</td><td>0.292</td><td>981</td><td>tags=33%, list=9%, signal=36%</td></tr><tr><td class='lessen'>2</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/NIELSEN_LEIOMYOSARCOMA_CNN1_UP'>NIELSEN_LEIOMYOSARCOMA_CNN1_UP</a></td><td><a href='NIELSEN_LEIOMYOSARCOMA_CNN1_UP.html'>Details ...</a></td><td>16</td><td>-0.78</td><td>-1.81</td><td>0.004</td><td>0.351</td><td>0.561</td><td>1698</td><td>tags=63%, list=15%, signal=74%</td></tr><tr><td class='lessen'>3</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN'>TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN</a></td><td><a href='TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN.html'>Details ...</a></td><td>44</td><td>-0.61</td><td>-1.78</td><td>0.000</td><td>0.384</td><td>0.754</td><td>1034</td><td>tags=34%, list=9%, signal=37%</td></tr><tr><td class='lessen'>4</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA'>TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA</a></td><td><a href='TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA.html'>Details ...</a></td><td>53</td><td>-0.58</td><td>-1.73</td><td>0.002</td><td>0.588</td><td>0.939</td><td>2638</td><td>tags=45%, list=24%, signal=59%</td></tr><tr><td class='lessen'>5</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/MIKKELSEN_ES_ICP_WITH_H3K27ME3'>MIKKELSEN_ES_ICP_WITH_H3K27ME3</a></td><td><a href='MIKKELSEN_ES_ICP_WITH_H3K27ME3.html'>Details ...</a></td><td>24</td><td>-0.68</td><td>-1.72</td><td>0.006</td><td>0.537</td><td>0.967</td><td>676</td><td>tags=46%, list=6%, signal=49%</td></tr><tr><td class='lessen'>6</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP'>CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP</a></td><td><a href='CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP.html'>Details ...</a></td><td>60</td><td>-0.56</td><td>-1.71</td><td>0.000</td><td>0.522</td><td>0.978</td><td>3028</td><td>tags=50%, list=27%, signal=68%</td></tr><tr><td class='lessen'>7</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/MIKKELSEN_MCV6_HCP_WITH_H3K27ME3'>MIKKELSEN_MCV6_HCP_WITH_H3K27ME3</a></td><td><a href='MIKKELSEN_MCV6_HCP_WITH_H3K27ME3.html'>Details ...</a></td><td>216</td><td>-0.47</td><td>-1.70</td><td>0.000</td><td>0.514</td><td>0.988</td><td>720</td><td>tags=26%, list=6%, signal=28%</td></tr><tr><td class='lessen'>8</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/KUNINGER_IGF1_VS_PDGFB_TARGETS_UP'>KUNINGER_IGF1_VS_PDGFB_TARGETS_UP</a></td><td><a href='KUNINGER_IGF1_VS_PDGFB_TARGETS_UP.html'>Details ...</a></td><td>58</td><td>-0.55</td><td>-1.68</td><td>0.000</td><td>0.598</td><td>0.998</td><td>1345</td><td>tags=29%, list=12%, signal=33%</td></tr><tr><td class='lessen'>9</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/BENPORATH_PRC2_TARGETS'>BENPORATH_PRC2_TARGETS</a></td><td><a href='BENPORATH_PRC2_TARGETS.html'>Details ...</a></td><td>338</td><td>-0.44</td><td>-1.68</td><td>0.000</td><td>0.562</td><td>0.998</td><td>841</td><td>tags=22%, list=8%, signal=23%</td></tr><tr><td class='lessen'>10</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP'>DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP</a></td><td><a href='DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP.html'>Details ...</a></td><td>45</td><td>-0.57</td><td>-1.67</td><td>0.008</td><td>0.593</td><td>1.000</td><td>662</td><td>tags=18%, list=6%, signal=19%</td></tr><tr><td class='lessen'>11</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_UP'>SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_UP</a></td><td><a href='SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_UP.html'>Details ...</a></td><td>8</td><td>-0.82</td><td>-1.65</td><td>0.008</td><td>0.679</td><td>1.000</td><td>941</td><td>tags=50%, list=8%, signal=55%</td></tr><tr><td class='lessen'>12</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HE_PTEN_TARGETS_DN'>HE_PTEN_TARGETS_DN</a></td><td><a href='HE_PTEN_TARGETS_DN.html'>Details ...</a></td><td>5</td><td>-0.91</td><td>-1.63</td><td>0.004</td><td>0.766</td><td>1.000</td><td>670</td><td>tags=60%, list=6%, signal=64%</td></tr><tr><td class='lessen'>13</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/MATZUK_MATERNAL_EFFECT'>MATZUK_MATERNAL_EFFECT</a></td><td><a href='MATZUK_MATERNAL_EFFECT.html'>Details ...</a></td><td>5</td><td>-0.91</td><td>-1.62</td><td>0.000</td><td>0.814</td><td>1.000</td><td>712</td><td>tags=60%, list=6%, signal=64%</td></tr><tr><td class='lessen'>14</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN'>SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN</a></td><td><a href='SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN.html'>Details ...</a></td><td>16</td><td>-0.69</td><td>-1.60</td><td>0.016</td><td>0.887</td><td>1.000</td><td>856</td><td>tags=31%, list=8%, signal=34%</td></tr><tr><td class='lessen'>15</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/STAEGE_EWING_FAMILY_TUMOR'>STAEGE_EWING_FAMILY_TUMOR</a></td><td><a href='STAEGE_EWING_FAMILY_TUMOR.html'>Details ...</a></td><td>22</td><td>-0.63</td><td>-1.59</td><td>0.012</td><td>0.914</td><td>1.000</td><td>1010</td><td>tags=36%, list=9%, signal=40%</td></tr><tr><td class='lessen'>16</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/GROSS_HYPOXIA_VIA_HIF1A_ONLY'>GROSS_HYPOXIA_VIA_HIF1A_ONLY</a></td><td><a href='GROSS_HYPOXIA_VIA_HIF1A_ONLY.html'>Details ...</a></td><td>7</td><td>-0.83</td><td>-1.59</td><td>0.026</td><td>0.869</td><td>1.000</td><td>778</td><td>tags=43%, list=7%, signal=46%</td></tr><tr><td class='lessen'>17</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN'>YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN</a></td><td><a href='YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN.html'>Details ...</a></td><td>151</td><td>-0.45</td><td>-1.59</td><td>0.002</td><td>0.892</td><td>1.000</td><td>1218</td><td>tags=25%, list=11%, signal=28%</td></tr><tr><td class='lessen'>18</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/RAMASWAMY_METASTASIS_DN'>RAMASWAMY_METASTASIS_DN</a></td><td><a href='RAMASWAMY_METASTASIS_DN.html'>Details ...</a></td><td>41</td><td>-0.54</td><td>-1.58</td><td>0.013</td><td>0.934</td><td>1.000</td><td>925</td><td>tags=24%, list=8%, signal=27%</td></tr><tr><td class='lessen'>19</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/MEISSNER_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3'>MEISSNER_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3</a></td><td><a href='MEISSNER_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3.html'>Details ...</a></td><td>10</td><td>-0.75</td><td>-1.57</td><td>0.025</td><td>0.936</td><td>1.000</td><td>91</td><td>tags=20%, list=1%, signal=20%</td></tr><tr><td class='lessen'>20</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP'>BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP</a></td><td><a href='BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP.html'>Details ...</a></td><td>40</td><td>-0.55</td><td>-1.56</td><td>0.010</td><td>0.951</td><td>1.000</td><td>1311</td><td>tags=23%, list=12%, signal=25%</td></tr><tr><td class='lessen'>21</td><td>CONRAD_GERMLINE_STEM_CELL</td><td></td><td>9</td><td>-0.75</td><td>-1.55</td><td>0.038</td><td>1.000</td><td>1.000</td><td>585</td><td>tags=33%, list=5%, signal=35%</td></tr><tr><td class='lessen'>22</td><td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_25</td><td></td><td>7</td><td>-0.80</td><td>-1.54</td><td>0.033</td><td>1.000</td><td>1.000</td><td>239</td><td>tags=29%, list=2%, signal=29%</td></tr><tr><td class='lessen'>23</td><td>IGLESIAS_E2F_TARGETS_DN</td><td></td><td>9</td><td>-0.74</td><td>-1.53</td><td>0.033</td><td>1.000</td><td>1.000</td><td>3</td><td>tags=11%, list=0%, signal=11%</td></tr><tr><td class='lessen'>24</td><td>THUM_SYSTOLIC_HEART_FAILURE_DN</td><td></td><td>163</td><td>-0.43</td><td>-1.53</td><td>0.002</td><td>1.000</td><td>1.000</td><td>1952</td><td>tags=29%, list=18%, signal=34%</td></tr><tr><td class='lessen'>25</td><td>SCHURINGA_STAT5A_TARGETS_UP</td><td></td><td>14</td><td>-0.67</td><td>-1.53</td><td>0.032</td><td>1.000</td><td>1.000</td><td>1676</td><td>tags=36%, list=15%, signal=42%</td></tr><tr><td class='lessen'>26</td><td>FALVELLA_SMOKERS_WITH_LUNG_CANCER</td><td></td><td>57</td><td>-0.51</td><td>-1.52</td><td>0.018</td><td>1.000</td><td>1.000</td><td>1264</td><td>tags=23%, list=11%, signal=26%</td></tr><tr><td class='lessen'>27</td><td>BENPORATH_ES_CORE_NINE_CORRELATED</td><td></td><td>87</td><td>-0.47</td><td>-1.52</td><td>0.014</td><td>1.000</td><td>1.000</td><td>1550</td><td>tags=24%, list=14%, signal=28%</td></tr><tr><td class='lessen'>28</td><td>MIKKELSEN_MEF_HCP_WITH_H3K27ME3</td><td></td><td>254</td><td>-0.41</td><td>-1.52</td><td>0.000</td><td>1.000</td><td>1.000</td><td>718</td><td>tags=22%, list=6%, signal=23%</td></tr><tr><td class='lessen'>29</td><td>TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN</td><td></td><td>131</td><td>-0.44</td><td>-1.51</td><td>0.002</td><td>1.000</td><td>1.000</td><td>1256</td><td>tags=26%, list=11%, signal=29%</td></tr><tr><td class='lessen'>30</td><td>MIKKELSEN_ES_HCP_WITH_H3K27ME3</td><td></td><td>16</td><td>-0.64</td><td>-1.51</td><td>0.050</td><td>1.000</td><td>1.000</td><td>601</td><td>tags=38%, list=5%, signal=40%</td></tr><tr><td class='lessen'>31</td><td>CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_UP</td><td></td><td>23</td><td>-0.59</td><td>-1.50</td><td>0.050</td><td>1.000</td><td>1.000</td><td>1546</td><td>tags=43%, list=14%, signal=50%</td></tr><tr><td class='lessen'>32</td><td>RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_DN</td><td></td><td>8</td><td>-0.74</td><td>-1.50</td><td>0.072</td><td>1.000</td><td>1.000</td><td>812</td><td>tags=25%, list=7%, signal=27%</td></tr><tr><td class='lessen'>33</td><td>VALK_AML_WITH_T_8_21_TRANSLOCATION</td><td></td><td>5</td><td>-0.84</td><td>-1.50</td><td>0.038</td><td>1.000</td><td>1.000</td><td>1595</td><td>tags=80%, list=14%, signal=93%</td></tr><tr><td class='lessen'>34</td><td>CALVET_IRINOTECAN_SENSITIVE_VS_RESISTANT_UP</td><td></td><td>5</td><td>-0.85</td><td>-1.49</td><td>0.029</td><td>1.000</td><td>1.000</td><td>812</td><td>tags=60%, list=7%, signal=65%</td></tr><tr><td class='lessen'>35</td><td>FOURNIER_ACINAR_DEVELOPMENT_EARLY_DN</td><td></td><td>5</td><td>-0.84</td><td>-1.49</td><td>0.033</td><td>1.000</td><td>1.000</td><td>289</td><td>tags=20%, list=3%, signal=21%</td></tr><tr><td class='lessen'>36</td><td>MEISSNER_NPC_ICP_WITH_H3_UNMETHYLATED</td><td></td><td>16</td><td>-0.63</td><td>-1.48</td><td>0.058</td><td>1.000</td><td>1.000</td><td>540</td><td>tags=25%, list=5%, signal=26%</td></tr><tr><td class='lessen'>37</td><td>ASTON_MAJOR_DEPRESSIVE_DISORDER_DN</td><td></td><td>124</td><td>-0.44</td><td>-1.48</td><td>0.009</td><td>1.000</td><td>1.000</td><td>1913</td><td>tags=23%, list=17%, signal=28%</td></tr><tr><td class='lessen'>38</td><td>TESAR_JAK_TARGETS_MOUSE_ES_D3_DN</td><td></td><td>6</td><td>-0.80</td><td>-1.48</td><td>0.051</td><td>1.000</td><td>1.000</td><td>1268</td><td>tags=50%, list=11%, signal=56%</td></tr><tr><td class='lessen'>39</td><td>SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_UP</td><td></td><td>8</td><td>-0.75</td><td>-1.48</td><td>0.052</td><td>1.000</td><td>1.000</td><td>2132</td><td>tags=75%, list=19%, signal=93%</td></tr><tr><td class='lessen'>40</td><td>DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP</td><td></td><td>48</td><td>-0.50</td><td>-1.47</td><td>0.029</td><td>1.000</td><td>1.000</td><td>610</td><td>tags=15%, list=5%, signal=15%</td></tr><tr><td class='lessen'>41</td><td>NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER</td><td></td><td>63</td><td>-0.49</td><td>-1.47</td><td>0.022</td><td>1.000</td><td>1.000</td><td>822</td><td>tags=17%, list=7%, signal=19%</td></tr><tr><td class='lessen'>42</td><td>DING_LUNG_CANCER_MUTATED_FREQUENTLY</td><td></td><td>11</td><td>-0.70</td><td>-1.47</td><td>0.045</td><td>1.000</td><td>1.000</td><td>27</td><td>tags=9%, list=0%, signal=9%</td></tr><tr><td class='lessen'>43</td><td>MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3</td><td></td><td>182</td><td>-0.40</td><td>-1.47</td><td>0.004</td><td>1.000</td><td>1.000</td><td>866</td><td>tags=22%, list=8%, signal=23%</td></tr><tr><td class='lessen'>44</td><td>CLIMENT_BREAST_CANCER_COPY_NUMBER_UP</td><td></td><td>21</td><td>-0.58</td><td>-1.46</td><td>0.053</td><td>1.000</td><td>1.000</td><td>802</td><td>tags=24%, list=7%, signal=26%</td></tr><tr><td class='lessen'>45</td><td>MIKKELSEN_NPC_ICP_WITH_H3K27ME3</td><td></td><td>5</td><td>-0.81</td><td>-1.46</td><td>0.049</td><td>1.000</td><td>1.000</td><td>256</td><td>tags=40%, list=2%, signal=41%</td></tr><tr><td class='lessen'>46</td><td>MATZUK_LUTEAL_GENES</td><td></td><td>7</td><td>-0.75</td><td>-1.46</td><td>0.067</td><td>1.000</td><td>1.000</td><td>1298</td><td>tags=43%, list=12%, signal=48%</td></tr><tr><td class='lessen'>47</td><td>GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION</td><td></td><td>32</td><td>-0.53</td><td>-1.45</td><td>0.047</td><td>1.000</td><td>1.000</td><td>1691</td><td>tags=28%, list=15%, signal=33%</td></tr><tr><td class='lessen'>48</td><td>CHOI_ATL_CHRONIC_VS_ACUTE_DN</td><td></td><td>17</td><td>-0.62</td><td>-1.45</td><td>0.053</td><td>1.000</td><td>1.000</td><td>1619</td><td>tags=35%, list=15%, signal=41%</td></tr><tr><td class='lessen'>49</td><td>NOUZOVA_METHYLATED_IN_APL</td><td></td><td>36</td><td>-0.52</td><td>-1.45</td><td>0.054</td><td>1.000</td><td>1.000</td><td>862</td><td>tags=22%, list=8%, signal=24%</td></tr><tr><td class='lessen'>50</td><td>TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_DN</td><td></td><td>5</td><td>-0.83</td><td>-1.45</td><td>0.052</td><td>1.000</td><td>1.000</td><td>1475</td><td>tags=80%, list=13%, signal=92%</td></tr><tr><td class='lessen'>51</td><td>CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE</td><td></td><td>24</td><td>-0.56</td><td>-1.44</td><td>0.057</td><td>1.000</td><td>1.000</td><td>676</td><td>tags=13%, list=6%, signal=13%</td></tr><tr><td class='lessen'>52</td><td>MATZUK_CENTRAL_FOR_FEMALE_FERTILITY</td><td></td><td>21</td><td>-0.59</td><td>-1.44</td><td>0.045</td><td>1.000</td><td>1.000</td><td>797</td><td>tags=29%, list=7%, signal=31%</td></tr><tr><td class='lessen'>53</td><td>AMIT_EGF_RESPONSE_40_MCF10A</td><td></td><td>17</td><td>-0.61</td><td>-1.44</td><td>0.064</td><td>1.000</td><td>1.000</td><td>2970</td><td>tags=59%, list=27%, signal=80%</td></tr><tr><td class='lessen'>54</td><td>REN_ALVEOLAR_RHABDOMYOSARCOMA_UP</td><td></td><td>78</td><td>-0.44</td><td>-1.43</td><td>0.022</td><td>1.000</td><td>1.000</td><td>849</td><td>tags=21%, list=8%, signal=22%</td></tr><tr><td class='lessen'>55</td><td>TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP</td><td></td><td>70</td><td>-0.46</td><td>-1.43</td><td>0.037</td><td>1.000</td><td>1.000</td><td>1721</td><td>tags=31%, list=15%, signal=37%</td></tr><tr><td class='lessen'>56</td><td>MIKKELSEN_IPS_WITH_HCP_H3K27ME3</td><td></td><td>39</td><td>-0.50</td><td>-1.43</td><td>0.045</td><td>1.000</td><td>1.000</td><td>601</td><td>tags=23%, list=5%, signal=24%</td></tr><tr><td class='lessen'>57</td><td>BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP</td><td></td><td>25</td><td>-0.55</td><td>-1.43</td><td>0.059</td><td>1.000</td><td>1.000</td><td>834</td><td>tags=24%, list=7%, signal=26%</td></tr><tr><td class='lessen'>58</td><td>AMIT_EGF_RESPONSE_60_HELA</td><td></td><td>39</td><td>-0.51</td><td>-1.43</td><td>0.068</td><td>1.000</td><td>1.000</td><td>1943</td><td>tags=41%, list=17%, signal=50%</td></tr><tr><td class='lessen'>59</td><td>LOPES_METHYLATED_IN_COLON_CANCER_DN</td><td></td><td>22</td><td>-0.57</td><td>-1.42</td><td>0.062</td><td>1.000</td><td>1.000</td><td>2752</td><td>tags=55%, list=25%, signal=72%</td></tr><tr><td class='lessen'>60</td><td>TRAYNOR_RETT_SYNDROM_UP</td><td></td><td>32</td><td>-0.52</td><td>-1.42</td><td>0.062</td><td>1.000</td><td>1.000</td><td>1653</td><td>tags=31%, list=15%, signal=37%</td></tr><tr><td class='lessen'>61</td><td>SU_SALIVARY_GLAND</td><td></td><td>6</td><td>-0.76</td><td>-1.42</td><td>0.091</td><td>1.000</td><td>1.000</td><td>562</td><td>tags=50%, list=5%, signal=53%</td></tr><tr><td class='lessen'>62</td><td>MIKKELSEN_DEDIFFERENTIATED_STATE_UP</td><td></td><td>6</td><td>-0.74</td><td>-1.41</td><td>0.114</td><td>1.000</td><td>1.000</td><td>273</td><td>tags=17%, list=2%, signal=17%</td></tr><tr><td class='lessen'>63</td><td>PLASARI_NFIC_TARGETS_BASAL_DN</td><td></td><td>18</td><td>-0.58</td><td>-1.41</td><td>0.066</td><td>1.000</td><td>1.000</td><td>1904</td><td>tags=50%, list=17%, signal=60%</td></tr><tr><td class='lessen'>64</td><td>TOMLINS_METASTASIS_UP</td><td></td><td>12</td><td>-0.65</td><td>-1.41</td><td>0.068</td><td>1.000</td><td>1.000</td><td>857</td><td>tags=25%, list=8%, signal=27%</td></tr><tr><td class='lessen'>65</td><td>JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_UP</td><td></td><td>7</td><td>-0.74</td><td>-1.41</td><td>0.117</td><td>1.000</td><td>1.000</td><td>1034</td><td>tags=43%, list=9%, signal=47%</td></tr><tr><td class='lessen'>66</td><td>KOBAYASHI_EGFR_SIGNALING_6HR_UP</td><td></td><td>6</td><td>-0.76</td><td>-1.41</td><td>0.087</td><td>1.000</td><td>1.000</td><td>856</td><td>tags=50%, list=8%, signal=54%</td></tr><tr><td class='lessen'>67</td><td>RODWELL_AGING_KIDNEY_NO_BLOOD_DN</td><td></td><td>116</td><td>-0.41</td><td>-1.41</td><td>0.017</td><td>1.000</td><td>1.000</td><td>1860</td><td>tags=34%, list=17%, signal=40%</td></tr><tr><td class='lessen'>68</td><td>KRISHNAN_FURIN_TARGETS_DN</td><td></td><td>6</td><td>-0.76</td><td>-1.40</td><td>0.094</td><td>1.000</td><td>1.000</td><td>2104</td><td>tags=67%, list=19%, signal=82%</td></tr><tr><td class='lessen'>69</td><td>MOOTHA_FFA_OXYDATION</td><td></td><td>19</td><td>-0.58</td><td>-1.40</td><td>0.085</td><td>1.000</td><td>1.000</td><td>3841</td><td>tags=63%, list=35%, signal=96%</td></tr><tr><td class='lessen'>70</td><td>JISON_SICKLE_CELL_DISEASE_DN</td><td></td><td>135</td><td>-0.40</td><td>-1.39</td><td>0.013</td><td>1.000</td><td>1.000</td><td>1948</td><td>tags=28%, list=17%, signal=34%</td></tr><tr><td class='lessen'>71</td><td>HESSON_TUMOR_SUPPRESSOR_CLUSTER_3P21_3</td><td></td><td>5</td><td>-0.77</td><td>-1.39</td><td>0.090</td><td>1.000</td><td>1.000</td><td>24</td><td>tags=20%, list=0%, signal=20%</td></tr><tr><td class='lessen'>72</td><td>DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN</td><td></td><td>67</td><td>-0.45</td><td>-1.39</td><td>0.036</td><td>1.000</td><td>1.000</td><td>3700</td><td>tags=57%, list=33%, signal=84%</td></tr><tr><td class='lessen'>73</td><td>MIKKELSEN_IPS_LCP_WITH_H3K27ME3</td><td></td><td>5</td><td>-0.77</td><td>-1.39</td><td>0.105</td><td>1.000</td><td>1.000</td><td>1361</td><td>tags=60%, list=12%, signal=68%</td></tr><tr><td class='lessen'>74</td><td>LINDVALL_IMMORTALIZED_BY_TERT_DN</td><td></td><td>69</td><td>-0.44</td><td>-1.39</td><td>0.041</td><td>1.000</td><td>1.000</td><td>1065</td><td>tags=17%, list=10%, signal=19%</td></tr><tr><td class='lessen'>75</td><td>KIM_MYCN_AMPLIFICATION_TARGETS_UP</td><td></td><td>70</td><td>-0.45</td><td>-1.38</td><td>0.050</td><td>1.000</td><td>1.000</td><td>1372</td><td>tags=23%, list=12%, signal=26%</td></tr><tr><td class='lessen'>76</td><td>BILANGES_SERUM_SENSITIVE_GENES</td><td></td><td>69</td><td>-0.44</td><td>-1.38</td><td>0.046</td><td>1.000</td><td>1.000</td><td>641</td><td>tags=13%, list=6%, signal=14%</td></tr><tr><td class='lessen'>77</td><td>ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_UP</td><td></td><td>10</td><td>-0.65</td><td>-1.38</td><td>0.108</td><td>1.000</td><td>1.000</td><td>1040</td><td>tags=30%, list=9%, signal=33%</td></tr><tr><td class='lessen'>78</td><td>MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_DN</td><td></td><td>9</td><td>-0.68</td><td>-1.38</td><td>0.114</td><td>1.000</td><td>1.000</td><td>851</td><td>tags=33%, list=8%, signal=36%</td></tr><tr><td class='lessen'>79</td><td>HATADA_METHYLATED_IN_LUNG_CANCER_UP</td><td></td><td>227</td><td>-0.37</td><td>-1.38</td><td>0.008</td><td>1.000</td><td>1.000</td><td>1224</td><td>tags=19%, list=11%, signal=21%</td></tr><tr><td class='lessen'>80</td><td>YANG_BREAST_CANCER_ESR1_LASER_DN</td><td></td><td>42</td><td>-0.48</td><td>-1.37</td><td>0.062</td><td>1.000</td><td>1.000</td><td>1790</td><td>tags=26%, list=16%, signal=31%</td></tr><tr><td class='lessen'>81</td><td>TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN</td><td></td><td>66</td><td>-0.45</td><td>-1.37</td><td>0.055</td><td>1.000</td><td>1.000</td><td>622</td><td>tags=20%, list=6%, signal=21%</td></tr><tr><td class='lessen'>82</td><td>HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN</td><td></td><td>18</td><td>-0.58</td><td>-1.37</td><td>0.111</td><td>1.000</td><td>1.000</td><td>1626</td><td>tags=33%, list=15%, signal=39%</td></tr><tr><td class='lessen'>83</td><td>TAGHAVI_NEOPLASTIC_TRANSFORMATION</td><td></td><td>10</td><td>-0.66</td><td>-1.37</td><td>0.114</td><td>1.000</td><td>1.000</td><td>666</td><td>tags=20%, list=6%, signal=21%</td></tr><tr><td class='lessen'>84</td><td>MEISSNER_BRAIN_HCP_WITH_H3K27ME3</td><td></td><td>115</td><td>-0.40</td><td>-1.37</td><td>0.032</td><td>1.000</td><td>1.000</td><td>937</td><td>tags=22%, list=8%, signal=23%</td></tr><tr><td class='lessen'>85</td><td>LANDEMAINE_LUNG_METASTASIS</td><td></td><td>13</td><td>-0.61</td><td>-1.37</td><td>0.126</td><td>1.000</td><td>1.000</td><td>2811</td><td>tags=69%, list=25%, signal=93%</td></tr><tr><td class='lessen'>86</td><td>MAINA_VHL_TARGETS_UP</td><td></td><td>7</td><td>-0.72</td><td>-1.37</td><td>0.119</td><td>1.000</td><td>1.000</td><td>851</td><td>tags=29%, list=8%, signal=31%</td></tr><tr><td class='lessen'>87</td><td>DE_YY1_TARGETS_UP</td><td></td><td>10</td><td>-0.66</td><td>-1.37</td><td>0.115</td><td>1.000</td><td>1.000</td><td>246</td><td>tags=20%, list=2%, signal=20%</td></tr><tr><td class='lessen'>88</td><td>KIM_GERMINAL_CENTER_T_HELPER_DN</td><td></td><td>16</td><td>-0.58</td><td>-1.37</td><td>0.086</td><td>1.000</td><td>1.000</td><td>1816</td><td>tags=38%, list=16%, signal=45%</td></tr><tr><td class='lessen'>89</td><td>KIM_MYCL1_AMPLIFICATION_TARGETS_DN</td><td></td><td>17</td><td>-0.57</td><td>-1.36</td><td>0.127</td><td>1.000</td><td>1.000</td><td>1002</td><td>tags=18%, list=9%, signal=19%</td></tr><tr><td class='lessen'>90</td><td>ZWANG_EGF_PERSISTENTLY_UP</td><td></td><td>20</td><td>-0.54</td><td>-1.36</td><td>0.111</td><td>1.000</td><td>1.000</td><td>1081</td><td>tags=20%, list=10%, signal=22%</td></tr><tr><td class='lessen'>91</td><td>IKEDA_MIR30_TARGETS_DN</td><td></td><td>21</td><td>-0.55</td><td>-1.36</td><td>0.126</td><td>1.000</td><td>1.000</td><td>2195</td><td>tags=38%, list=20%, signal=47%</td></tr><tr><td class='lessen'>92</td><td>DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2</td><td></td><td>100</td><td>-0.41</td><td>-1.36</td><td>0.034</td><td>1.000</td><td>1.000</td><td>870</td><td>tags=11%, list=8%, signal=12%</td></tr><tr><td class='lessen'>93</td><td>OKAWA_NEUROBLASTOMA_1P36_31_DELETION</td><td></td><td>20</td><td>-0.56</td><td>-1.36</td><td>0.090</td><td>1.000</td><td>1.000</td><td>1784</td><td>tags=40%, list=16%, signal=48%</td></tr><tr><td class='lessen'>94</td><td>HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN</td><td></td><td>21</td><td>-0.54</td><td>-1.36</td><td>0.108</td><td>1.000</td><td>1.000</td><td>564</td><td>tags=24%, list=5%, signal=25%</td></tr><tr><td class='lessen'>95</td><td>VALK_AML_CLUSTER_13</td><td></td><td>20</td><td>-0.55</td><td>-1.36</td><td>0.122</td><td>1.000</td><td>1.000</td><td>1218</td><td>tags=20%, list=11%, signal=22%</td></tr><tr><td class='lessen'>96</td><td>MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED</td><td></td><td>98</td><td>-0.41</td><td>-1.35</td><td>0.036</td><td>1.000</td><td>1.000</td><td>801</td><td>tags=23%, list=7%, signal=25%</td></tr><tr><td class='lessen'>97</td><td>GALIE_TUMOR_STEMNESS_GENES</td><td></td><td>6</td><td>-0.74</td><td>-1.35</td><td>0.105</td><td>1.000</td><td>1.000</td><td>114</td><td>tags=17%, list=1%, signal=17%</td></tr><tr><td class='lessen'>98</td><td>MELLMAN_TUT1_TARGETS_DN</td><td></td><td>42</td><td>-0.48</td><td>-1.35</td><td>0.069</td><td>1.000</td><td>1.000</td><td>2384</td><td>tags=43%, list=21%, signal=54%</td></tr><tr><td class='lessen'>99</td><td>NIKOLSKY_BREAST_CANCER_5P15_AMPLICON</td><td></td><td>17</td><td>-0.57</td><td>-1.35</td><td>0.121</td><td>1.000</td><td>1.000</td><td>214</td><td>tags=18%, list=2%, signal=18%</td></tr><tr><td class='lessen'>100</td><td>WANG_RECURRENT_LIVER_CANCER_DN</td><td></td><td>14</td><td>-0.60</td><td>-1.35</td><td>0.109</td><td>1.000</td><td>1.000</td><td>2180</td><td>tags=50%, list=20%, signal=62%</td></tr><tr><td class='lessen'>101</td><td>RICKMAN_HEAD_AND_NECK_CANCER_F</td><td></td><td>32</td><td>-0.49</td><td>-1.35</td><td>0.083</td><td>1.000</td><td>1.000</td><td>1145</td><td>tags=34%, list=10%, signal=38%</td></tr><tr><td class='lessen'>102</td><td>ASTON_MAJOR_DEPRESSIVE_DISORDER_UP</td><td></td><td>36</td><td>-0.49</td><td>-1.35</td><td>0.106</td><td>1.000</td><td>1.000</td><td>995</td><td>tags=19%, list=9%, signal=21%</td></tr><tr><td class='lessen'>103</td><td>MIKKELSEN_MEF_ICP_WITH_H3K27ME3</td><td></td><td>97</td><td>-0.40</td><td>-1.34</td><td>0.036</td><td>1.000</td><td>1.000</td><td>722</td><td>tags=16%, list=6%, signal=17%</td></tr><tr><td class='lessen'>104</td><td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP</td><td></td><td>17</td><td>-0.58</td><td>-1.34</td><td>0.127</td><td>1.000</td><td>1.000</td><td>1105</td><td>tags=29%, list=10%, signal=33%</td></tr><tr><td class='lessen'>105</td><td>SANDERSON_PPARA_TARGETS</td><td></td><td>14</td><td>-0.59</td><td>-1.34</td><td>0.146</td><td>1.000</td><td>1.000</td><td>3512</td><td>tags=71%, list=32%, signal=104%</td></tr><tr><td class='lessen'>106</td><td>FINETTI_BREAST_CANCERS_KINOME_GRAY</td><td></td><td>13</td><td>-0.59</td><td>-1.33</td><td>0.136</td><td>1.000</td><td>1.000</td><td>3521</td><td>tags=69%, list=32%, signal=101%</td></tr><tr><td class='lessen'>107</td><td>SU_KIDNEY</td><td></td><td>6</td><td>-0.72</td><td>-1.33</td><td>0.165</td><td>1.000</td><td>1.000</td><td>2633</td><td>tags=67%, list=24%, signal=87%</td></tr><tr><td class='lessen'>108</td><td>GHO_ATF5_TARGETS_UP</td><td></td><td>9</td><td>-0.64</td><td>-1.33</td><td>0.159</td><td>1.000</td><td>1.000</td><td>3446</td><td>tags=78%, list=31%, signal=113%</td></tr><tr><td class='lessen'>109</td><td>SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP</td><td></td><td>25</td><td>-0.51</td><td>-1.32</td><td>0.117</td><td>1.000</td><td>1.000</td><td>1502</td><td>tags=28%, list=13%, signal=32%</td></tr><tr><td class='lessen'>110</td><td>LAIHO_COLORECTAL_CANCER_SERRATED_DN</td><td></td><td>61</td><td>-0.43</td><td>-1.32</td><td>0.063</td><td>1.000</td><td>1.000</td><td>2693</td><td>tags=36%, list=24%, signal=47%</td></tr><tr><td class='lessen'>111</td><td>NEWMAN_ERCC6_TARGETS_DN</td><td></td><td>24</td><td>-0.52</td><td>-1.32</td><td>0.122</td><td>1.000</td><td>1.000</td><td>1094</td><td>tags=38%, list=10%, signal=41%</td></tr><tr><td class='lessen'>112</td><td>ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_DN</td><td></td><td>229</td><td>-0.36</td><td>-1.32</td><td>0.016</td><td>1.000</td><td>1.000</td><td>1351</td><td>tags=21%, list=12%, signal=23%</td></tr><tr><td class='lessen'>113</td><td>WHITE_NEUROBLASTOMA_WITH_1P36.3_DELETION</td><td></td><td>19</td><td>-0.54</td><td>-1.32</td><td>0.133</td><td>1.000</td><td>1.000</td><td>1784</td><td>tags=37%, list=16%, signal=44%</td></tr><tr><td class='lessen'>114</td><td>BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN</td><td></td><td>28</td><td>-0.50</td><td>-1.32</td><td>0.123</td><td>1.000</td><td>1.000</td><td>1889</td><td>tags=32%, list=17%, signal=39%</td></tr><tr><td class='lessen'>115</td><td>GOERING_BLOOD_HDL_CHOLESTEROL_QTL_TRANS</td><td></td><td>7</td><td>-0.69</td><td>-1.32</td><td>0.173</td><td>1.000</td><td>1.000</td><td>182</td><td>tags=14%, list=2%, signal=15%</td></tr><tr><td class='lessen'>116</td><td>DORN_ADENOVIRUS_INFECTION_32HR_DN</td><td></td><td>32</td><td>-0.48</td><td>-1.31</td><td>0.122</td><td>1.000</td><td>1.000</td><td>1171</td><td>tags=25%, list=11%, signal=28%</td></tr><tr><td class='lessen'>117</td><td>MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP</td><td></td><td>14</td><td>-0.58</td><td>-1.31</td><td>0.180</td><td>1.000</td><td>1.000</td><td>2509</td><td>tags=43%, list=23%, signal=55%</td></tr><tr><td class='lessen'>118</td><td>MIKKELSEN_NPC_HCP_WITH_H3K27ME3</td><td></td><td>160</td><td>-0.37</td><td>-1.31</td><td>0.040</td><td>1.000</td><td>1.000</td><td>708</td><td>tags=17%, list=6%, signal=18%</td></tr><tr><td class='lessen'>119</td><td>LIU_CDX2_TARGETS_UP</td><td></td><td>25</td><td>-0.51</td><td>-1.30</td><td>0.143</td><td>1.000</td><td>1.000</td><td>523</td><td>tags=28%, list=5%, signal=29%</td></tr><tr><td class='lessen'>120</td><td>WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN</td><td></td><td>21</td><td>-0.52</td><td>-1.30</td><td>0.137</td><td>1.000</td><td>1.000</td><td>805</td><td>tags=19%, list=7%, signal=20%</td></tr><tr><td class='lessen'>121</td><td>CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2</td><td></td><td>231</td><td>-0.36</td><td>-1.30</td><td>0.027</td><td>1.000</td><td>1.000</td><td>1403</td><td>tags=21%, list=13%, signal=24%</td></tr><tr><td class='lessen'>122</td><td>SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP</td><td></td><td>12</td><td>-0.61</td><td>-1.30</td><td>0.155</td><td>1.000</td><td>1.000</td><td>3470</td><td>tags=58%, list=31%, signal=85%</td></tr><tr><td class='lessen'>123</td><td>SMID_BREAST_CANCER_RELAPSE_IN_LIVER_UP</td><td></td><td>6</td><td>-0.69</td><td>-1.30</td><td>0.184</td><td>1.000</td><td>1.000</td><td>260</td><td>tags=33%, list=2%, signal=34%</td></tr><tr><td class='lessen'>124</td><td>NOUSHMEHR_GBM_SILENCED_BY_METHYLATION</td><td></td><td>32</td><td>-0.48</td><td>-1.30</td><td>0.127</td><td>1.000</td><td>1.000</td><td>185</td><td>tags=13%, list=2%, signal=13%</td></tr><tr><td class='lessen'>125</td><td>HUNSBERGER_EXERCISE_REGULATED_GENES</td><td></td><td>23</td><td>-0.52</td><td>-1.30</td><td>0.153</td><td>1.000</td><td>1.000</td><td>632</td><td>tags=17%, list=6%, signal=18%</td></tr><tr><td class='lessen'>126</td><td>AMIT_DELAYED_EARLY_GENES</td><td></td><td>17</td><td>-0.54</td><td>-1.30</td><td>0.152</td><td>1.000</td><td>1.000</td><td>1526</td><td>tags=47%, list=14%, signal=54%</td></tr><tr><td class='lessen'>127</td><td>MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3</td><td></td><td>79</td><td>-0.40</td><td>-1.29</td><td>0.084</td><td>1.000</td><td>1.000</td><td>1202</td><td>tags=20%, list=11%, signal=23%</td></tr><tr><td class='lessen'>128</td><td>BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN</td><td></td><td>130</td><td>-0.38</td><td>-1.29</td><td>0.050</td><td>1.000</td><td>1.000</td><td>1168</td><td>tags=15%, list=10%, signal=16%</td></tr><tr><td class='lessen'>129</td><td>CHEN_HOXA5_TARGETS_6HR_UP</td><td></td><td>8</td><td>-0.65</td><td>-1.29</td><td>0.198</td><td>1.000</td><td>1.000</td><td>2426</td><td>tags=63%, list=22%, signal=80%</td></tr><tr><td class='lessen'>130</td><td>BILANGES_RAPAMYCIN_SENSITIVE_GENES</td><td></td><td>32</td><td>-0.47</td><td>-1.29</td><td>0.140</td><td>1.000</td><td>1.000</td><td>1661</td><td>tags=25%, list=15%, signal=29%</td></tr><tr><td class='lessen'>131</td><td>BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN</td><td></td><td>44</td><td>-0.45</td><td>-1.28</td><td>0.108</td><td>1.000</td><td>1.000</td><td>1401</td><td>tags=23%, list=13%, signal=26%</td></tr><tr><td class='lessen'>132</td><td>LOPEZ_MESOTELIOMA_SURVIVAL_TIME_DN</td><td></td><td>7</td><td>-0.66</td><td>-1.28</td><td>0.207</td><td>1.000</td><td>1.000</td><td>2436</td><td>tags=71%, list=22%, signal=91%</td></tr><tr><td class='lessen'>133</td><td>SU_PLACENTA</td><td></td><td>15</td><td>-0.56</td><td>-1.28</td><td>0.168</td><td>1.000</td><td>1.000</td><td>94</td><td>tags=13%, list=1%, signal=13%</td></tr><tr><td class='lessen'>134</td><td>ZHENG_IL22_SIGNALING_UP</td><td></td><td>40</td><td>-0.45</td><td>-1.28</td><td>0.124</td><td>1.000</td><td>1.000</td><td>1018</td><td>tags=23%, list=9%, signal=25%</td></tr><tr><td class='lessen'>135</td><td>ZHAN_MULTIPLE_MYELOMA_MF_DN</td><td></td><td>26</td><td>-0.48</td><td>-1.28</td><td>0.155</td><td>1.000</td><td>1.000</td><td>1635</td><td>tags=35%, list=15%, signal=40%</td></tr><tr><td class='lessen'>136</td><td>PETRETTO_CARDIAC_HYPERTROPHY</td><td></td><td>30</td><td>-0.48</td><td>-1.28</td><td>0.143</td><td>1.000</td><td>1.000</td><td>1918</td><td>tags=30%, list=17%, signal=36%</td></tr><tr><td class='lessen'>137</td><td>TIAN_TNF_SIGNALING_NOT_VIA_NFKB</td><td></td><td>21</td><td>-0.51</td><td>-1.28</td><td>0.170</td><td>1.000</td><td>1.000</td><td>2426</td><td>tags=52%, list=22%, signal=67%</td></tr><tr><td class='lessen'>138</td><td>DORN_ADENOVIRUS_INFECTION_48HR_DN</td><td></td><td>32</td><td>-0.48</td><td>-1.28</td><td>0.148</td><td>1.000</td><td>1.000</td><td>1171</td><td>tags=25%, list=11%, signal=28%</td></tr><tr><td class='lessen'>139</td><td>RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP</td><td></td><td>97</td><td>-0.39</td><td>-1.28</td><td>0.080</td><td>1.000</td><td>1.000</td><td>737</td><td>tags=9%, list=7%, signal=10%</td></tr><tr><td class='lessen'>140</td><td>DAIRKEE_CANCER_PRONE_RESPONSE_BPA</td><td></td><td>41</td><td>-0.45</td><td>-1.28</td><td>0.151</td><td>1.000</td><td>1.000</td><td>2921</td><td>tags=46%, list=26%, signal=63%</td></tr><tr><td class='lessen'>141</td><td>MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED</td><td></td><td>39</td><td>-0.45</td><td>-1.28</td><td>0.130</td><td>1.000</td><td>1.000</td><td>1283</td><td>tags=38%, list=12%, signal=43%</td></tr><tr><td class='lessen'>142</td><td>MIKKELSEN_NPC_ICP_WITH_H3K4ME3</td><td></td><td>320</td><td>-0.34</td><td>-1.28</td><td>0.016</td><td>1.000</td><td>1.000</td><td>1444</td><td>tags=19%, list=13%, signal=21%</td></tr><tr><td class='lessen'>143</td><td>VERHAAK_GLIOBLASTOMA_PRONEURAL</td><td></td><td>111</td><td>-0.38</td><td>-1.27</td><td>0.073</td><td>1.000</td><td>1.000</td><td>1195</td><td>tags=20%, list=11%, signal=22%</td></tr><tr><td class='lessen'>144</td><td>YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_DN</td><td></td><td>44</td><td>-0.44</td><td>-1.27</td><td>0.138</td><td>1.000</td><td>1.000</td><td>2770</td><td>tags=36%, list=25%, signal=48%</td></tr><tr><td class='lessen'>145</td><td>VECCHI_GASTRIC_CANCER_EARLY_DN</td><td></td><td>243</td><td>-0.34</td><td>-1.27</td><td>0.035</td><td>1.000</td><td>1.000</td><td>1013</td><td>tags=18%, list=9%, signal=19%</td></tr><tr><td class='lessen'>146</td><td>URS_ADIPOCYTE_DIFFERENTIATION_UP</td><td></td><td>62</td><td>-0.42</td><td>-1.27</td><td>0.121</td><td>1.000</td><td>1.000</td><td>1390</td><td>tags=21%, list=12%, signal=24%</td></tr><tr><td class='lessen'>147</td><td>MARKS_ACETYLATED_NON_HISTONE_PROTEINS</td><td></td><td>12</td><td>-0.59</td><td>-1.27</td><td>0.171</td><td>1.000</td><td>1.000</td><td>2784</td><td>tags=58%, list=25%, signal=78%</td></tr><tr><td class='lessen'>148</td><td>HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR</td><td></td><td>30</td><td>-0.47</td><td>-1.27</td><td>0.165</td><td>1.000</td><td>1.000</td><td>1164</td><td>tags=20%, list=10%, signal=22%</td></tr><tr><td class='lessen'>149</td><td>PYEON_HPV_POSITIVE_TUMORS_UP</td><td></td><td>60</td><td>-0.41</td><td>-1.27</td><td>0.116</td><td>1.000</td><td>1.000</td><td>1340</td><td>tags=25%, list=12%, signal=28%</td></tr><tr><td class='lessen'>150</td><td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_9</td><td></td><td>7</td><td>-0.65</td><td>-1.26</td><td>0.230</td><td>1.000</td><td>1.000</td><td>1672</td><td>tags=57%, list=15%, signal=67%</td></tr><tr><td class='lessen'>151</td><td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP</td><td></td><td>159</td><td>-0.36</td><td>-1.26</td><td>0.061</td><td>1.000</td><td>1.000</td><td>824</td><td>tags=16%, list=7%, signal=17%</td></tr><tr><td class='lessen'>152</td><td>SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP</td><td></td><td>22</td><td>-0.51</td><td>-1.26</td><td>0.181</td><td>1.000</td><td>1.000</td><td>2286</td><td>tags=36%, list=21%, signal=46%</td></tr><tr><td class='lessen'>153</td><td>MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3</td><td></td><td>84</td><td>-0.39</td><td>-1.26</td><td>0.112</td><td>1.000</td><td>1.000</td><td>417</td><td>tags=12%, list=4%, signal=12%</td></tr><tr><td class='lessen'>154</td><td>LIU_TOPBP1_TARGETS</td><td></td><td>9</td><td>-0.61</td><td>-1.25</td><td>0.219</td><td>1.000</td><td>1.000</td><td>496</td><td>tags=22%, list=4%, signal=23%</td></tr><tr><td class='lessen'>155</td><td>LA_MEN1_TARGETS</td><td></td><td>20</td><td>-0.51</td><td>-1.25</td><td>0.206</td><td>1.000</td><td>1.000</td><td>678</td><td>tags=20%, list=6%, signal=21%</td></tr><tr><td class='lessen'>156</td><td>LIN_NPAS4_TARGETS_DN</td><td></td><td>46</td><td>-0.43</td><td>-1.25</td><td>0.149</td><td>1.000</td><td>1.000</td><td>1216</td><td>tags=24%, list=11%, signal=27%</td></tr><tr><td class='lessen'>157</td><td>BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_DN</td><td></td><td>16</td><td>-0.54</td><td>-1.25</td><td>0.196</td><td>1.000</td><td>1.000</td><td>2037</td><td>tags=44%, list=18%, signal=53%</td></tr><tr><td class='lessen'>158</td><td>SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP</td><td></td><td>57</td><td>-0.42</td><td>-1.25</td><td>0.139</td><td>1.000</td><td>1.000</td><td>1568</td><td>tags=25%, list=14%, signal=28%</td></tr><tr><td class='lessen'>159</td><td>COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP</td><td></td><td>25</td><td>-0.49</td><td>-1.25</td><td>0.160</td><td>1.000</td><td>1.000</td><td>841</td><td>tags=20%, list=8%, signal=22%</td></tr><tr><td class='lessen'>160</td><td>STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP</td><td></td><td>31</td><td>-0.47</td><td>-1.25</td><td>0.147</td><td>1.000</td><td>1.000</td><td>1353</td><td>tags=26%, list=12%, signal=29%</td></tr><tr><td class='lessen'>161</td><td>MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP</td><td></td><td>38</td><td>-0.44</td><td>-1.25</td><td>0.133</td><td>1.000</td><td>1.000</td><td>2839</td><td>tags=37%, list=26%, signal=49%</td></tr><tr><td class='lessen'>162</td><td>SUZUKI_RESPONSE_TO_TSA</td><td></td><td>14</td><td>-0.56</td><td>-1.25</td><td>0.178</td><td>1.000</td><td>1.000</td><td>2990</td><td>tags=50%, list=27%, signal=68%</td></tr><tr><td class='lessen'>163</td><td>SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_DN</td><td></td><td>6</td><td>-0.67</td><td>-1.24</td><td>0.238</td><td>1.000</td><td>1.000</td><td>445</td><td>tags=17%, list=4%, signal=17%</td></tr><tr><td class='lessen'>164</td><td>KAPOSI_LIVER_CANCER_MET_DN</td><td></td><td>6</td><td>-0.65</td><td>-1.24</td><td>0.244</td><td>1.000</td><td>1.000</td><td>1831</td><td>tags=50%, list=16%, signal=60%</td></tr><tr><td class='lessen'>165</td><td>SASSON_RESPONSE_TO_FORSKOLIN_DN</td><td></td><td>78</td><td>-0.38</td><td>-1.24</td><td>0.117</td><td>1.000</td><td>1.000</td><td>1094</td><td>tags=13%, list=10%, signal=14%</td></tr><tr><td class='lessen'>166</td><td>CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP</td><td></td><td>80</td><td>-0.38</td><td>-1.24</td><td>0.106</td><td>1.000</td><td>1.000</td><td>1526</td><td>tags=24%, list=14%, signal=27%</td></tr><tr><td class='lessen'>167</td><td>YOKOE_CANCER_TESTIS_ANTIGENS</td><td></td><td>22</td><td>-0.50</td><td>-1.24</td><td>0.214</td><td>1.000</td><td>1.000</td><td>522</td><td>tags=18%, list=5%, signal=19%</td></tr><tr><td class='lessen'>168</td><td>MAHAJAN_RESPONSE_TO_IL1A_DN</td><td></td><td>60</td><td>-0.41</td><td>-1.24</td><td>0.151</td><td>1.000</td><td>1.000</td><td>2765</td><td>tags=42%, list=25%, signal=55%</td></tr><tr><td class='lessen'>169</td><td>MOTAMED_RESPONSE_TO_ANDROGEN_DN</td><td></td><td>5</td><td>-0.70</td><td>-1.23</td><td>0.248</td><td>1.000</td><td>1.000</td><td>2189</td><td>tags=60%, list=20%, signal=75%</td></tr><tr><td class='lessen'>170</td><td>HOLLEMAN_DAUNORUBICIN_ALL_DN</td><td></td><td>6</td><td>-0.66</td><td>-1.23</td><td>0.268</td><td>1.000</td><td>1.000</td><td>782</td><td>tags=33%, list=7%, signal=36%</td></tr><tr><td class='lessen'>171</td><td>GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN</td><td></td><td>46</td><td>-0.42</td><td>-1.23</td><td>0.150</td><td>1.000</td><td>1.000</td><td>1106</td><td>tags=17%, list=10%, signal=19%</td></tr><tr><td class='lessen'>172</td><td>JOHNSTONE_PARVB_TARGETS_1_DN</td><td></td><td>37</td><td>-0.44</td><td>-1.23</td><td>0.158</td><td>1.000</td><td>1.000</td><td>1244</td><td>tags=22%, list=11%, signal=24%</td></tr><tr><td class='lessen'>173</td><td>GHANDHI_DIRECT_IRRADIATION_UP</td><td></td><td>69</td><td>-0.39</td><td>-1.23</td><td>0.133</td><td>1.000</td><td>1.000</td><td>1131</td><td>tags=20%, list=10%, signal=22%</td></tr><tr><td class='lessen'>174</td><td>CASTELLANO_HRAS_AND_NRAS_TARGETS_DN</td><td></td><td>7</td><td>-0.64</td><td>-1.22</td><td>0.262</td><td>1.000</td><td>1.000</td><td>323</td><td>tags=14%, list=3%, signal=15%</td></tr><tr><td class='lessen'>175</td><td>RODWELL_AGING_KIDNEY_DN</td><td></td><td>109</td><td>-0.37</td><td>-1.21</td><td>0.111</td><td>1.000</td><td>1.000</td><td>1929</td><td>tags=34%, list=17%, signal=41%</td></tr><tr><td class='lessen'>176</td><td>SASSON_RESPONSE_TO_GONADOTROPHINS_DN</td><td></td><td>77</td><td>-0.38</td><td>-1.21</td><td>0.144</td><td>1.000</td><td>1.000</td><td>1144</td><td>tags=14%, list=10%, signal=16%</td></tr><tr><td class='lessen'>177</td><td>LEIN_LOCALIZED_TO_DISTAL_AND_PROXIMAL_DENDRITES</td><td></td><td>12</td><td>-0.56</td><td>-1.21</td><td>0.224</td><td>1.000</td><td>1.000</td><td>2086</td><td>tags=50%, list=19%, signal=61%</td></tr><tr><td class='lessen'>178</td><td>GERHOLD_ADIPOGENESIS_UP</td><td></td><td>45</td><td>-0.42</td><td>-1.20</td><td>0.186</td><td>1.000</td><td>1.000</td><td>2281</td><td>tags=33%, list=20%, signal=42%</td></tr><tr><td class='lessen'>179</td><td>GRANDVAUX_IRF3_TARGETS_DN</td><td></td><td>15</td><td>-0.52</td><td>-1.20</td><td>0.227</td><td>1.000</td><td>1.000</td><td>3516</td><td>tags=53%, list=32%, signal=78%</td></tr><tr><td class='lessen'>180</td><td>SCHMAHL_PDGF_SIGNALING</td><td></td><td>7</td><td>-0.62</td><td>-1.20</td><td>0.260</td><td>1.000</td><td>1.000</td><td>3322</td><td>tags=71%, list=30%, signal=102%</td></tr><tr><td class='lessen'>181</td><td>PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN</td><td></td><td>105</td><td>-0.36</td><td>-1.20</td><td>0.129</td><td>1.000</td><td>1.000</td><td>2452</td><td>tags=38%, list=22%, signal=48%</td></tr><tr><td class='lessen'>182</td><td>MURAKAMI_UV_RESPONSE_24HR</td><td></td><td>14</td><td>-0.53</td><td>-1.19</td><td>0.261</td><td>1.000</td><td>1.000</td><td>563</td><td>tags=21%, list=5%, signal=23%</td></tr><tr><td class='lessen'>183</td><td>NADERI_BREAST_CANCER_PROGNOSIS_DN</td><td></td><td>15</td><td>-0.52</td><td>-1.19</td><td>0.230</td><td>1.000</td><td>1.000</td><td>994</td><td>tags=27%, list=9%, signal=29%</td></tr><tr><td class='lessen'>184</td><td>HOLLEMAN_DAUNORUBICIN_B_ALL_UP</td><td></td><td>9</td><td>-0.58</td><td>-1.19</td><td>0.264</td><td>1.000</td><td>1.000</td><td>878</td><td>tags=22%, list=8%, signal=24%</td></tr><tr><td class='lessen'>185</td><td>PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP</td><td></td><td>130</td><td>-0.35</td><td>-1.19</td><td>0.122</td><td>1.000</td><td>1.000</td><td>2133</td><td>tags=29%, list=19%, signal=36%</td></tr><tr><td class='lessen'>186</td><td>BOQUEST_STEM_CELL_UP</td><td></td><td>214</td><td>-0.32</td><td>-1.19</td><td>0.097</td><td>1.000</td><td>1.000</td><td>1010</td><td>tags=15%, list=9%, signal=17%</td></tr><tr><td class='lessen'>187</td><td>MONTERO_THYROID_CANCER_POOR_SURVIVAL_DN</td><td></td><td>7</td><td>-0.62</td><td>-1.19</td><td>0.296</td><td>1.000</td><td>1.000</td><td>600</td><td>tags=14%, list=5%, signal=15%</td></tr><tr><td class='lessen'>188</td><td>HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_UP</td><td></td><td>10</td><td>-0.57</td><td>-1.19</td><td>0.276</td><td>1.000</td><td>1.000</td><td>3394</td><td>tags=60%, list=30%, signal=86%</td></tr><tr><td class='lessen'>189</td><td>GENTILE_UV_HIGH_DOSE_UP</td><td></td><td>20</td><td>-0.48</td><td>-1.19</td><td>0.239</td><td>1.000</td><td>1.000</td><td>778</td><td>tags=25%, list=7%, signal=27%</td></tr><tr><td class='lessen'>190</td><td>BOYAULT_LIVER_CANCER_SUBCLASS_G2</td><td></td><td>24</td><td>-0.47</td><td>-1.19</td><td>0.223</td><td>1.000</td><td>1.000</td><td>1081</td><td>tags=21%, list=10%, signal=23%</td></tr><tr><td class='lessen'>191</td><td>VERRECCHIA_RESPONSE_TO_TGFB1_C4</td><td></td><td>12</td><td>-0.55</td><td>-1.18</td><td>0.232</td><td>1.000</td><td>1.000</td><td>23</td><td>tags=8%, list=0%, signal=8%</td></tr><tr><td class='lessen'>192</td><td>CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN</td><td></td><td>139</td><td>-0.34</td><td>-1.18</td><td>0.112</td><td>1.000</td><td>1.000</td><td>2988</td><td>tags=43%, list=27%, signal=58%</td></tr><tr><td class='lessen'>193</td><td>WANG_LSD1_TARGETS_DN</td><td></td><td>30</td><td>-0.44</td><td>-1.18</td><td>0.221</td><td>1.000</td><td>1.000</td><td>1034</td><td>tags=30%, list=9%, signal=33%</td></tr><tr><td class='lessen'>194</td><td>HOLLEMAN_DAUNORUBICIN_B_ALL_DN</td><td></td><td>10</td><td>-0.55</td><td>-1.18</td><td>0.291</td><td>1.000</td><td>1.000</td><td>782</td><td>tags=20%, list=7%, signal=21%</td></tr><tr><td class='lessen'>195</td><td>EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION</td><td></td><td>40</td><td>-0.42</td><td>-1.18</td><td>0.205</td><td>1.000</td><td>1.000</td><td>531</td><td>tags=15%, list=5%, signal=16%</td></tr><tr><td class='lessen'>196</td><td>COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN</td><td></td><td>24</td><td>-0.46</td><td>-1.18</td><td>0.236</td><td>1.000</td><td>1.000</td><td>599</td><td>tags=13%, list=5%, signal=13%</td></tr><tr><td class='lessen'>197</td><td>MCCABE_HOXC6_TARGETS_CANCER_DN</td><td></td><td>17</td><td>-0.50</td><td>-1.18</td><td>0.252</td><td>1.000</td><td>1.000</td><td>53</td><td>tags=6%, list=0%, signal=6%</td></tr><tr><td class='lessen'>198</td><td>WHITEHURST_PACLITAXEL_SENSITIVITY</td><td></td><td>27</td><td>-0.45</td><td>-1.18</td><td>0.220</td><td>1.000</td><td>1.000</td><td>2425</td><td>tags=33%, list=22%, signal=43%</td></tr><tr><td class='lessen'>199</td><td>DONATO_CELL_CYCLE_TRETINOIN</td><td></td><td>6</td><td>-0.63</td><td>-1.18</td><td>0.312</td><td>1.000</td><td>1.000</td><td>3689</td><td>tags=83%, list=33%, signal=125%</td></tr><tr><td class='lessen'>200</td><td>HOFFMAN_CLOCK_TARGETS_UP</td><td></td><td>8</td><td>-0.59</td><td>-1.18</td><td>0.287</td><td>1.000</td><td>1.000</td><td>2670</td><td>tags=63%, list=24%, signal=82%</td></tr><tr><td class='lessen'>201</td><td>DAIRKEE_TERT_TARGETS_DN</td><td></td><td>82</td><td>-0.37</td><td>-1.18</td><td>0.166</td><td>1.000</td><td>1.000</td><td>1657</td><td>tags=17%, list=15%, signal=20%</td></tr><tr><td class='lessen'>202</td><td>YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN</td><td></td><td>10</td><td>-0.56</td><td>-1.17</td><td>0.310</td><td>1.000</td><td>1.000</td><td>3678</td><td>tags=60%, list=33%, signal=90%</td></tr><tr><td class='lessen'>203</td><td>DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN</td><td></td><td>71</td><td>-0.37</td><td>-1.17</td><td>0.194</td><td>1.000</td><td>1.000</td><td>1633</td><td>tags=20%, list=15%, signal=23%</td></tr><tr><td class='lessen'>204</td><td>BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN</td><td></td><td>17</td><td>-0.50</td><td>-1.17</td><td>0.269</td><td>1.000</td><td>1.000</td><td>1417</td><td>tags=24%, list=13%, signal=27%</td></tr><tr><td class='lessen'>205</td><td>CHASSOT_SKIN_WOUND</td><td></td><td>10</td><td>-0.56</td><td>-1.17</td><td>0.285</td><td>1.000</td><td>1.000</td><td>1382</td><td>tags=50%, list=12%, signal=57%</td></tr><tr><td class='lessen'>206</td><td>STARK_HYPPOCAMPUS_22Q11_DELETION_UP</td><td></td><td>37</td><td>-0.42</td><td>-1.17</td><td>0.199</td><td>1.000</td><td>1.000</td><td>922</td><td>tags=14%, list=8%, signal=15%</td></tr><tr><td class='lessen'>207</td><td>TERAO_AOX4_TARGETS_HG_DN</td><td></td><td>5</td><td>-0.66</td><td>-1.17</td><td>0.343</td><td>1.000</td><td>1.000</td><td>516</td><td>tags=20%, list=5%, signal=21%</td></tr><tr><td class='lessen'>208</td><td>TCGA_GLIOBLASTOMA_COPY_NUMBER_UP</td><td></td><td>56</td><td>-0.39</td><td>-1.17</td><td>0.201</td><td>1.000</td><td>1.000</td><td>87</td><td>tags=5%, list=1%, signal=5%</td></tr><tr><td class='lessen'>209</td><td>ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN</td><td></td><td>40</td><td>-0.41</td><td>-1.17</td><td>0.229</td><td>1.000</td><td>1.000</td><td>1337</td><td>tags=20%, list=12%, signal=23%</td></tr><tr><td class='lessen'>210</td><td>SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP</td><td></td><td>94</td><td>-0.36</td><td>-1.17</td><td>0.178</td><td>1.000</td><td>1.000</td><td>1657</td><td>tags=24%, list=15%, signal=29%</td></tr><tr><td class='lessen'>211</td><td>PIONTEK_PKD1_TARGETS_UP</td><td></td><td>29</td><td>-0.43</td><td>-1.17</td><td>0.237</td><td>1.000</td><td>1.000</td><td>1658</td><td>tags=34%, list=15%, signal=40%</td></tr><tr><td class='lessen'>212</td><td>BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN</td><td></td><td>41</td><td>-0.41</td><td>-1.17</td><td>0.215</td><td>1.000</td><td>1.000</td><td>1213</td><td>tags=17%, list=11%, signal=19%</td></tr><tr><td class='lessen'>213</td><td>GROSS_ELK3_TARGETS_DN</td><td></td><td>26</td><td>-0.45</td><td>-1.17</td><td>0.241</td><td>1.000</td><td>1.000</td><td>1600</td><td>tags=27%, list=14%, signal=31%</td></tr><tr><td class='lessen'>214</td><td>HAEGERSTRAND_RESPONSE_TO_IMATINIB</td><td></td><td>9</td><td>-0.57</td><td>-1.17</td><td>0.303</td><td>1.000</td><td>1.000</td><td>17</td><td>tags=11%, list=0%, signal=11%</td></tr><tr><td class='lessen'>215</td><td>DORN_ADENOVIRUS_INFECTION_12HR_UP</td><td></td><td>25</td><td>-0.45</td><td>-1.17</td><td>0.244</td><td>1.000</td><td>1.000</td><td>1816</td><td>tags=36%, list=16%, signal=43%</td></tr><tr><td class='lessen'>216</td><td>VALK_AML_CLUSTER_2</td><td></td><td>20</td><td>-0.49</td><td>-1.17</td><td>0.267</td><td>1.000</td><td>1.000</td><td>2064</td><td>tags=40%, list=19%, signal=49%</td></tr><tr><td class='lessen'>217</td><td>EGUCHI_CELL_CYCLE_RB1_TARGETS</td><td></td><td>21</td><td>-0.47</td><td>-1.17</td><td>0.282</td><td>1.000</td><td>1.000</td><td>618</td><td>tags=24%, list=6%, signal=25%</td></tr><tr><td class='lessen'>218</td><td>CHANDRAN_METASTASIS_TOP50_UP</td><td></td><td>28</td><td>-0.44</td><td>-1.17</td><td>0.243</td><td>1.000</td><td>1.000</td><td>2576</td><td>tags=50%, list=23%, signal=65%</td></tr><tr><td class='lessen'>219</td><td>RUIZ_TNC_TARGETS_UP</td><td></td><td>127</td><td>-0.34</td><td>-1.17</td><td>0.151</td><td>1.000</td><td>1.000</td><td>1874</td><td>tags=25%, list=17%, signal=30%</td></tr><tr><td class='lessen'>220</td><td>ZHOU_TNF_SIGNALING_30MIN</td><td></td><td>45</td><td>-0.40</td><td>-1.16</td><td>0.229</td><td>1.000</td><td>1.000</td><td>1489</td><td>tags=24%, list=13%, signal=28%</td></tr><tr><td class='lessen'>221</td><td>SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN</td><td></td><td>13</td><td>-0.52</td><td>-1.16</td><td>0.277</td><td>1.000</td><td>1.000</td><td>1597</td><td>tags=46%, list=14%, signal=54%</td></tr><tr><td class='lessen'>222</td><td>SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN</td><td></td><td>182</td><td>-0.32</td><td>-1.16</td><td>0.118</td><td>1.000</td><td>1.000</td><td>585</td><td>tags=16%, list=5%, signal=17%</td></tr><tr><td class='lessen'>223</td><td>ZHU_SKIL_TARGETS_UP</td><td></td><td>19</td><td>-0.48</td><td>-1.16</td><td>0.271</td><td>1.000</td><td>1.000</td><td>670</td><td>tags=21%, list=6%, signal=22%</td></tr><tr><td class='lessen'>224</td><td>AMIT_EGF_RESPONSE_240_HELA</td><td></td><td>50</td><td>-0.40</td><td>-1.16</td><td>0.225</td><td>1.000</td><td>1.000</td><td>1096</td><td>tags=14%, list=10%, signal=15%</td></tr><tr><td class='lessen'>225</td><td>THUM_MIR21_TARGETS_HEART_DISEASE_UP</td><td></td><td>14</td><td>-0.52</td><td>-1.16</td><td>0.267</td><td>1.000</td><td>1.000</td><td>260</td><td>tags=21%, list=2%, signal=22%</td></tr><tr><td class='lessen'>226</td><td>LEE_DOUBLE_POLAR_THYMOCYTE</td><td></td><td>18</td><td>-0.49</td><td>-1.16</td><td>0.294</td><td>1.000</td><td>1.000</td><td>802</td><td>tags=28%, list=7%, signal=30%</td></tr><tr><td class='lessen'>227</td><td>MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN</td><td></td><td>21</td><td>-0.47</td><td>-1.16</td><td>0.253</td><td>1.000</td><td>1.000</td><td>1926</td><td>tags=29%, list=17%, signal=34%</td></tr><tr><td class='lessen'>228</td><td>RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN</td><td></td><td>390</td><td>-0.30</td><td>-1.16</td><td>0.062</td><td>1.000</td><td>1.000</td><td>1741</td><td>tags=18%, list=16%, signal=21%</td></tr><tr><td class='lessen'>229</td><td>SHEN_SMARCA2_TARGETS_UP</td><td></td><td>332</td><td>-0.30</td><td>-1.16</td><td>0.090</td><td>1.000</td><td>1.000</td><td>3928</td><td>tags=43%, list=35%, signal=65%</td></tr><tr><td class='lessen'>230</td><td>CHIBA_RESPONSE_TO_TSA_DN</td><td></td><td>20</td><td>-0.47</td><td>-1.16</td><td>0.246</td><td>1.000</td><td>1.000</td><td>2962</td><td>tags=55%, list=27%, signal=75%</td></tr><tr><td class='lessen'>231</td><td>BOYLAN_MULTIPLE_MYELOMA_PCA3_DN</td><td></td><td>53</td><td>-0.39</td><td>-1.16</td><td>0.232</td><td>1.000</td><td>1.000</td><td>159</td><td>tags=8%, list=1%, signal=8%</td></tr><tr><td class='lessen'>232</td><td>CHESLER_BRAIN_QTL_TRANS</td><td></td><td>6</td><td>-0.61</td><td>-1.16</td><td>0.323</td><td>1.000</td><td>1.000</td><td>116</td><td>tags=17%, list=1%, signal=17%</td></tr><tr><td class='lessen'>233</td><td>AZARE_STAT3_TARGETS</td><td></td><td>18</td><td>-0.48</td><td>-1.16</td><td>0.283</td><td>1.000</td><td>1.000</td><td>545</td><td>tags=11%, list=5%, signal=12%</td></tr><tr><td class='lessen'>234</td><td>WANG_RESPONSE_TO_BEXAROTENE_DN</td><td></td><td>24</td><td>-0.45</td><td>-1.16</td><td>0.255</td><td>1.000</td><td>1.000</td><td>615</td><td>tags=17%, list=6%, signal=18%</td></tr><tr><td class='lessen'>235</td><td>VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1</td><td></td><td>37</td><td>-0.41</td><td>-1.16</td><td>0.238</td><td>1.000</td><td>1.000</td><td>23</td><td>tags=5%, list=0%, signal=5%</td></tr><tr><td class='lessen'>236</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1</td><td></td><td>61</td><td>-0.38</td><td>-1.16</td><td>0.217</td><td>1.000</td><td>1.000</td><td>1440</td><td>tags=23%, list=13%, signal=26%</td></tr><tr><td class='lessen'>237</td><td>BROWNE_HCMV_INFECTION_10HR_DN</td><td></td><td>43</td><td>-0.40</td><td>-1.15</td><td>0.226</td><td>1.000</td><td>1.000</td><td>2615</td><td>tags=42%, list=23%, signal=55%</td></tr><tr><td class='lessen'>238</td><td>MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP</td><td></td><td>60</td><td>-0.38</td><td>-1.15</td><td>0.218</td><td>1.000</td><td>1.000</td><td>1029</td><td>tags=17%, list=9%, signal=18%</td></tr><tr><td class='lessen'>239</td><td>CADWELL_ATG16L1_TARGETS_UP</td><td></td><td>71</td><td>-0.37</td><td>-1.15</td><td>0.221</td><td>1.000</td><td>1.000</td><td>999</td><td>tags=18%, list=9%, signal=20%</td></tr><tr><td class='lessen'>240</td><td>BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN</td><td></td><td>26</td><td>-0.44</td><td>-1.15</td><td>0.256</td><td>1.000</td><td>1.000</td><td>1889</td><td>tags=35%, list=17%, signal=42%</td></tr><tr><td class='lessen'>241</td><td>NOUSHMEHR_GBM_SOMATIC_MUTATED</td><td></td><td>8</td><td>-0.58</td><td>-1.15</td><td>0.324</td><td>1.000</td><td>1.000</td><td>1170</td><td>tags=25%, list=11%, signal=28%</td></tr><tr><td class='lessen'>242</td><td>SAGIV_CD24_TARGETS_UP</td><td></td><td>21</td><td>-0.46</td><td>-1.15</td><td>0.257</td><td>1.000</td><td>1.000</td><td>3481</td><td>tags=57%, list=31%, signal=83%</td></tr><tr><td class='lessen'>243</td><td>MILI_PSEUDOPODIA_HAPTOTAXIS_UP</td><td></td><td>390</td><td>-0.30</td><td>-1.15</td><td>0.110</td><td>1.000</td><td>1.000</td><td>3404</td><td>tags=38%, list=31%, signal=53%</td></tr><tr><td class='lessen'>244</td><td>COLLER_MYC_TARGETS_DN</td><td></td><td>8</td><td>-0.57</td><td>-1.15</td><td>0.326</td><td>1.000</td><td>1.000</td><td>81</td><td>tags=13%, list=1%, signal=13%</td></tr><tr><td class='lessen'>245</td><td>NAKAMURA_METASTASIS_MODEL_DN</td><td></td><td>32</td><td>-0.42</td><td>-1.15</td><td>0.260</td><td>1.000</td><td>1.000</td><td>1385</td><td>tags=31%, list=12%, signal=36%</td></tr><tr><td class='lessen'>246</td><td>GHANDHI_BYSTANDER_IRRADIATION_UP</td><td></td><td>58</td><td>-0.38</td><td>-1.15</td><td>0.227</td><td>1.000</td><td>1.000</td><td>1009</td><td>tags=21%, list=9%, signal=23%</td></tr><tr><td class='lessen'>247</td><td>YUAN_ZNF143_PARTNERS</td><td></td><td>18</td><td>-0.48</td><td>-1.15</td><td>0.296</td><td>1.000</td><td>1.000</td><td>1786</td><td>tags=39%, list=16%, signal=46%</td></tr><tr><td class='lessen'>248</td><td>MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN</td><td></td><td>40</td><td>-0.41</td><td>-1.15</td><td>0.260</td><td>1.000</td><td>1.000</td><td>595</td><td>tags=20%, list=5%, signal=21%</td></tr><tr><td class='lessen'>249</td><td>MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED</td><td></td><td>30</td><td>-0.42</td><td>-1.14</td><td>0.264</td><td>1.000</td><td>1.000</td><td>770</td><td>tags=27%, list=7%, signal=29%</td></tr><tr><td class='lessen'>250</td><td>SERVITJA_LIVER_HNF1A_TARGETS_UP</td><td></td><td>121</td><td>-0.34</td><td>-1.14</td><td>0.188</td><td>1.000</td><td>1.000</td><td>1643</td><td>tags=22%, list=15%, signal=26%</td></tr><tr><td class='lessen'>251</td><td>SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN</td><td></td><td>26</td><td>-0.44</td><td>-1.14</td><td>0.268</td><td>1.000</td><td>1.000</td><td>3737</td><td>tags=58%, list=34%, signal=87%</td></tr><tr><td class='lessen'>252</td><td>NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON</td><td></td><td>88</td><td>-0.35</td><td>-1.14</td><td>0.210</td><td>1.000</td><td>1.000</td><td>1333</td><td>tags=23%, list=12%, signal=26%</td></tr><tr><td class='lessen'>253</td><td>SESTO_RESPONSE_TO_UV_C2</td><td></td><td>40</td><td>-0.40</td><td>-1.14</td><td>0.227</td><td>1.000</td><td>1.000</td><td>3158</td><td>tags=48%, list=28%, signal=66%</td></tr><tr><td class='lessen'>254</td><td>ONDER_CDH1_TARGETS_2_UP</td><td></td><td>206</td><td>-0.31</td><td>-1.14</td><td>0.148</td><td>1.000</td><td>1.000</td><td>1685</td><td>tags=22%, list=15%, signal=25%</td></tr><tr><td class='lessen'>255</td><td>LEIN_PONS_MARKERS</td><td></td><td>68</td><td>-0.36</td><td>-1.14</td><td>0.225</td><td>1.000</td><td>1.000</td><td>509</td><td>tags=12%, list=5%, signal=12%</td></tr><tr><td class='lessen'>256</td><td>HASINA_NOL7_TARGETS_DN</td><td></td><td>10</td><td>-0.54</td><td>-1.14</td><td>0.338</td><td>1.000</td><td>1.000</td><td>16</td><td>tags=10%, list=0%, signal=10%</td></tr><tr><td class='lessen'>257</td><td>HOEGERKORP_CD44_TARGETS_TEMPORAL_UP</td><td></td><td>9</td><td>-0.55</td><td>-1.13</td><td>0.315</td><td>1.000</td><td>1.000</td><td>1774</td><td>tags=33%, list=16%, signal=40%</td></tr><tr><td class='lessen'>258</td><td>AMIT_SERUM_RESPONSE_40_MCF10A</td><td></td><td>27</td><td>-0.43</td><td>-1.13</td><td>0.276</td><td>1.000</td><td>1.000</td><td>1420</td><td>tags=30%, list=13%, signal=34%</td></tr><tr><td class='lessen'>259</td><td>HEIDENBLAD_AMPLIFIED_IN_SOFT_TISSUE_CANCER</td><td></td><td>11</td><td>-0.52</td><td>-1.13</td><td>0.309</td><td>1.000</td><td>1.000</td><td>6</td><td>tags=9%, list=0%, signal=9%</td></tr><tr><td class='lessen'>260</td><td>GHO_ATF5_TARGETS_DN</td><td></td><td>14</td><td>-0.49</td><td>-1.13</td><td>0.298</td><td>1.000</td><td>1.000</td><td>211</td><td>tags=14%, list=2%, signal=15%</td></tr><tr><td class='lessen'>261</td><td>MEISSNER_NPC_HCP_WITH_H3K4ME2</td><td></td><td>341</td><td>-0.29</td><td>-1.13</td><td>0.138</td><td>1.000</td><td>1.000</td><td>886</td><td>tags=13%, list=8%, signal=13%</td></tr><tr><td class='lessen'>262</td><td>SILIGAN_BOUND_BY_EWS_FLT1_FUSION</td><td></td><td>33</td><td>-0.41</td><td>-1.13</td><td>0.300</td><td>1.000</td><td>1.000</td><td>1827</td><td>tags=27%, list=16%, signal=33%</td></tr><tr><td class='lessen'>263</td><td>NIELSEN_SCHWANNOMA_DN</td><td></td><td>13</td><td>-0.51</td><td>-1.13</td><td>0.325</td><td>1.000</td><td>1.000</td><td>2669</td><td>tags=46%, list=24%, signal=61%</td></tr><tr><td class='lessen'>264</td><td>PLASARI_TGFB1_TARGETS_10HR_DN</td><td></td><td>204</td><td>-0.31</td><td>-1.13</td><td>0.174</td><td>1.000</td><td>1.000</td><td>1702</td><td>tags=25%, list=15%, signal=28%</td></tr><tr><td class='lessen'>265</td><td>CHEN_HOXA5_TARGETS_9HR_UP</td><td></td><td>149</td><td>-0.32</td><td>-1.13</td><td>0.180</td><td>1.000</td><td>1.000</td><td>2426</td><td>tags=32%, list=22%, signal=41%</td></tr><tr><td class='lessen'>266</td><td>TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_UP</td><td></td><td>15</td><td>-0.49</td><td>-1.13</td><td>0.340</td><td>1.000</td><td>1.000</td><td>387</td><td>tags=20%, list=3%, signal=21%</td></tr><tr><td class='lessen'>267</td><td>NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN</td><td></td><td>56</td><td>-0.37</td><td>-1.12</td><td>0.257</td><td>1.000</td><td>1.000</td><td>2299</td><td>tags=38%, list=21%, signal=47%</td></tr><tr><td class='lessen'>268</td><td>WOO_LIVER_CANCER_RECURRENCE_DN</td><td></td><td>62</td><td>-0.36</td><td>-1.12</td><td>0.245</td><td>1.000</td><td>1.000</td><td>2974</td><td>tags=44%, list=27%, signal=59%</td></tr><tr><td class='lessen'>269</td><td>BILANGES_SERUM_SENSITIVE_VIA_TSC1</td><td></td><td>16</td><td>-0.49</td><td>-1.12</td><td>0.309</td><td>1.000</td><td>1.000</td><td>1250</td><td>tags=25%, list=11%, signal=28%</td></tr><tr><td class='lessen'>270</td><td>CHESLER_BRAIN_D6MIT150_QTL_TRANS</td><td></td><td>5</td><td>-0.62</td><td>-1.12</td><td>0.385</td><td>1.000</td><td>1.000</td><td>453</td><td>tags=20%, list=4%, signal=21%</td></tr><tr><td class='lessen'>271</td><td>KAN_RESPONSE_TO_ARSENIC_TRIOXIDE</td><td></td><td>90</td><td>-0.34</td><td>-1.12</td><td>0.246</td><td>1.000</td><td>1.000</td><td>1310</td><td>tags=16%, list=12%, signal=17%</td></tr><tr><td class='lessen'>272</td><td>STAMBOLSKY_BOUND_BY_MUTATED_TP53</td><td></td><td>12</td><td>-0.51</td><td>-1.12</td><td>0.336</td><td>1.000</td><td>1.000</td><td>865</td><td>tags=17%, list=8%, signal=18%</td></tr><tr><td class='lessen'>273</td><td>MCBRYAN_PUBERTAL_BREAST_3_4WK_UP</td><td></td><td>171</td><td>-0.32</td><td>-1.12</td><td>0.209</td><td>1.000</td><td>1.000</td><td>962</td><td>tags=12%, list=9%, signal=13%</td></tr><tr><td class='lessen'>274</td><td>SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN</td><td></td><td>120</td><td>-0.33</td><td>-1.11</td><td>0.232</td><td>1.000</td><td>1.000</td><td>1661</td><td>tags=23%, list=15%, signal=26%</td></tr><tr><td class='lessen'>275</td><td>NIKOLSKY_BREAST_CANCER_6P24_P22_AMPLICON</td><td></td><td>16</td><td>-0.47</td><td>-1.11</td><td>0.339</td><td>1.000</td><td>1.000</td><td>2376</td><td>tags=44%, list=21%, signal=56%</td></tr><tr><td class='lessen'>276</td><td>HOELZEL_NF1_TARGETS_DN</td><td></td><td>71</td><td>-0.35</td><td>-1.11</td><td>0.262</td><td>1.000</td><td>1.000</td><td>1077</td><td>tags=17%, list=10%, signal=19%</td></tr><tr><td class='lessen'>277</td><td>IKEDA_MIR133_TARGETS_UP</td><td></td><td>41</td><td>-0.38</td><td>-1.11</td><td>0.312</td><td>1.000</td><td>1.000</td><td>3124</td><td>tags=37%, list=28%, signal=51%</td></tr><tr><td class='lessen'>278</td><td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP</td><td></td><td>71</td><td>-0.35</td><td>-1.11</td><td>0.256</td><td>1.000</td><td>1.000</td><td>418</td><td>tags=8%, list=4%, signal=9%</td></tr><tr><td class='lessen'>279</td><td>BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN</td><td></td><td>11</td><td>-0.52</td><td>-1.11</td><td>0.378</td><td>1.000</td><td>1.000</td><td>2111</td><td>tags=45%, list=19%, signal=56%</td></tr><tr><td class='lessen'>280</td><td>YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP</td><td></td><td>66</td><td>-0.36</td><td>-1.11</td><td>0.278</td><td>1.000</td><td>1.000</td><td>2529</td><td>tags=32%, list=23%, signal=41%</td></tr><tr><td class='lessen'>281</td><td>SMID_BREAST_CANCER_LUMINAL_A_UP</td><td></td><td>68</td><td>-0.36</td><td>-1.11</td><td>0.287</td><td>1.000</td><td>1.000</td><td>1903</td><td>tags=29%, list=17%, signal=35%</td></tr><tr><td class='lessen'>282</td><td>MATZUK_POST-IMPLANTATION_AND_POST-PARTUM</td><td></td><td>11</td><td>-0.51</td><td>-1.11</td><td>0.353</td><td>1.000</td><td>1.000</td><td>2543</td><td>tags=55%, list=23%, signal=71%</td></tr><tr><td class='lessen'>283</td><td>VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP</td><td></td><td>73</td><td>-0.35</td><td>-1.11</td><td>0.266</td><td>1.000</td><td>1.000</td><td>554</td><td>tags=11%, list=5%, signal=11%</td></tr><tr><td class='lessen'>284</td><td>SMID_BREAST_CANCER_NORMAL_LIKE_DN</td><td></td><td>5</td><td>-0.62</td><td>-1.11</td><td>0.410</td><td>1.000</td><td>1.000</td><td>53</td><td>tags=20%, list=0%, signal=20%</td></tr><tr><td class='lessen'>285</td><td>NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON</td><td></td><td>35</td><td>-0.41</td><td>-1.11</td><td>0.304</td><td>1.000</td><td>1.000</td><td>554</td><td>tags=11%, list=5%, signal=12%</td></tr><tr><td class='lessen'>286</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP</td><td></td><td>18</td><td>-0.47</td><td>-1.10</td><td>0.339</td><td>1.000</td><td>1.000</td><td>2488</td><td>tags=39%, list=22%, signal=50%</td></tr><tr><td class='lessen'>287</td><td>KIM_MYCL1_AMPLIFICATION_TARGETS_UP</td><td></td><td>6</td><td>-0.59</td><td>-1.10</td><td>0.402</td><td>1.000</td><td>1.000</td><td>2534</td><td>tags=67%, list=23%, signal=86%</td></tr><tr><td class='lessen'>288</td><td>SABATES_COLORECTAL_ADENOMA_SIZE_UP</td><td></td><td>14</td><td>-0.49</td><td>-1.10</td><td>0.354</td><td>1.000</td><td>1.000</td><td>3909</td><td>tags=57%, list=35%, signal=88%</td></tr><tr><td class='lessen'>289</td><td>HWANG_PROSTATE_CANCER_MARKERS</td><td></td><td>22</td><td>-0.43</td><td>-1.10</td><td>0.343</td><td>1.000</td><td>1.000</td><td>1076</td><td>tags=14%, list=10%, signal=15%</td></tr><tr><td class='lessen'>290</td><td>CROMER_TUMORIGENESIS_DN</td><td></td><td>29</td><td>-0.41</td><td>-1.10</td><td>0.312</td><td>1.000</td><td>1.000</td><td>556</td><td>tags=17%, list=5%, signal=18%</td></tr><tr><td class='lessen'>291</td><td>VALK_AML_CLUSTER_4</td><td></td><td>20</td><td>-0.44</td><td>-1.10</td><td>0.348</td><td>1.000</td><td>1.000</td><td>1951</td><td>tags=40%, list=18%, signal=48%</td></tr><tr><td class='lessen'>292</td><td>LEE_NEURAL_CREST_STEM_CELL_UP</td><td></td><td>104</td><td>-0.33</td><td>-1.10</td><td>0.258</td><td>1.000</td><td>1.000</td><td>1780</td><td>tags=23%, list=16%, signal=27%</td></tr><tr><td class='lessen'>293</td><td>DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN</td><td></td><td>27</td><td>-0.42</td><td>-1.10</td><td>0.328</td><td>1.000</td><td>1.000</td><td>998</td><td>tags=19%, list=9%, signal=20%</td></tr><tr><td class='lessen'>294</td><td>LEE_TARGETS_OF_PTCH1_AND_SUFU_DN</td><td></td><td>61</td><td>-0.35</td><td>-1.10</td><td>0.300</td><td>1.000</td><td>1.000</td><td>977</td><td>tags=16%, list=9%, signal=18%</td></tr><tr><td class='lessen'>295</td><td>ROSS_ACUTE_MYELOID_LEUKEMIA_CBF</td><td></td><td>59</td><td>-0.36</td><td>-1.10</td><td>0.308</td><td>1.000</td><td>1.000</td><td>733</td><td>tags=12%, list=7%, signal=13%</td></tr><tr><td class='lessen'>296</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_UP</td><td></td><td>10</td><td>-0.53</td><td>-1.10</td><td>0.357</td><td>1.000</td><td>1.000</td><td>2452</td><td>tags=50%, list=22%, signal=64%</td></tr><tr><td class='lessen'>297</td><td>MATZUK_MEIOTIC_AND_DNA_REPAIR</td><td></td><td>31</td><td>-0.40</td><td>-1.10</td><td>0.330</td><td>1.000</td><td>1.000</td><td>1066</td><td>tags=26%, list=10%, signal=28%</td></tr><tr><td class='lessen'>298</td><td>OHGUCHI_LIVER_HNF4A_TARGETS_UP</td><td></td><td>37</td><td>-0.39</td><td>-1.09</td><td>0.313</td><td>1.000</td><td>1.000</td><td>1376</td><td>tags=19%, list=12%, signal=22%</td></tr><tr><td class='lessen'>299</td><td>POOLA_INVASIVE_BREAST_CANCER_DN</td><td></td><td>102</td><td>-0.33</td><td>-1.09</td><td>0.282</td><td>1.000</td><td>1.000</td><td>845</td><td>tags=13%, list=8%, signal=14%</td></tr><tr><td class='lessen'>300</td><td>KANG_DOXORUBICIN_RESISTANCE_DN</td><td></td><td>15</td><td>-0.47</td><td>-1.09</td><td>0.344</td><td>1.000</td><td>1.000</td><td>3535</td><td>tags=53%, list=32%, signal=78%</td></tr><tr><td class='lessen'>301</td><td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_15</td><td></td><td>9</td><td>-0.54</td><td>-1.09</td><td>0.378</td><td>1.000</td><td>1.000</td><td>2731</td><td>tags=44%, list=25%, signal=59%</td></tr><tr><td class='lessen'>302</td><td>ALONSO_METASTASIS_DN</td><td></td><td>15</td><td>-0.49</td><td>-1.09</td><td>0.360</td><td>1.000</td><td>1.000</td><td>1342</td><td>tags=27%, list=12%, signal=30%</td></tr><tr><td class='lessen'>303</td><td>RATTENBACHER_BOUND_BY_CELF1</td><td></td><td>292</td><td>-0.29</td><td>-1.09</td><td>0.207</td><td>1.000</td><td>1.000</td><td>1244</td><td>tags=11%, list=11%, signal=12%</td></tr><tr><td class='lessen'>304</td><td>LEIN_NEURON_MARKERS</td><td></td><td>51</td><td>-0.37</td><td>-1.09</td><td>0.322</td><td>1.000</td><td>1.000</td><td>1444</td><td>tags=27%, list=13%, signal=31%</td></tr><tr><td class='lessen'>305</td><td>ROSS_AML_WITH_AML1_ETO_FUSION</td><td></td><td>52</td><td>-0.37</td><td>-1.09</td><td>0.295</td><td>1.000</td><td>1.000</td><td>862</td><td>tags=13%, list=8%, signal=15%</td></tr><tr><td class='lessen'>306</td><td>MCBRYAN_TERMINAL_END_BUD_UP</td><td></td><td>11</td><td>-0.51</td><td>-1.09</td><td>0.373</td><td>1.000</td><td>1.000</td><td>556</td><td>tags=27%, list=5%, signal=29%</td></tr><tr><td class='lessen'>307</td><td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN</td><td></td><td>26</td><td>-0.42</td><td>-1.09</td><td>0.338</td><td>1.000</td><td>1.000</td><td>1203</td><td>tags=23%, list=11%, signal=26%</td></tr><tr><td class='lessen'>308</td><td>BURTON_ADIPOGENESIS_11</td><td></td><td>45</td><td>-0.38</td><td>-1.09</td><td>0.302</td><td>1.000</td><td>1.000</td><td>3481</td><td>tags=56%, list=31%, signal=81%</td></tr><tr><td class='lessen'>309</td><td>WANG_MLL_TARGETS</td><td></td><td>219</td><td>-0.29</td><td>-1.09</td><td>0.250</td><td>1.000</td><td>1.000</td><td>1594</td><td>tags=21%, list=14%, signal=25%</td></tr><tr><td class='lessen'>310</td><td>PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP</td><td></td><td>36</td><td>-0.39</td><td>-1.09</td><td>0.311</td><td>1.000</td><td>1.000</td><td>1314</td><td>tags=19%, list=12%, signal=22%</td></tr><tr><td class='lessen'>311</td><td>ZWANG_EGF_PERSISTENTLY_DN</td><td></td><td>39</td><td>-0.39</td><td>-1.09</td><td>0.342</td><td>1.000</td><td>1.000</td><td>2523</td><td>tags=31%, list=23%, signal=40%</td></tr><tr><td class='lessen'>312</td><td>TERAMOTO_OPN_TARGETS_CLUSTER_1</td><td></td><td>10</td><td>-0.52</td><td>-1.09</td><td>0.381</td><td>1.000</td><td>1.000</td><td>1661</td><td>tags=40%, list=15%, signal=47%</td></tr><tr><td class='lessen'>313</td><td>SANSOM_APC_TARGETS</td><td></td><td>143</td><td>-0.31</td><td>-1.09</td><td>0.262</td><td>1.000</td><td>1.000</td><td>1211</td><td>tags=15%, list=11%, signal=17%</td></tr><tr><td class='lessen'>314</td><td>LIU_IL13_MEMORY_MODEL_DN</td><td></td><td>5</td><td>-0.59</td><td>-1.09</td><td>0.386</td><td>1.000</td><td>1.000</td><td>2293</td><td>tags=60%, list=21%, signal=76%</td></tr><tr><td class='lessen'>315</td><td>MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3</td><td></td><td>130</td><td>-0.32</td><td>-1.08</td><td>0.258</td><td>1.000</td><td>1.000</td><td>1282</td><td>tags=24%, list=12%, signal=27%</td></tr><tr><td class='lessen'>316</td><td>KIM_WT1_TARGETS_UP</td><td></td><td>173</td><td>-0.30</td><td>-1.08</td><td>0.255</td><td>1.000</td><td>1.000</td><td>2124</td><td>tags=24%, list=19%, signal=29%</td></tr><tr><td class='lessen'>317</td><td>MEISSNER_BRAIN_HCP_WITH_H3K4ME2</td><td></td><td>14</td><td>-0.49</td><td>-1.08</td><td>0.382</td><td>1.000</td><td>1.000</td><td>498</td><td>tags=21%, list=4%, signal=22%</td></tr><tr><td class='lessen'>318</td><td>MURATA_VIRULENCE_OF_H_PILORI</td><td></td><td>19</td><td>-0.45</td><td>-1.08</td><td>0.382</td><td>1.000</td><td>1.000</td><td>802</td><td>tags=16%, list=7%, signal=17%</td></tr><tr><td class='lessen'>319</td><td>LOPEZ_MESOTELIOMA_SURVIVAL_TIME_UP</td><td></td><td>12</td><td>-0.49</td><td>-1.08</td><td>0.377</td><td>1.000</td><td>1.000</td><td>654</td><td>tags=25%, list=6%, signal=27%</td></tr><tr><td class='lessen'>320</td><td>BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP</td><td></td><td>343</td><td>-0.28</td><td>-1.08</td><td>0.215</td><td>1.000</td><td>1.000</td><td>1530</td><td>tags=20%, list=14%, signal=22%</td></tr><tr><td class='lessen'>321</td><td>PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN</td><td></td><td>38</td><td>-0.38</td><td>-1.08</td><td>0.333</td><td>1.000</td><td>1.000</td><td>1918</td><td>tags=29%, list=17%, signal=35%</td></tr><tr><td class='lessen'>322</td><td>DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN</td><td></td><td>384</td><td>-0.28</td><td>-1.08</td><td>0.199</td><td>1.000</td><td>1.000</td><td>3451</td><td>tags=45%, list=31%, signal=62%</td></tr><tr><td class='lessen'>323</td><td>LIU_TARGETS_OF_VMYB_VS_CMYB_UP</td><td></td><td>12</td><td>-0.49</td><td>-1.08</td><td>0.361</td><td>1.000</td><td>1.000</td><td>1261</td><td>tags=25%, list=11%, signal=28%</td></tr><tr><td class='lessen'>324</td><td>MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN</td><td></td><td>54</td><td>-0.36</td><td>-1.08</td><td>0.316</td><td>1.000</td><td>1.000</td><td>2424</td><td>tags=35%, list=22%, signal=45%</td></tr><tr><td class='lessen'>325</td><td>CHOW_RASSF1_TARGETS_UP</td><td></td><td>22</td><td>-0.43</td><td>-1.08</td><td>0.364</td><td>1.000</td><td>1.000</td><td>2180</td><td>tags=32%, list=20%, signal=39%</td></tr><tr><td class='lessen'>326</td><td>CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY</td><td></td><td>20</td><td>-0.43</td><td>-1.08</td><td>0.368</td><td>1.000</td><td>1.000</td><td>319</td><td>tags=15%, list=3%, signal=15%</td></tr><tr><td class='lessen'>327</td><td>RAO_BOUND_BY_SALL4_ISOFORM_A</td><td></td><td>113</td><td>-0.32</td><td>-1.08</td><td>0.285</td><td>1.000</td><td>1.000</td><td>1471</td><td>tags=19%, list=13%, signal=21%</td></tr><tr><td class='lessen'>328</td><td>ODONNELL_METASTASIS_UP</td><td></td><td>49</td><td>-0.37</td><td>-1.08</td><td>0.331</td><td>1.000</td><td>1.000</td><td>815</td><td>tags=14%, list=7%, signal=15%</td></tr><tr><td class='lessen'>329</td><td>MOHANKUMAR_TLX1_TARGETS_DN</td><td></td><td>108</td><td>-0.32</td><td>-1.08</td><td>0.294</td><td>1.000</td><td>1.000</td><td>1014</td><td>tags=15%, list=9%, signal=16%</td></tr><tr><td class='lessen'>330</td><td>LEI_HOXC8_TARGETS_DN</td><td></td><td>17</td><td>-0.45</td><td>-1.07</td><td>0.390</td><td>1.000</td><td>1.000</td><td>891</td><td>tags=18%, list=8%, signal=19%</td></tr><tr><td class='lessen'>331</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_DN</td><td></td><td>11</td><td>-0.50</td><td>-1.07</td><td>0.389</td><td>1.000</td><td>1.000</td><td>2188</td><td>tags=55%, list=20%, signal=68%</td></tr><tr><td class='lessen'>332</td><td>RICKMAN_HEAD_AND_NECK_CANCER_A</td><td></td><td>57</td><td>-0.36</td><td>-1.07</td><td>0.315</td><td>1.000</td><td>1.000</td><td>1264</td><td>tags=21%, list=11%, signal=24%</td></tr><tr><td class='lessen'>333</td><td>CADWELL_ATG16L1_TARGETS_DN</td><td></td><td>49</td><td>-0.36</td><td>-1.07</td><td>0.354</td><td>1.000</td><td>1.000</td><td>2778</td><td>tags=37%, list=25%, signal=49%</td></tr><tr><td class='lessen'>334</td><td>BOYLAN_MULTIPLE_MYELOMA_C_DN</td><td></td><td>43</td><td>-0.37</td><td>-1.07</td><td>0.341</td><td>1.000</td><td>1.000</td><td>964</td><td>tags=16%, list=9%, signal=18%</td></tr><tr><td class='lessen'>335</td><td>FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_DN</td><td></td><td>5</td><td>-0.59</td><td>-1.07</td><td>0.402</td><td>1.000</td><td>1.000</td><td>523</td><td>tags=40%, list=5%, signal=42%</td></tr><tr><td class='lessen'>336</td><td>DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN</td><td></td><td>54</td><td>-0.36</td><td>-1.07</td><td>0.342</td><td>1.000</td><td>1.000</td><td>1145</td><td>tags=19%, list=10%, signal=21%</td></tr><tr><td class='lessen'>337</td><td>LEIN_MIDBRAIN_MARKERS</td><td></td><td>55</td><td>-0.35</td><td>-1.07</td><td>0.329</td><td>1.000</td><td>1.000</td><td>563</td><td>tags=13%, list=5%, signal=13%</td></tr><tr><td class='lessen'>338</td><td>RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP</td><td></td><td>174</td><td>-0.30</td><td>-1.06</td><td>0.278</td><td>1.000</td><td>1.000</td><td>1896</td><td>tags=24%, list=17%, signal=29%</td></tr><tr><td class='lessen'>339</td><td>DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN</td><td></td><td>60</td><td>-0.35</td><td>-1.06</td><td>0.339</td><td>1.000</td><td>1.000</td><td>2920</td><td>tags=47%, list=26%, signal=63%</td></tr><tr><td class='lessen'>340</td><td>BURTON_ADIPOGENESIS_1</td><td></td><td>28</td><td>-0.40</td><td>-1.06</td><td>0.366</td><td>1.000</td><td>1.000</td><td>2180</td><td>tags=43%, list=20%, signal=53%</td></tr><tr><td class='lessen'>341</td><td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN</td><td></td><td>14</td><td>-0.47</td><td>-1.06</td><td>0.385</td><td>1.000</td><td>1.000</td><td>1010</td><td>tags=29%, list=9%, signal=31%</td></tr><tr><td class='lessen'>342</td><td>MIKKELSEN_ES_ICP_WITH_H3K4ME3</td><td></td><td>479</td><td>-0.27</td><td>-1.06</td><td>0.247</td><td>1.000</td><td>1.000</td><td>1248</td><td>tags=16%, list=11%, signal=17%</td></tr><tr><td class='lessen'>343</td><td>WANG_THOC1_TARGETS_DN</td><td></td><td>14</td><td>-0.46</td><td>-1.06</td><td>0.376</td><td>1.000</td><td>1.000</td><td>1514</td><td>tags=29%, list=14%, signal=33%</td></tr><tr><td class='lessen'>344</td><td>BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP</td><td></td><td>33</td><td>-0.39</td><td>-1.06</td><td>0.344</td><td>1.000</td><td>1.000</td><td>699</td><td>tags=12%, list=6%, signal=13%</td></tr><tr><td class='lessen'>345</td><td>FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN</td><td></td><td>45</td><td>-0.37</td><td>-1.06</td><td>0.377</td><td>1.000</td><td>1.000</td><td>1759</td><td>tags=20%, list=16%, signal=24%</td></tr><tr><td class='lessen'>346</td><td>ZUCCHI_METASTASIS_UP</td><td></td><td>36</td><td>-0.38</td><td>-1.06</td><td>0.365</td><td>1.000</td><td>1.000</td><td>1027</td><td>tags=11%, list=9%, signal=12%</td></tr><tr><td class='lessen'>347</td><td>ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN</td><td></td><td>30</td><td>-0.40</td><td>-1.06</td><td>0.340</td><td>1.000</td><td>1.000</td><td>797</td><td>tags=13%, list=7%, signal=14%</td></tr><tr><td class='lessen'>348</td><td>GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP</td><td></td><td>10</td><td>-0.50</td><td>-1.06</td><td>0.413</td><td>1.000</td><td>1.000</td><td>1044</td><td>tags=20%, list=9%, signal=22%</td></tr><tr><td class='lessen'>349</td><td>FU_INTERACT_WITH_ALKBH8</td><td></td><td>12</td><td>-0.48</td><td>-1.06</td><td>0.396</td><td>1.000</td><td>1.000</td><td>3265</td><td>tags=58%, list=29%, signal=82%</td></tr><tr><td class='lessen'>350</td><td>MCBRYAN_PUBERTAL_BREAST_5_6WK_DN</td><td></td><td>111</td><td>-0.32</td><td>-1.06</td><td>0.336</td><td>1.000</td><td>1.000</td><td>1918</td><td>tags=18%, list=17%, signal=22%</td></tr><tr><td class='lessen'>351</td><td>PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP</td><td></td><td>21</td><td>-0.43</td><td>-1.06</td><td>0.384</td><td>1.000</td><td>1.000</td><td>1420</td><td>tags=24%, list=13%, signal=27%</td></tr><tr><td class='lessen'>352</td><td>LIANG_SILENCED_BY_METHYLATION_UP</td><td></td><td>21</td><td>-0.43</td><td>-1.06</td><td>0.368</td><td>1.000</td><td>1.000</td><td>578</td><td>tags=19%, list=5%, signal=20%</td></tr><tr><td class='lessen'>353</td><td>IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP</td><td></td><td>23</td><td>-0.41</td><td>-1.05</td><td>0.364</td><td>1.000</td><td>1.000</td><td>1879</td><td>tags=26%, list=17%, signal=31%</td></tr><tr><td class='lessen'>354</td><td>ROY_WOUND_BLOOD_VESSEL_DN</td><td></td><td>13</td><td>-0.47</td><td>-1.05</td><td>0.406</td><td>1.000</td><td>1.000</td><td>1721</td><td>tags=23%, list=15%, signal=27%</td></tr><tr><td class='lessen'>355</td><td>CHESLER_BRAIN_QTL_CIS</td><td></td><td>51</td><td>-0.35</td><td>-1.05</td><td>0.355</td><td>1.000</td><td>1.000</td><td>1232</td><td>tags=12%, list=11%, signal=13%</td></tr><tr><td class='lessen'>356</td><td>GABRIELY_MIR21_TARGETS</td><td></td><td>238</td><td>-0.28</td><td>-1.05</td><td>0.303</td><td>1.000</td><td>1.000</td><td>3687</td><td>tags=47%, list=33%, signal=69%</td></tr><tr><td class='lessen'>357</td><td>MUNSHI_MULTIPLE_MYELOMA_UP</td><td></td><td>75</td><td>-0.33</td><td>-1.05</td><td>0.367</td><td>1.000</td><td>1.000</td><td>1695</td><td>tags=19%, list=15%, signal=22%</td></tr><tr><td class='lessen'>358</td><td>CHEN_PDGF_TARGETS</td><td></td><td>15</td><td>-0.46</td><td>-1.05</td><td>0.398</td><td>1.000</td><td>1.000</td><td>2499</td><td>tags=40%, list=22%, signal=52%</td></tr><tr><td class='lessen'>359</td><td>ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF</td><td></td><td>34</td><td>-0.38</td><td>-1.05</td><td>0.407</td><td>1.000</td><td>1.000</td><td>780</td><td>tags=12%, list=7%, signal=13%</td></tr><tr><td class='lessen'>360</td><td>WESTON_VEGFA_TARGETS_12HR</td><td></td><td>34</td><td>-0.38</td><td>-1.05</td><td>0.368</td><td>1.000</td><td>1.000</td><td>798</td><td>tags=12%, list=7%, signal=13%</td></tr><tr><td class='lessen'>361</td><td>ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_UP</td><td></td><td>10</td><td>-0.51</td><td>-1.05</td><td>0.429</td><td>1.000</td><td>1.000</td><td>591</td><td>tags=20%, list=5%, signal=21%</td></tr><tr><td class='lessen'>362</td><td>HAMAI_APOPTOSIS_VIA_TRAIL_UP</td><td></td><td>446</td><td>-0.27</td><td>-1.05</td><td>0.283</td><td>1.000</td><td>1.000</td><td>3047</td><td>tags=36%, list=27%, signal=48%</td></tr><tr><td class='lessen'>363</td><td>MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP</td><td></td><td>14</td><td>-0.47</td><td>-1.05</td><td>0.417</td><td>1.000</td><td>1.000</td><td>1010</td><td>tags=21%, list=9%, signal=24%</td></tr><tr><td class='lessen'>364</td><td>BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN</td><td></td><td>41</td><td>-0.36</td><td>-1.05</td><td>0.378</td><td>1.000</td><td>1.000</td><td>2079</td><td>tags=27%, list=19%, signal=33%</td></tr><tr><td class='lessen'>365</td><td>PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_UP</td><td></td><td>10</td><td>-0.51</td><td>-1.05</td><td>0.458</td><td>1.000</td><td>1.000</td><td>1309</td><td>tags=30%, list=12%, signal=34%</td></tr><tr><td class='lessen'>366</td><td>GRESHOCK_CANCER_COPY_NUMBER_UP</td><td></td><td>278</td><td>-0.28</td><td>-1.05</td><td>0.331</td><td>1.000</td><td>1.000</td><td>2977</td><td>tags=37%, list=27%, signal=49%</td></tr><tr><td class='lessen'>367</td><td>WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR</td><td></td><td>114</td><td>-0.30</td><td>-1.04</td><td>0.365</td><td>1.000</td><td>1.000</td><td>1662</td><td>tags=18%, list=15%, signal=20%</td></tr><tr><td class='lessen'>368</td><td>BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN</td><td></td><td>114</td><td>-0.31</td><td>-1.04</td><td>0.373</td><td>1.000</td><td>1.000</td><td>1760</td><td>tags=23%, list=16%, signal=27%</td></tr><tr><td class='lessen'>369</td><td>ZHU_CMV_24_HR_UP</td><td></td><td>76</td><td>-0.33</td><td>-1.04</td><td>0.382</td><td>1.000</td><td>1.000</td><td>2453</td><td>tags=24%, list=22%, signal=30%</td></tr><tr><td class='lessen'>370</td><td>DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP</td><td></td><td>245</td><td>-0.28</td><td>-1.04</td><td>0.334</td><td>1.000</td><td>1.000</td><td>1788</td><td>tags=17%, list=16%, signal=19%</td></tr><tr><td class='lessen'>371</td><td>JAZAG_TGFB1_SIGNALING_DN</td><td></td><td>26</td><td>-0.40</td><td>-1.04</td><td>0.404</td><td>1.000</td><td>1.000</td><td>1016</td><td>tags=15%, list=9%, signal=17%</td></tr><tr><td class='lessen'>372</td><td>GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP</td><td></td><td>415</td><td>-0.27</td><td>-1.04</td><td>0.301</td><td>1.000</td><td>1.000</td><td>2001</td><td>tags=20%, list=18%, signal=24%</td></tr><tr><td class='lessen'>373</td><td>RIZKI_TUMOR_INVASIVENESS_2D_UP</td><td></td><td>57</td><td>-0.34</td><td>-1.04</td><td>0.402</td><td>1.000</td><td>1.000</td><td>1524</td><td>tags=18%, list=14%, signal=20%</td></tr><tr><td class='lessen'>374</td><td>ZHANG_BREAST_CANCER_PROGENITORS_UP</td><td></td><td>325</td><td>-0.27</td><td>-1.04</td><td>0.319</td><td>1.000</td><td>1.000</td><td>2476</td><td>tags=26%, list=22%, signal=32%</td></tr><tr><td class='lessen'>375</td><td>LIM_MAMMARY_STEM_CELL_UP</td><td></td><td>395</td><td>-0.27</td><td>-1.04</td><td>0.335</td><td>1.000</td><td>1.000</td><td>1001</td><td>tags=12%, list=9%, signal=13%</td></tr><tr><td class='lessen'>376</td><td>COLLIS_PRKDC_REGULATORS</td><td></td><td>15</td><td>-0.45</td><td>-1.04</td><td>0.421</td><td>1.000</td><td>1.000</td><td>3423</td><td>tags=33%, list=31%, signal=48%</td></tr><tr><td class='lessen'>377</td><td>SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN</td><td></td><td>23</td><td>-0.41</td><td>-1.04</td><td>0.407</td><td>1.000</td><td>1.000</td><td>453</td><td>tags=9%, list=4%, signal=9%</td></tr><tr><td class='lessen'>378</td><td>MANTOVANI_VIRAL_GPCR_SIGNALING_DN</td><td></td><td>34</td><td>-0.38</td><td>-1.03</td><td>0.434</td><td>1.000</td><td>1.000</td><td>1324</td><td>tags=26%, list=12%, signal=30%</td></tr><tr><td class='lessen'>379</td><td>TIAN_BHLHA15_TARGETS</td><td></td><td>14</td><td>-0.46</td><td>-1.03</td><td>0.436</td><td>1.000</td><td>1.000</td><td>1013</td><td>tags=21%, list=9%, signal=24%</td></tr><tr><td class='lessen'>380</td><td>PASINI_SUZ12_TARGETS_UP</td><td></td><td>74</td><td>-0.33</td><td>-1.03</td><td>0.398</td><td>1.000</td><td>1.000</td><td>1390</td><td>tags=20%, list=12%, signal=23%</td></tr><tr><td class='lessen'>381</td><td>GENTILE_UV_LOW_DOSE_DN</td><td></td><td>56</td><td>-0.34</td><td>-1.03</td><td>0.411</td><td>1.000</td><td>1.000</td><td>972</td><td>tags=11%, list=9%, signal=12%</td></tr><tr><td class='lessen'>382</td><td>HEDENFALK_BREAST_CANCER_BRACX_DN</td><td></td><td>17</td><td>-0.44</td><td>-1.03</td><td>0.403</td><td>1.000</td><td>1.000</td><td>3028</td><td>tags=53%, list=27%, signal=73%</td></tr><tr><td class='lessen'>383</td><td>OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP</td><td></td><td>187</td><td>-0.28</td><td>-1.03</td><td>0.358</td><td>1.000</td><td>1.000</td><td>1496</td><td>tags=18%, list=13%, signal=21%</td></tr><tr><td class='lessen'>384</td><td>MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3</td><td></td><td>20</td><td>-0.42</td><td>-1.03</td><td>0.423</td><td>1.000</td><td>1.000</td><td>567</td><td>tags=20%, list=5%, signal=21%</td></tr><tr><td class='lessen'>385</td><td>EHLERS_ANEUPLOIDY_UP</td><td></td><td>31</td><td>-0.38</td><td>-1.03</td><td>0.414</td><td>1.000</td><td>1.000</td><td>3202</td><td>tags=45%, list=29%, signal=63%</td></tr><tr><td class='lessen'>386</td><td>YANG_BCL3_TARGETS_UP</td><td></td><td>290</td><td>-0.27</td><td>-1.03</td><td>0.364</td><td>1.000</td><td>1.000</td><td>1583</td><td>tags=17%, list=14%, signal=20%</td></tr><tr><td class='lessen'>387</td><td>FUJIWARA_PARK2_IN_LIVER_CANCER_DN</td><td></td><td>5</td><td>-0.58</td><td>-1.03</td><td>0.506</td><td>1.000</td><td>1.000</td><td>802</td><td>tags=40%, list=7%, signal=43%</td></tr><tr><td class='lessen'>388</td><td>KONDO_EZH2_TARGETS</td><td></td><td>155</td><td>-0.29</td><td>-1.03</td><td>0.387</td><td>1.000</td><td>1.000</td><td>1210</td><td>tags=12%, list=11%, signal=14%</td></tr><tr><td class='lessen'>389</td><td>GESERICK_TERT_TARGETS_DN</td><td></td><td>20</td><td>-0.42</td><td>-1.03</td><td>0.434</td><td>1.000</td><td>1.000</td><td>1657</td><td>tags=40%, list=15%, signal=47%</td></tr><tr><td class='lessen'>390</td><td>GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP</td><td></td><td>58</td><td>-0.34</td><td>-1.02</td><td>0.418</td><td>1.000</td><td>1.000</td><td>1999</td><td>tags=19%, list=18%, signal=23%</td></tr><tr><td class='lessen'>391</td><td>YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN</td><td></td><td>59</td><td>-0.34</td><td>-1.02</td><td>0.398</td><td>1.000</td><td>1.000</td><td>1440</td><td>tags=19%, list=13%, signal=21%</td></tr><tr><td class='lessen'>392</td><td>KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3</td><td></td><td>51</td><td>-0.34</td><td>-1.02</td><td>0.417</td><td>1.000</td><td>1.000</td><td>1010</td><td>tags=14%, list=9%, signal=15%</td></tr><tr><td class='lessen'>393</td><td>JAEGER_METASTASIS_DN</td><td></td><td>165</td><td>-0.29</td><td>-1.02</td><td>0.391</td><td>1.000</td><td>1.000</td><td>1217</td><td>tags=18%, list=11%, signal=19%</td></tr><tr><td class='lessen'>394</td><td>WHITFIELD_CELL_CYCLE_S</td><td></td><td>115</td><td>-0.31</td><td>-1.02</td><td>0.395</td><td>1.000</td><td>1.000</td><td>2020</td><td>tags=25%, list=18%, signal=30%</td></tr><tr><td class='lessen'>395</td><td>ABRAMSON_INTERACT_WITH_AIRE</td><td></td><td>38</td><td>-0.36</td><td>-1.02</td><td>0.429</td><td>1.000</td><td>1.000</td><td>1796</td><td>tags=34%, list=16%, signal=41%</td></tr><tr><td class='lessen'>396</td><td>DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP</td><td></td><td>236</td><td>-0.27</td><td>-1.02</td><td>0.379</td><td>1.000</td><td>1.000</td><td>2023</td><td>tags=19%, list=18%, signal=23%</td></tr><tr><td class='lessen'>397</td><td>HINATA_NFKB_TARGETS_KERATINOCYTE_UP</td><td></td><td>73</td><td>-0.33</td><td>-1.02</td><td>0.427</td><td>1.000</td><td>1.000</td><td>1617</td><td>tags=15%, list=15%, signal=18%</td></tr><tr><td class='lessen'>398</td><td>KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP</td><td></td><td>71</td><td>-0.32</td><td>-1.02</td><td>0.400</td><td>1.000</td><td>1.000</td><td>2116</td><td>tags=31%, list=19%, signal=38%</td></tr><tr><td class='lessen'>399</td><td>HUTTMANN_B_CLL_POOR_SURVIVAL_DN</td><td></td><td>47</td><td>-0.35</td><td>-1.02</td><td>0.411</td><td>1.000</td><td>1.000</td><td>1370</td><td>tags=19%, list=12%, signal=22%</td></tr><tr><td class='lessen'>400</td><td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_17</td><td></td><td>15</td><td>-0.45</td><td>-1.02</td><td>0.446</td><td>1.000</td><td>1.000</td><td>2925</td><td>tags=40%, list=26%, signal=54%</td></tr><tr><td class='lessen'>401</td><td>XU_HGF_TARGETS_REPRESSED_BY_AKT1_UP</td><td></td><td>8</td><td>-0.51</td><td>-1.02</td><td>0.467</td><td>1.000</td><td>1.000</td><td>2585</td><td>tags=38%, list=23%, signal=49%</td></tr><tr><td class='lessen'>402</td><td>WENG_POR_TARGETS_GLOBAL_DN</td><td></td><td>20</td><td>-0.41</td><td>-1.02</td><td>0.449</td><td>1.000</td><td>1.000</td><td>1781</td><td>tags=30%, list=16%, signal=36%</td></tr><tr><td class='lessen'>403</td><td>AMIT_EGF_RESPONSE_20_HELA</td><td></td><td>9</td><td>-0.50</td><td>-1.01</td><td>0.496</td><td>1.000</td><td>1.000</td><td>2443</td><td>tags=56%, list=22%, signal=71%</td></tr><tr><td class='lessen'>404</td><td>TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP</td><td></td><td>207</td><td>-0.28</td><td>-1.01</td><td>0.425</td><td>1.000</td><td>1.000</td><td>1460</td><td>tags=16%, list=13%, signal=19%</td></tr><tr><td class='lessen'>405</td><td>RIZ_ERYTHROID_DIFFERENTIATION_6HR</td><td></td><td>24</td><td>-0.40</td><td>-1.01</td><td>0.429</td><td>1.000</td><td>1.000</td><td>132</td><td>tags=13%, list=1%, signal=13%</td></tr><tr><td class='lessen'>406</td><td>KREPPEL_CD99_TARGETS_DN</td><td></td><td>7</td><td>-0.53</td><td>-1.01</td><td>0.473</td><td>1.000</td><td>1.000</td><td>2324</td><td>tags=57%, list=21%, signal=72%</td></tr><tr><td class='lessen'>407</td><td>PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN</td><td></td><td>135</td><td>-0.29</td><td>-1.01</td><td>0.416</td><td>1.000</td><td>1.000</td><td>1038</td><td>tags=12%, list=9%, signal=13%</td></tr><tr><td class='lessen'>408</td><td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_24</td><td></td><td>12</td><td>-0.46</td><td>-1.01</td><td>0.472</td><td>1.000</td><td>1.000</td><td>2925</td><td>tags=42%, list=26%, signal=56%</td></tr><tr><td class='lessen'>409</td><td>CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN</td><td></td><td>39</td><td>-0.36</td><td>-1.01</td><td>0.437</td><td>1.000</td><td>1.000</td><td>277</td><td>tags=10%, list=2%, signal=10%</td></tr><tr><td class='lessen'>410</td><td>CONRAD_STEM_CELL</td><td></td><td>26</td><td>-0.38</td><td>-1.01</td><td>0.426</td><td>1.000</td><td>1.000</td><td>1075</td><td>tags=19%, list=10%, signal=21%</td></tr><tr><td class='lessen'>411</td><td>HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP</td><td></td><td>17</td><td>-0.43</td><td>-1.01</td><td>0.445</td><td>1.000</td><td>1.000</td><td>499</td><td>tags=12%, list=4%, signal=12%</td></tr><tr><td class='lessen'>412</td><td>MIZUSHIMA_AUTOPHAGOSOME_FORMATION</td><td></td><td>15</td><td>-0.45</td><td>-1.01</td><td>0.455</td><td>1.000</td><td>1.000</td><td>3717</td><td>tags=67%, list=33%, signal=100%</td></tr><tr><td class='lessen'>413</td><td>TSAI_RESPONSE_TO_RADIATION_THERAPY</td><td></td><td>28</td><td>-0.38</td><td>-1.01</td><td>0.441</td><td>1.000</td><td>1.000</td><td>567</td><td>tags=11%, list=5%, signal=11%</td></tr><tr><td class='lessen'>414</td><td>STREICHER_LSM1_TARGETS_UP</td><td></td><td>38</td><td>-0.37</td><td>-1.01</td><td>0.452</td><td>1.000</td><td>1.000</td><td>1930</td><td>tags=29%, list=17%, signal=35%</td></tr><tr><td class='lessen'>415</td><td>CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP</td><td></td><td>189</td><td>-0.28</td><td>-1.01</td><td>0.417</td><td>1.000</td><td>1.000</td><td>1615</td><td>tags=16%, list=15%, signal=19%</td></tr><tr><td class='lessen'>416</td><td>NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON</td><td></td><td>96</td><td>-0.31</td><td>-1.01</td><td>0.438</td><td>1.000</td><td>1.000</td><td>2191</td><td>tags=25%, list=20%, signal=31%</td></tr><tr><td class='lessen'>417</td><td>YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP</td><td></td><td>42</td><td>-0.35</td><td>-1.01</td><td>0.451</td><td>1.000</td><td>1.000</td><td>2400</td><td>tags=29%, list=22%, signal=36%</td></tr><tr><td class='lessen'>418</td><td>MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN</td><td></td><td>130</td><td>-0.29</td><td>-1.01</td><td>0.442</td><td>1.000</td><td>1.000</td><td>3218</td><td>tags=38%, list=29%, signal=52%</td></tr><tr><td class='lessen'>419</td><td>KAAB_FAILED_HEART_ATRIUM_UP</td><td></td><td>26</td><td>-0.38</td><td>-1.01</td><td>0.436</td><td>1.000</td><td>1.000</td><td>1672</td><td>tags=23%, list=15%, signal=27%</td></tr><tr><td class='lessen'>420</td><td>LEE_LIVER_CANCER_MYC_E2F1_DN</td><td></td><td>54</td><td>-0.34</td><td>-1.01</td><td>0.449</td><td>1.000</td><td>1.000</td><td>2523</td><td>tags=33%, list=23%, signal=43%</td></tr><tr><td class='lessen'>421</td><td>MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP</td><td></td><td>279</td><td>-0.27</td><td>-1.00</td><td>0.419</td><td>1.000</td><td>1.000</td><td>1143</td><td>tags=13%, list=10%, signal=14%</td></tr><tr><td class='lessen'>422</td><td>LU_AGING_BRAIN_DN</td><td></td><td>120</td><td>-0.30</td><td>-1.00</td><td>0.433</td><td>1.000</td><td>1.000</td><td>1307</td><td>tags=16%, list=12%, signal=18%</td></tr><tr><td class='lessen'>423</td><td>LINDVALL_IMMORTALIZED_BY_TERT_UP</td><td></td><td>68</td><td>-0.32</td><td>-1.00</td><td>0.448</td><td>1.000</td><td>1.000</td><td>2342</td><td>tags=29%, list=21%, signal=37%</td></tr><tr><td class='lessen'>424</td><td>LIU_CMYB_TARGETS_DN</td><td></td><td>6</td><td>-0.53</td><td>-1.00</td><td>0.489</td><td>1.000</td><td>1.000</td><td>3078</td><td>tags=50%, list=28%, signal=69%</td></tr><tr><td class='lessen'>425</td><td>NIKOLSKY_BREAST_CANCER_16P13_AMPLICON</td><td></td><td>75</td><td>-0.32</td><td>-1.00</td><td>0.427</td><td>1.000</td><td>1.000</td><td>2057</td><td>tags=28%, list=18%, signal=34%</td></tr><tr><td class='lessen'>426</td><td>GROSS_HYPOXIA_VIA_ELK3_DN</td><td></td><td>131</td><td>-0.29</td><td>-1.00</td><td>0.437</td><td>1.000</td><td>1.000</td><td>1657</td><td>tags=20%, list=15%, signal=23%</td></tr><tr><td class='lessen'>427</td><td>FIGUEROA_AML_METHYLATION_CLUSTER_5_DN</td><td></td><td>29</td><td>-0.37</td><td>-1.00</td><td>0.464</td><td>1.000</td><td>1.000</td><td>669</td><td>tags=14%, list=6%, signal=15%</td></tr><tr><td class='lessen'>428</td><td>BURTON_ADIPOGENESIS_3</td><td></td><td>90</td><td>-0.31</td><td>-1.00</td><td>0.447</td><td>1.000</td><td>1.000</td><td>1140</td><td>tags=17%, list=10%, signal=18%</td></tr><tr><td class='lessen'>429</td><td>JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP</td><td></td><td>87</td><td>-0.31</td><td>-1.00</td><td>0.445</td><td>1.000</td><td>1.000</td><td>637</td><td>tags=10%, list=6%, signal=11%</td></tr><tr><td class='lessen'>430</td><td>KAYO_CALORIE_RESTRICTION_MUSCLE_DN</td><td></td><td>65</td><td>-0.32</td><td>-1.00</td><td>0.455</td><td>1.000</td><td>1.000</td><td>1619</td><td>tags=15%, list=15%, signal=18%</td></tr><tr><td class='lessen'>431</td><td>BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN</td><td></td><td>31</td><td>-0.37</td><td>-1.00</td><td>0.470</td><td>1.000</td><td>1.000</td><td>2778</td><td>tags=39%, list=25%, signal=51%</td></tr><tr><td class='lessen'>432</td><td>ZHAN_MULTIPLE_MYELOMA_SUBGROUPS</td><td></td><td>29</td><td>-0.38</td><td>-1.00</td><td>0.463</td><td>1.000</td><td>1.000</td><td>2151</td><td>tags=34%, list=19%, signal=43%</td></tr><tr><td class='lessen'>433</td><td>CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70</td><td></td><td>50</td><td>-0.34</td><td>-1.00</td><td>0.444</td><td>1.000</td><td>1.000</td><td>743</td><td>tags=8%, list=7%, signal=9%</td></tr><tr><td class='lessen'>434</td><td>MCBRYAN_PUBERTAL_BREAST_4_5WK_UP</td><td></td><td>215</td><td>-0.27</td><td>-1.00</td><td>0.438</td><td>1.000</td><td>1.000</td><td>1238</td><td>tags=16%, list=11%, signal=18%</td></tr><tr><td class='lessen'>435</td><td>AMIT_EGF_RESPONSE_40_HELA</td><td></td><td>35</td><td>-0.36</td><td>-1.00</td><td>0.479</td><td>1.000</td><td>1.000</td><td>2381</td><td>tags=43%, list=21%, signal=54%</td></tr><tr><td class='lessen'>436</td><td>DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_UP</td><td></td><td>12</td><td>-0.46</td><td>-1.00</td><td>0.502</td><td>1.000</td><td>1.000</td><td>278</td><td>tags=8%, list=2%, signal=9%</td></tr><tr><td class='lessen'>437</td><td>STARK_BRAIN_22Q11_DELETION</td><td></td><td>6</td><td>-0.55</td><td>-1.00</td><td>0.506</td><td>1.000</td><td>1.000</td><td>216</td><td>tags=33%, list=2%, signal=34%</td></tr><tr><td class='lessen'>438</td><td>ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR</td><td></td><td>68</td><td>-0.32</td><td>-1.00</td><td>0.440</td><td>1.000</td><td>1.000</td><td>1828</td><td>tags=28%, list=16%, signal=33%</td></tr><tr><td class='lessen'>439</td><td>BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN</td><td></td><td>76</td><td>-0.31</td><td>-1.00</td><td>0.452</td><td>1.000</td><td>1.000</td><td>2506</td><td>tags=32%, list=23%, signal=40%</td></tr><tr><td class='lessen'>440</td><td>KOHOUTEK_CCNT1_TARGETS</td><td></td><td>41</td><td>-0.35</td><td>-0.99</td><td>0.473</td><td>1.000</td><td>1.000</td><td>1314</td><td>tags=22%, list=12%, signal=25%</td></tr><tr><td class='lessen'>441</td><td>WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN</td><td></td><td>19</td><td>-0.41</td><td>-0.99</td><td>0.477</td><td>1.000</td><td>1.000</td><td>712</td><td>tags=16%, list=6%, signal=17%</td></tr><tr><td class='lessen'>442</td><td>LI_WILMS_TUMOR</td><td></td><td>16</td><td>-0.42</td><td>-0.99</td><td>0.476</td><td>1.000</td><td>1.000</td><td>961</td><td>tags=25%, list=9%, signal=27%</td></tr><tr><td class='lessen'>443</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_4</td><td></td><td>13</td><td>-0.45</td><td>-0.99</td><td>0.485</td><td>1.000</td><td>1.000</td><td>222</td><td>tags=15%, list=2%, signal=16%</td></tr><tr><td class='lessen'>444</td><td>OUILLETTE_CLL_13Q14_DELETION_UP</td><td></td><td>52</td><td>-0.33</td><td>-0.99</td><td>0.446</td><td>1.000</td><td>1.000</td><td>1932</td><td>tags=23%, list=17%, signal=28%</td></tr><tr><td class='lessen'>445</td><td>BROWNE_HCMV_INFECTION_1HR_UP</td><td></td><td>41</td><td>-0.35</td><td>-0.99</td><td>0.463</td><td>1.000</td><td>1.000</td><td>1420</td><td>tags=20%, list=13%, signal=22%</td></tr><tr><td class='lessen'>446</td><td>WANG_CISPLATIN_RESPONSE_AND_XPC_DN</td><td></td><td>177</td><td>-0.28</td><td>-0.99</td><td>0.463</td><td>1.000</td><td>1.000</td><td>1711</td><td>tags=16%, list=15%, signal=19%</td></tr><tr><td class='lessen'>447</td><td>KIM_MYC_AMPLIFICATION_TARGETS_DN</td><td></td><td>63</td><td>-0.32</td><td>-0.99</td><td>0.470</td><td>1.000</td><td>1.000</td><td>814</td><td>tags=11%, list=7%, signal=12%</td></tr><tr><td class='lessen'>448</td><td>POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP</td><td></td><td>33</td><td>-0.36</td><td>-0.99</td><td>0.458</td><td>1.000</td><td>1.000</td><td>257</td><td>tags=9%, list=2%, signal=9%</td></tr><tr><td class='lessen'>449</td><td>CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP</td><td></td><td>129</td><td>-0.29</td><td>-0.99</td><td>0.464</td><td>1.000</td><td>1.000</td><td>2394</td><td>tags=30%, list=22%, signal=38%</td></tr><tr><td class='lessen'>450</td><td>KORKOLA_TERATOMA_UP</td><td></td><td>13</td><td>-0.44</td><td>-0.99</td><td>0.503</td><td>1.000</td><td>1.000</td><td>81</td><td>tags=8%, list=1%, signal=8%</td></tr><tr><td class='lessen'>451</td><td>DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP</td><td></td><td>207</td><td>-0.27</td><td>-0.99</td><td>0.484</td><td>1.000</td><td>1.000</td><td>1704</td><td>tags=16%, list=15%, signal=19%</td></tr><tr><td class='lessen'>452</td><td>ZHENG_GLIOBLASTOMA_PLASTICITY_UP</td><td></td><td>201</td><td>-0.27</td><td>-0.99</td><td>0.470</td><td>1.000</td><td>1.000</td><td>1036</td><td>tags=15%, list=9%, signal=17%</td></tr><tr><td class='lessen'>453</td><td>CHENG_IMPRINTED_BY_ESTRADIOL</td><td></td><td>68</td><td>-0.31</td><td>-0.99</td><td>0.454</td><td>1.000</td><td>1.000</td><td>1882</td><td>tags=28%, list=17%, signal=33%</td></tr><tr><td class='lessen'>454</td><td>NAGASHIMA_EGF_SIGNALING_UP</td><td></td><td>48</td><td>-0.34</td><td>-0.99</td><td>0.462</td><td>1.000</td><td>1.000</td><td>1417</td><td>tags=25%, list=13%, signal=29%</td></tr><tr><td class='lessen'>455</td><td>OUILLETTE_CLL_13Q14_DELETION_DN</td><td></td><td>47</td><td>-0.34</td><td>-0.99</td><td>0.485</td><td>1.000</td><td>1.000</td><td>2895</td><td>tags=43%, list=26%, signal=57%</td></tr><tr><td class='lessen'>456</td><td>VANHARANTA_UTERINE_FIBROID_DN</td><td></td><td>53</td><td>-0.33</td><td>-0.99</td><td>0.467</td><td>1.000</td><td>1.000</td><td>2745</td><td>tags=34%, list=25%, signal=45%</td></tr><tr><td class='lessen'>457</td><td>WANG_CLIM2_TARGETS_UP</td><td></td><td>171</td><td>-0.28</td><td>-0.99</td><td>0.498</td><td>1.000</td><td>1.000</td><td>2214</td><td>tags=22%, list=20%, signal=27%</td></tr><tr><td class='lessen'>458</td><td>MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_2</td><td></td><td>7</td><td>-0.50</td><td>-0.98</td><td>0.508</td><td>1.000</td><td>1.000</td><td>1247</td><td>tags=43%, list=11%, signal=48%</td></tr><tr><td class='lessen'>459</td><td>SHIPP_DLBCL_CURED_VS_FATAL_UP</td><td></td><td>28</td><td>-0.37</td><td>-0.98</td><td>0.485</td><td>1.000</td><td>1.000</td><td>702</td><td>tags=21%, list=6%, signal=23%</td></tr><tr><td class='lessen'>460</td><td>STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP</td><td></td><td>21</td><td>-0.40</td><td>-0.98</td><td>0.481</td><td>1.000</td><td>1.000</td><td>1116</td><td>tags=14%, list=10%, signal=16%</td></tr><tr><td class='lessen'>461</td><td>RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN</td><td></td><td>10</td><td>-0.47</td><td>-0.98</td><td>0.512</td><td>1.000</td><td>1.000</td><td>99</td><td>tags=10%, list=1%, signal=10%</td></tr><tr><td class='lessen'>462</td><td>CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN</td><td></td><td>35</td><td>-0.36</td><td>-0.98</td><td>0.496</td><td>1.000</td><td>1.000</td><td>845</td><td>tags=14%, list=8%, signal=15%</td></tr><tr><td class='lessen'>463</td><td>NIKOLSKY_BREAST_CANCER_22Q13_AMPLICON</td><td></td><td>13</td><td>-0.45</td><td>-0.98</td><td>0.518</td><td>1.000</td><td>1.000</td><td>1352</td><td>tags=38%, list=12%, signal=44%</td></tr><tr><td class='lessen'>464</td><td>HELLER_SILENCED_BY_METHYLATION_DN</td><td></td><td>83</td><td>-0.31</td><td>-0.98</td><td>0.501</td><td>1.000</td><td>1.000</td><td>2020</td><td>tags=25%, list=18%, signal=31%</td></tr><tr><td class='lessen'>465</td><td>ROVERSI_GLIOMA_COPY_NUMBER_DN</td><td></td><td>41</td><td>-0.34</td><td>-0.98</td><td>0.495</td><td>1.000</td><td>1.000</td><td>2851</td><td>tags=39%, list=26%, signal=52%</td></tr><tr><td class='lessen'>466</td><td>LEE_LIVER_CANCER_DENA_DN</td><td></td><td>57</td><td>-0.32</td><td>-0.98</td><td>0.487</td><td>1.000</td><td>1.000</td><td>2230</td><td>tags=39%, list=20%, signal=48%</td></tr><tr><td class='lessen'>467</td><td>MOOTHA_TCA</td><td></td><td>15</td><td>-0.42</td><td>-0.98</td><td>0.510</td><td>1.000</td><td>1.000</td><td>3084</td><td>tags=47%, list=28%, signal=64%</td></tr><tr><td class='lessen'>468</td><td>MADAN_DPPA4_TARGETS</td><td></td><td>26</td><td>-0.38</td><td>-0.98</td><td>0.493</td><td>1.000</td><td>1.000</td><td>580</td><td>tags=19%, list=5%, signal=20%</td></tr><tr><td class='lessen'>469</td><td>SANSOM_APC_TARGETS_UP</td><td></td><td>97</td><td>-0.30</td><td>-0.98</td><td>0.489</td><td>1.000</td><td>1.000</td><td>1622</td><td>tags=18%, list=15%, signal=20%</td></tr><tr><td class='lessen'>470</td><td>BOYLAN_MULTIPLE_MYELOMA_C_D_UP</td><td></td><td>105</td><td>-0.29</td><td>-0.98</td><td>0.481</td><td>1.000</td><td>1.000</td><td>1460</td><td>tags=18%, list=13%, signal=21%</td></tr><tr><td class='lessen'>471</td><td>MCBRYAN_PUBERTAL_BREAST_6_7WK_UP</td><td></td><td>164</td><td>-0.27</td><td>-0.98</td><td>0.497</td><td>1.000</td><td>1.000</td><td>1918</td><td>tags=16%, list=17%, signal=20%</td></tr><tr><td class='lessen'>472</td><td>NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_DN</td><td></td><td>15</td><td>-0.43</td><td>-0.98</td><td>0.499</td><td>1.000</td><td>1.000</td><td>195</td><td>tags=7%, list=2%, signal=7%</td></tr><tr><td class='lessen'>473</td><td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_16</td><td></td><td>8</td><td>-0.49</td><td>-0.98</td><td>0.517</td><td>1.000</td><td>1.000</td><td>1927</td><td>tags=50%, list=17%, signal=60%</td></tr><tr><td class='lessen'>474</td><td>PUJANA_BRCA_CENTERED_NETWORK</td><td></td><td>106</td><td>-0.29</td><td>-0.98</td><td>0.510</td><td>1.000</td><td>1.000</td><td>2025</td><td>tags=27%, list=18%, signal=33%</td></tr><tr><td class='lessen'>475</td><td>SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_UP</td><td></td><td>10</td><td>-0.46</td><td>-0.98</td><td>0.509</td><td>1.000</td><td>1.000</td><td>4430</td><td>tags=60%, list=40%, signal=100%</td></tr><tr><td class='lessen'>476</td><td>ZEMBUTSU_SENSITIVITY_TO_VINCRISTINE</td><td></td><td>15</td><td>-0.43</td><td>-0.98</td><td>0.504</td><td>1.000</td><td>1.000</td><td>645</td><td>tags=13%, list=6%, signal=14%</td></tr><tr><td class='lessen'>477</td><td>TOMIDA_LUNG_CANCER_POOR_SURVIVAL</td><td></td><td>5</td><td>-0.56</td><td>-0.98</td><td>0.542</td><td>1.000</td><td>1.000</td><td>368</td><td>tags=20%, list=3%, signal=21%</td></tr><tr><td class='lessen'>478</td><td>WILCOX_RESPONSE_TO_PROGESTERONE_UP</td><td></td><td>102</td><td>-0.29</td><td>-0.98</td><td>0.503</td><td>1.000</td><td>1.000</td><td>1044</td><td>tags=13%, list=9%, signal=14%</td></tr><tr><td class='lessen'>479</td><td>IKEDA_MIR1_TARGETS_DN</td><td></td><td>6</td><td>-0.54</td><td>-0.98</td><td>0.536</td><td>1.000</td><td>1.000</td><td>2171</td><td>tags=50%, list=20%, signal=62%</td></tr><tr><td class='lessen'>480</td><td>ZWANG_EGF_INTERVAL_DN</td><td></td><td>152</td><td>-0.28</td><td>-0.97</td><td>0.542</td><td>1.000</td><td>1.000</td><td>1725</td><td>tags=21%, list=15%, signal=25%</td></tr><tr><td class='lessen'>481</td><td>PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6</td><td></td><td>21</td><td>-0.39</td><td>-0.97</td><td>0.471</td><td>1.000</td><td>1.000</td><td>793</td><td>tags=14%, list=7%, signal=15%</td></tr><tr><td class='lessen'>482</td><td>MURAKAMI_UV_RESPONSE_6HR_DN</td><td></td><td>15</td><td>-0.43</td><td>-0.97</td><td>0.497</td><td>1.000</td><td>1.000</td><td>516</td><td>tags=13%, list=5%, signal=14%</td></tr><tr><td class='lessen'>483</td><td>DELACROIX_RAR_BOUND_ES</td><td></td><td>328</td><td>-0.26</td><td>-0.97</td><td>0.545</td><td>1.000</td><td>1.000</td><td>937</td><td>tags=9%, list=8%, signal=10%</td></tr><tr><td class='lessen'>484</td><td>LIU_LIVER_CANCER</td><td></td><td>25</td><td>-0.37</td><td>-0.97</td><td>0.497</td><td>1.000</td><td>1.000</td><td>2909</td><td>tags=36%, list=26%, signal=49%</td></tr><tr><td class='lessen'>485</td><td>ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP</td><td></td><td>61</td><td>-0.32</td><td>-0.97</td><td>0.522</td><td>1.000</td><td>1.000</td><td>2069</td><td>tags=33%, list=19%, signal=40%</td></tr><tr><td class='lessen'>486</td><td>SMID_BREAST_CANCER_ERBB2_DN</td><td></td><td>5</td><td>-0.55</td><td>-0.97</td><td>0.546</td><td>1.000</td><td>1.000</td><td>1010</td><td>tags=40%, list=9%, signal=44%</td></tr><tr><td class='lessen'>487</td><td>ANASTASSIOU_CANCER_MESENCHYMAL_TRANSITION_SIGNATURE</td><td></td><td>55</td><td>-0.32</td><td>-0.97</td><td>0.532</td><td>1.000</td><td>1.000</td><td>599</td><td>tags=11%, list=5%, signal=11%</td></tr><tr><td class='lessen'>488</td><td>LEE_AGING_MUSCLE_UP</td><td></td><td>36</td><td>-0.35</td><td>-0.97</td><td>0.512</td><td>1.000</td><td>1.000</td><td>1898</td><td>tags=28%, list=17%, signal=33%</td></tr><tr><td class='lessen'>489</td><td>RADMACHER_AML_PROGNOSIS</td><td></td><td>63</td><td>-0.31</td><td>-0.97</td><td>0.506</td><td>1.000</td><td>1.000</td><td>2100</td><td>tags=22%, list=19%, signal=27%</td></tr><tr><td class='lessen'>490</td><td>RODRIGUES_DCC_TARGETS_DN</td><td></td><td>106</td><td>-0.29</td><td>-0.97</td><td>0.533</td><td>1.000</td><td>1.000</td><td>2693</td><td>tags=35%, list=24%, signal=46%</td></tr><tr><td class='lessen'>491</td><td>DAIRKEE_CANCER_PRONE_RESPONSE_E2</td><td></td><td>24</td><td>-0.38</td><td>-0.97</td><td>0.506</td><td>1.000</td><td>1.000</td><td>1185</td><td>tags=25%, list=11%, signal=28%</td></tr><tr><td class='lessen'>492</td><td>CHANG_CORE_SERUM_RESPONSE_UP</td><td></td><td>165</td><td>-0.27</td><td>-0.97</td><td>0.518</td><td>1.000</td><td>1.000</td><td>2425</td><td>tags=24%, list=22%, signal=31%</td></tr><tr><td class='lessen'>493</td><td>KIM_WT1_TARGETS_12HR_DN</td><td></td><td>167</td><td>-0.27</td><td>-0.97</td><td>0.550</td><td>1.000</td><td>1.000</td><td>1416</td><td>tags=13%, list=13%, signal=14%</td></tr><tr><td class='lessen'>494</td><td>SENESE_HDAC1_AND_HDAC2_TARGETS_DN</td><td></td><td>168</td><td>-0.27</td><td>-0.96</td><td>0.542</td><td>1.000</td><td>1.000</td><td>1173</td><td>tags=14%, list=11%, signal=16%</td></tr><tr><td class='lessen'>495</td><td>ZHANG_TLX_TARGETS_UP</td><td></td><td>72</td><td>-0.30</td><td>-0.96</td><td>0.506</td><td>1.000</td><td>1.000</td><td>1172</td><td>tags=19%, list=11%, signal=22%</td></tr><tr><td class='lessen'>496</td><td>LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES</td><td></td><td>29</td><td>-0.36</td><td>-0.96</td><td>0.503</td><td>1.000</td><td>1.000</td><td>952</td><td>tags=17%, list=9%, signal=19%</td></tr><tr><td class='lessen'>497</td><td>VERRECCHIA_RESPONSE_TO_TGFB1_C2</td><td></td><td>24</td><td>-0.37</td><td>-0.96</td><td>0.499</td><td>1.000</td><td>1.000</td><td>277</td><td>tags=8%, list=2%, signal=9%</td></tr><tr><td class='lessen'>498</td><td>ZHENG_FOXP3_TARGETS_IN_THYMUS_UP</td><td></td><td>153</td><td>-0.27</td><td>-0.96</td><td>0.547</td><td>1.000</td><td>1.000</td><td>3249</td><td>tags=39%, list=29%, signal=54%</td></tr><tr><td class='lessen'>499</td><td>THEODOROU_MAMMARY_TUMORIGENESIS</td><td></td><td>18</td><td>-0.40</td><td>-0.96</td><td>0.527</td><td>1.000</td><td>1.000</td><td>418</td><td>tags=11%, list=4%, signal=12%</td></tr><tr><td class='lessen'>500</td><td>PALOMERO_GSI_SENSITIVITY_UP</td><td></td><td>7</td><td>-0.51</td><td>-0.96</td><td>0.557</td><td>1.000</td><td>1.000</td><td>101</td><td>tags=14%, list=1%, signal=14%</td></tr><tr><td class='lessen'>501</td><td>MIKKELSEN_IPS_ICP_WITH_H3K27ME3</td><td></td><td>31</td><td>-0.36</td><td>-0.96</td><td>0.525</td><td>1.000</td><td>1.000</td><td>676</td><td>tags=19%, list=6%, signal=21%</td></tr><tr><td class='lessen'>502</td><td>ROVERSI_GLIOMA_LOH_REGIONS</td><td></td><td>31</td><td>-0.35</td><td>-0.96</td><td>0.512</td><td>1.000</td><td>1.000</td><td>2869</td><td>tags=39%, list=26%, signal=52%</td></tr><tr><td class='lessen'>503</td><td>SHEPARD_CRUSH_AND_BURN_MUTANT_UP</td><td></td><td>147</td><td>-0.27</td><td>-0.96</td><td>0.555</td><td>1.000</td><td>1.000</td><td>1141</td><td>tags=14%, list=10%, signal=15%</td></tr><tr><td class='lessen'>504</td><td>WANG_SMARCE1_TARGETS_UP</td><td></td><td>214</td><td>-0.26</td><td>-0.96</td><td>0.591</td><td>1.000</td><td>1.000</td><td>1149</td><td>tags=13%, list=10%, signal=14%</td></tr><tr><td class='lessen'>505</td><td>KORKOLA_EMBRYONAL_CARCINOMA_UP</td><td></td><td>31</td><td>-0.36</td><td>-0.96</td><td>0.531</td><td>1.000</td><td>1.000</td><td>575</td><td>tags=10%, list=5%, signal=10%</td></tr><tr><td class='lessen'>506</td><td>LEIN_MEDULLA_MARKERS</td><td></td><td>58</td><td>-0.32</td><td>-0.96</td><td>0.542</td><td>1.000</td><td>1.000</td><td>509</td><td>tags=10%, list=5%, signal=11%</td></tr><tr><td class='lessen'>507</td><td>POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN</td><td></td><td>46</td><td>-0.33</td><td>-0.96</td><td>0.536</td><td>1.000</td><td>1.000</td><td>2075</td><td>tags=28%, list=19%, signal=35%</td></tr><tr><td class='lessen'>508</td><td>WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2</td><td></td><td>48</td><td>-0.33</td><td>-0.96</td><td>0.536</td><td>1.000</td><td>1.000</td><td>578</td><td>tags=10%, list=5%, signal=11%</td></tr><tr><td class='lessen'>509</td><td>JEPSEN_SMRT_TARGETS</td><td></td><td>28</td><td>-0.36</td><td>-0.96</td><td>0.511</td><td>1.000</td><td>1.000</td><td>516</td><td>tags=14%, list=5%, signal=15%</td></tr><tr><td class='lessen'>510</td><td>TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA</td><td></td><td>62</td><td>-0.31</td><td>-0.96</td><td>0.565</td><td>1.000</td><td>1.000</td><td>1806</td><td>tags=24%, list=16%, signal=29%</td></tr><tr><td class='lessen'>511</td><td>ROME_INSULIN_TARGETS_IN_MUSCLE_DN</td><td></td><td>117</td><td>-0.28</td><td>-0.96</td><td>0.545</td><td>1.000</td><td>1.000</td><td>1342</td><td>tags=15%, list=12%, signal=17%</td></tr><tr><td class='lessen'>512</td><td>ZUCCHI_METASTASIS_DN</td><td></td><td>34</td><td>-0.35</td><td>-0.96</td><td>0.512</td><td>1.000</td><td>1.000</td><td>1603</td><td>tags=21%, list=14%, signal=24%</td></tr><tr><td class='lessen'>513</td><td>TANG_SENESCENCE_TP53_TARGETS_UP</td><td></td><td>25</td><td>-0.37</td><td>-0.96</td><td>0.518</td><td>1.000</td><td>1.000</td><td>81</td><td>tags=8%, list=1%, signal=8%</td></tr><tr><td class='lessen'>514</td><td>TIEN_INTESTINE_PROBIOTICS_6HR_UP</td><td></td><td>47</td><td>-0.33</td><td>-0.96</td><td>0.516</td><td>1.000</td><td>1.000</td><td>2041</td><td>tags=28%, list=18%, signal=34%</td></tr><tr><td class='lessen'>515</td><td>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP</td><td></td><td>121</td><td>-0.28</td><td>-0.96</td><td>0.565</td><td>1.000</td><td>1.000</td><td>1150</td><td>tags=15%, list=10%, signal=16%</td></tr><tr><td class='lessen'>516</td><td>BROWNE_HCMV_INFECTION_30MIN_UP</td><td></td><td>40</td><td>-0.34</td><td>-0.96</td><td>0.521</td><td>1.000</td><td>1.000</td><td>1256</td><td>tags=23%, list=11%, signal=25%</td></tr><tr><td class='lessen'>517</td><td>ELVIDGE_HYPOXIA_BY_DMOG_UP</td><td></td><td>105</td><td>-0.28</td><td>-0.95</td><td>0.559</td><td>1.000</td><td>1.000</td><td>1630</td><td>tags=20%, list=15%, signal=23%</td></tr><tr><td class='lessen'>518</td><td>IVANOVA_HEMATOPOIESIS_STEM_CELL</td><td></td><td>186</td><td>-0.26</td><td>-0.95</td><td>0.575</td><td>1.000</td><td>1.000</td><td>1452</td><td>tags=17%, list=13%, signal=19%</td></tr><tr><td class='lessen'>519</td><td>SCHUHMACHER_MYC_TARGETS_DN</td><td></td><td>7</td><td>-0.50</td><td>-0.95</td><td>0.586</td><td>1.000</td><td>1.000</td><td>18</td><td>tags=14%, list=0%, signal=14%</td></tr><tr><td class='lessen'>520</td><td>BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP</td><td></td><td>25</td><td>-0.37</td><td>-0.95</td><td>0.528</td><td>1.000</td><td>1.000</td><td>1290</td><td>tags=24%, list=12%, signal=27%</td></tr><tr><td class='lessen'>521</td><td>XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN</td><td></td><td>15</td><td>-0.41</td><td>-0.95</td><td>0.528</td><td>1.000</td><td>1.000</td><td>278</td><td>tags=13%, list=2%, signal=14%</td></tr><tr><td class='lessen'>522</td><td>DURCHDEWALD_SKIN_CARCINOGENESIS_DN</td><td></td><td>207</td><td>-0.26</td><td>-0.95</td><td>0.631</td><td>1.000</td><td>1.000</td><td>3138</td><td>tags=39%, list=28%, signal=53%</td></tr><tr><td class='lessen'>523</td><td>HEDENFALK_BREAST_CANCER_HEREDITARY_VS_SPORADIC</td><td></td><td>38</td><td>-0.34</td><td>-0.95</td><td>0.531</td><td>1.000</td><td>1.000</td><td>1052</td><td>tags=13%, list=9%, signal=14%</td></tr><tr><td class='lessen'>524</td><td>SEMBA_FHIT_TARGETS_DN</td><td></td><td>9</td><td>-0.46</td><td>-0.95</td><td>0.538</td><td>1.000</td><td>1.000</td><td>1225</td><td>tags=33%, list=11%, signal=37%</td></tr><tr><td class='lessen'>525</td><td>HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_DN</td><td></td><td>7</td><td>-0.50</td><td>-0.95</td><td>0.559</td><td>1.000</td><td>1.000</td><td>778</td><td>tags=29%, list=7%, signal=31%</td></tr><tr><td class='lessen'>526</td><td>ONDER_CDH1_SIGNALING_VIA_CTNNB1</td><td></td><td>63</td><td>-0.31</td><td>-0.95</td><td>0.542</td><td>1.000</td><td>1.000</td><td>1137</td><td>tags=16%, list=10%, signal=18%</td></tr><tr><td class='lessen'>527</td><td>BENPORATH_ES_CORE_NINE</td><td></td><td>8</td><td>-0.48</td><td>-0.95</td><td>0.551</td><td>1.000</td><td>1.000</td><td>633</td><td>tags=25%, list=6%, signal=26%</td></tr><tr><td class='lessen'>528</td><td>ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP</td><td></td><td>167</td><td>-0.27</td><td>-0.95</td><td>0.596</td><td>1.000</td><td>1.000</td><td>1550</td><td>tags=17%, list=14%, signal=19%</td></tr><tr><td class='lessen'>529</td><td>SU_LIVER</td><td></td><td>42</td><td>-0.34</td><td>-0.95</td><td>0.538</td><td>1.000</td><td>1.000</td><td>2116</td><td>tags=24%, list=19%, signal=29%</td></tr><tr><td class='lessen'>530</td><td>MURAKAMI_UV_RESPONSE_1HR_UP</td><td></td><td>12</td><td>-0.44</td><td>-0.95</td><td>0.534</td><td>1.000</td><td>1.000</td><td>1490</td><td>tags=25%, list=13%, signal=29%</td></tr><tr><td class='lessen'>531</td><td>PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1</td><td></td><td>36</td><td>-0.34</td><td>-0.95</td><td>0.534</td><td>1.000</td><td>1.000</td><td>1020</td><td>tags=25%, list=9%, signal=27%</td></tr><tr><td class='lessen'>532</td><td>MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3</td><td></td><td>41</td><td>-0.33</td><td>-0.95</td><td>0.558</td><td>1.000</td><td>1.000</td><td>1310</td><td>tags=24%, list=12%, signal=28%</td></tr><tr><td class='lessen'>533</td><td>SABATES_COLORECTAL_ADENOMA_UP</td><td></td><td>80</td><td>-0.30</td><td>-0.95</td><td>0.562</td><td>1.000</td><td>1.000</td><td>791</td><td>tags=13%, list=7%, signal=13%</td></tr><tr><td class='lessen'>534</td><td>MOOTHA_ROS</td><td></td><td>6</td><td>-0.51</td><td>-0.94</td><td>0.560</td><td>1.000</td><td>1.000</td><td>604</td><td>tags=17%, list=5%, signal=18%</td></tr><tr><td class='lessen'>535</td><td>AMIT_EGF_RESPONSE_120_HELA</td><td></td><td>55</td><td>-0.31</td><td>-0.94</td><td>0.541</td><td>1.000</td><td>1.000</td><td>1552</td><td>tags=20%, list=14%, signal=23%</td></tr><tr><td class='lessen'>536</td><td>CHEBOTAEV_GR_TARGETS_UP</td><td></td><td>61</td><td>-0.31</td><td>-0.94</td><td>0.572</td><td>1.000</td><td>1.000</td><td>2667</td><td>tags=26%, list=24%, signal=34%</td></tr><tr><td class='lessen'>537</td><td>MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED</td><td></td><td>18</td><td>-0.39</td><td>-0.94</td><td>0.537</td><td>1.000</td><td>1.000</td><td>664</td><td>tags=28%, list=6%, signal=29%</td></tr><tr><td class='lessen'>538</td><td>RIZKI_TUMOR_INVASIVENESS_3D_DN</td><td></td><td>208</td><td>-0.26</td><td>-0.94</td><td>0.603</td><td>1.000</td><td>1.000</td><td>1836</td><td>tags=21%, list=16%, signal=25%</td></tr><tr><td class='lessen'>539</td><td>YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_UP</td><td></td><td>24</td><td>-0.36</td><td>-0.94</td><td>0.565</td><td>1.000</td><td>1.000</td><td>2132</td><td>tags=25%, list=19%, signal=31%</td></tr><tr><td class='lessen'>540</td><td>JOHNSTONE_PARVB_TARGETS_2_DN</td><td></td><td>265</td><td>-0.25</td><td>-0.94</td><td>0.635</td><td>1.000</td><td>1.000</td><td>3033</td><td>tags=29%, list=27%, signal=39%</td></tr><tr><td class='lessen'>541</td><td>ENK_UV_RESPONSE_KERATINOCYTE_DN</td><td></td><td>406</td><td>-0.24</td><td>-0.94</td><td>0.669</td><td>1.000</td><td>1.000</td><td>3146</td><td>tags=32%, list=28%, signal=43%</td></tr><tr><td class='lessen'>542</td><td>IKEDA_MIR1_TARGETS_UP</td><td></td><td>49</td><td>-0.32</td><td>-0.94</td><td>0.561</td><td>1.000</td><td>1.000</td><td>3571</td><td>tags=49%, list=32%, signal=72%</td></tr><tr><td class='lessen'>543</td><td>SANSOM_APC_TARGETS_REQUIRE_MYC</td><td></td><td>157</td><td>-0.27</td><td>-0.94</td><td>0.610</td><td>1.000</td><td>1.000</td><td>1885</td><td>tags=18%, list=17%, signal=22%</td></tr><tr><td class='lessen'>544</td><td>HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP</td><td></td><td>19</td><td>-0.38</td><td>-0.94</td><td>0.542</td><td>1.000</td><td>1.000</td><td>257</td><td>tags=11%, list=2%, signal=11%</td></tr><tr><td class='lessen'>545</td><td>DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN</td><td></td><td>16</td><td>-0.40</td><td>-0.94</td><td>0.573</td><td>1.000</td><td>1.000</td><td>1019</td><td>tags=19%, list=9%, signal=21%</td></tr><tr><td class='lessen'>546</td><td>NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON</td><td></td><td>101</td><td>-0.28</td><td>-0.94</td><td>0.600</td><td>1.000</td><td>1.000</td><td>822</td><td>tags=9%, list=7%, signal=10%</td></tr><tr><td class='lessen'>547</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN</td><td></td><td>21</td><td>-0.37</td><td>-0.94</td><td>0.545</td><td>1.000</td><td>1.000</td><td>1150</td><td>tags=19%, list=10%, signal=21%</td></tr><tr><td class='lessen'>548</td><td>ZEILSTRA_CD44_TARGETS_DN</td><td></td><td>7</td><td>-0.48</td><td>-0.94</td><td>0.572</td><td>1.000</td><td>1.000</td><td>388</td><td>tags=14%, list=3%, signal=15%</td></tr><tr><td class='lessen'>549</td><td>ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN</td><td></td><td>76</td><td>-0.30</td><td>-0.94</td><td>0.571</td><td>1.000</td><td>1.000</td><td>2403</td><td>tags=32%, list=22%, signal=40%</td></tr><tr><td class='lessen'>550</td><td>ZHANG_BREAST_CANCER_PROGENITORS_DN</td><td></td><td>123</td><td>-0.27</td><td>-0.94</td><td>0.601</td><td>1.000</td><td>1.000</td><td>1188</td><td>tags=13%, list=11%, signal=14%</td></tr><tr><td class='lessen'>551</td><td>THILLAINADESAN_ZNF217_TARGETS_UP</td><td></td><td>33</td><td>-0.34</td><td>-0.94</td><td>0.568</td><td>1.000</td><td>1.000</td><td>1250</td><td>tags=18%, list=11%, signal=20%</td></tr><tr><td class='lessen'>552</td><td>KORKOLA_TERATOMA</td><td></td><td>34</td><td>-0.34</td><td>-0.94</td><td>0.530</td><td>1.000</td><td>1.000</td><td>1247</td><td>tags=26%, list=11%, signal=30%</td></tr><tr><td class='lessen'>553</td><td>ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF</td><td></td><td>173</td><td>-0.26</td><td>-0.93</td><td>0.619</td><td>1.000</td><td>1.000</td><td>2546</td><td>tags=32%, list=23%, signal=41%</td></tr><tr><td class='lessen'>554</td><td>GRADE_COLON_VS_RECTAL_CANCER_UP</td><td></td><td>28</td><td>-0.36</td><td>-0.93</td><td>0.539</td><td>1.000</td><td>1.000</td><td>608</td><td>tags=7%, list=5%, signal=8%</td></tr><tr><td class='lessen'>555</td><td>GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN</td><td></td><td>52</td><td>-0.31</td><td>-0.93</td><td>0.587</td><td>1.000</td><td>1.000</td><td>3206</td><td>tags=44%, list=29%, signal=62%</td></tr><tr><td class='lessen'>556</td><td>BRACHAT_RESPONSE_TO_METHOTREXATE_UP</td><td></td><td>18</td><td>-0.39</td><td>-0.93</td><td>0.553</td><td>1.000</td><td>1.000</td><td>1141</td><td>tags=22%, list=10%, signal=25%</td></tr><tr><td class='lessen'>557</td><td>SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A</td><td></td><td>18</td><td>-0.39</td><td>-0.93</td><td>0.572</td><td>1.000</td><td>1.000</td><td>1835</td><td>tags=39%, list=16%, signal=46%</td></tr><tr><td class='lessen'>558</td><td>RUAN_RESPONSE_TO_TROGLITAZONE_DN</td><td></td><td>18</td><td>-0.40</td><td>-0.93</td><td>0.569</td><td>1.000</td><td>1.000</td><td>1205</td><td>tags=22%, list=11%, signal=25%</td></tr><tr><td class='lessen'>559</td><td>SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP</td><td></td><td>268</td><td>-0.25</td><td>-0.93</td><td>0.686</td><td>1.000</td><td>1.000</td><td>1551</td><td>tags=16%, list=14%, signal=18%</td></tr><tr><td class='lessen'>560</td><td>GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB</td><td></td><td>101</td><td>-0.28</td><td>-0.93</td><td>0.612</td><td>1.000</td><td>1.000</td><td>837</td><td>tags=10%, list=8%, signal=11%</td></tr><tr><td class='lessen'>561</td><td>IVANOVSKA_MIR106B_TARGETS</td><td></td><td>74</td><td>-0.29</td><td>-0.93</td><td>0.618</td><td>1.000</td><td>1.000</td><td>1314</td><td>tags=12%, list=12%, signal=14%</td></tr><tr><td class='lessen'>562</td><td>NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN</td><td></td><td>54</td><td>-0.31</td><td>-0.93</td><td>0.582</td><td>1.000</td><td>1.000</td><td>260</td><td>tags=9%, list=2%, signal=9%</td></tr><tr><td class='lessen'>563</td><td>GERY_CEBP_TARGETS</td><td></td><td>103</td><td>-0.28</td><td>-0.93</td><td>0.618</td><td>1.000</td><td>1.000</td><td>1358</td><td>tags=19%, list=12%, signal=22%</td></tr><tr><td class='lessen'>564</td><td>CHANG_POU5F1_TARGETS_UP</td><td></td><td>13</td><td>-0.42</td><td>-0.93</td><td>0.559</td><td>1.000</td><td>1.000</td><td>939</td><td>tags=15%, list=8%, signal=17%</td></tr><tr><td class='lessen'>565</td><td>DIERICK_SEROTONIN_FUNCTION_GENES</td><td></td><td>5</td><td>-0.52</td><td>-0.93</td><td>0.600</td><td>1.000</td><td>1.000</td><td>1581</td><td>tags=40%, list=14%, signal=47%</td></tr><tr><td class='lessen'>566</td><td>LI_ADIPOGENESIS_BY_ACTIVATED_PPARG</td><td></td><td>16</td><td>-0.39</td><td>-0.93</td><td>0.548</td><td>1.000</td><td>1.000</td><td>1583</td><td>tags=31%, list=14%, signal=36%</td></tr><tr><td class='lessen'>567</td><td>GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN</td><td></td><td>120</td><td>-0.28</td><td>-0.93</td><td>0.649</td><td>1.000</td><td>1.000</td><td>2780</td><td>tags=33%, list=25%, signal=44%</td></tr><tr><td class='lessen'>568</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2</td><td></td><td>66</td><td>-0.30</td><td>-0.93</td><td>0.589</td><td>1.000</td><td>1.000</td><td>1657</td><td>tags=26%, list=15%, signal=30%</td></tr><tr><td class='lessen'>569</td><td>ULE_SPLICING_VIA_NOVA2</td><td></td><td>30</td><td>-0.34</td><td>-0.93</td><td>0.581</td><td>1.000</td><td>1.000</td><td>4081</td><td>tags=63%, list=37%, signal=100%</td></tr><tr><td class='lessen'>570</td><td>SENESE_HDAC1_TARGETS_DN</td><td></td><td>177</td><td>-0.26</td><td>-0.93</td><td>0.668</td><td>1.000</td><td>1.000</td><td>1481</td><td>tags=18%, list=13%, signal=20%</td></tr><tr><td class='lessen'>571</td><td>BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN</td><td></td><td>46</td><td>-0.32</td><td>-0.93</td><td>0.577</td><td>1.000</td><td>1.000</td><td>2988</td><td>tags=39%, list=27%, signal=53%</td></tr><tr><td class='lessen'>572</td><td>CORRADETTI_MTOR_PATHWAY_REGULATORS_DN</td><td></td><td>5</td><td>-0.51</td><td>-0.92</td><td>0.582</td><td>1.000</td><td>1.000</td><td>2325</td><td>tags=40%, list=21%, signal=51%</td></tr><tr><td class='lessen'>573</td><td>RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP</td><td></td><td>19</td><td>-0.37</td><td>-0.92</td><td>0.558</td><td>1.000</td><td>1.000</td><td>1685</td><td>tags=21%, list=15%, signal=25%</td></tr><tr><td class='lessen'>574</td><td>KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD</td><td></td><td>20</td><td>-0.37</td><td>-0.92</td><td>0.574</td><td>1.000</td><td>1.000</td><td>1595</td><td>tags=25%, list=14%, signal=29%</td></tr><tr><td class='lessen'>575</td><td>WOOD_EBV_EBNA1_TARGETS_UP</td><td></td><td>93</td><td>-0.28</td><td>-0.92</td><td>0.637</td><td>1.000</td><td>1.000</td><td>423</td><td>tags=5%, list=4%, signal=6%</td></tr><tr><td class='lessen'>576</td><td>PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_UP</td><td></td><td>26</td><td>-0.36</td><td>-0.92</td><td>0.583</td><td>1.000</td><td>1.000</td><td>1904</td><td>tags=27%, list=17%, signal=32%</td></tr><tr><td class='lessen'>577</td><td>GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN</td><td></td><td>192</td><td>-0.26</td><td>-0.92</td><td>0.667</td><td>1.000</td><td>1.000</td><td>860</td><td>tags=10%, list=8%, signal=11%</td></tr><tr><td class='lessen'>578</td><td>RAO_BOUND_BY_SALL4_ISOFORM_B</td><td></td><td>380</td><td>-0.24</td><td>-0.92</td><td>0.740</td><td>1.000</td><td>1.000</td><td>1842</td><td>tags=19%, list=17%, signal=22%</td></tr><tr><td class='lessen'>579</td><td>MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP</td><td></td><td>104</td><td>-0.28</td><td>-0.92</td><td>0.633</td><td>1.000</td><td>1.000</td><td>2950</td><td>tags=36%, list=26%, signal=48%</td></tr><tr><td class='lessen'>580</td><td>ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN</td><td></td><td>15</td><td>-0.41</td><td>-0.92</td><td>0.575</td><td>1.000</td><td>1.000</td><td>551</td><td>tags=13%, list=5%, signal=14%</td></tr><tr><td class='lessen'>581</td><td>BHAT_ESR1_TARGETS_VIA_AKT1_DN</td><td></td><td>67</td><td>-0.29</td><td>-0.92</td><td>0.631</td><td>1.000</td><td>1.000</td><td>3041</td><td>tags=37%, list=27%, signal=51%</td></tr><tr><td class='lessen'>582</td><td>LEIN_CHOROID_PLEXUS_MARKERS</td><td></td><td>80</td><td>-0.29</td><td>-0.92</td><td>0.608</td><td>1.000</td><td>1.000</td><td>1079</td><td>tags=10%, list=10%, signal=11%</td></tr><tr><td class='lessen'>583</td><td>SHEPARD_BMYB_MORPHOLINO_UP</td><td></td><td>164</td><td>-0.26</td><td>-0.92</td><td>0.669</td><td>1.000</td><td>1.000</td><td>1034</td><td>tags=10%, list=9%, signal=11%</td></tr><tr><td class='lessen'>584</td><td>BILANGES_SERUM_RESPONSE_TRANSLATION</td><td></td><td>31</td><td>-0.34</td><td>-0.92</td><td>0.588</td><td>1.000</td><td>1.000</td><td>794</td><td>tags=13%, list=7%, signal=14%</td></tr><tr><td class='lessen'>585</td><td>PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP</td><td></td><td>62</td><td>-0.30</td><td>-0.92</td><td>0.609</td><td>1.000</td><td>1.000</td><td>1850</td><td>tags=26%, list=17%, signal=31%</td></tr><tr><td class='lessen'>586</td><td>GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP</td><td></td><td>158</td><td>-0.26</td><td>-0.92</td><td>0.661</td><td>1.000</td><td>1.000</td><td>1047</td><td>tags=10%, list=9%, signal=11%</td></tr><tr><td class='lessen'>587</td><td>BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN</td><td></td><td>42</td><td>-0.32</td><td>-0.92</td><td>0.600</td><td>1.000</td><td>1.000</td><td>1165</td><td>tags=14%, list=10%, signal=16%</td></tr><tr><td class='lessen'>588</td><td>MOOTHA_GLYCOGEN_METABOLISM</td><td></td><td>16</td><td>-0.39</td><td>-0.92</td><td>0.575</td><td>1.000</td><td>1.000</td><td>3553</td><td>tags=63%, list=32%, signal=92%</td></tr><tr><td class='lessen'>589</td><td>LOPES_METHYLATED_IN_COLON_CANCER_UP</td><td></td><td>18</td><td>-0.39</td><td>-0.92</td><td>0.586</td><td>1.000</td><td>1.000</td><td>981</td><td>tags=28%, list=9%, signal=30%</td></tr><tr><td class='lessen'>590</td><td>CHOW_RASSF1_TARGETS_DN</td><td></td><td>23</td><td>-0.36</td><td>-0.92</td><td>0.589</td><td>1.000</td><td>1.000</td><td>1597</td><td>tags=26%, list=14%, signal=30%</td></tr><tr><td class='lessen'>591</td><td>DORN_ADENOVIRUS_INFECTION_24HR_UP</td><td></td><td>10</td><td>-0.43</td><td>-0.92</td><td>0.584</td><td>1.000</td><td>1.000</td><td>2070</td><td>tags=40%, list=19%, signal=49%</td></tr><tr><td class='lessen'>592</td><td>FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN</td><td></td><td>451</td><td>-0.24</td><td>-0.92</td><td>0.808</td><td>1.000</td><td>1.000</td><td>2534</td><td>tags=29%, list=23%, signal=36%</td></tr><tr><td class='lessen'>593</td><td>DEN_INTERACT_WITH_LCA5</td><td></td><td>25</td><td>-0.35</td><td>-0.92</td><td>0.587</td><td>1.000</td><td>1.000</td><td>1105</td><td>tags=12%, list=10%, signal=13%</td></tr><tr><td class='lessen'>594</td><td>PHESSE_TARGETS_OF_APC_AND_MBD2_DN</td><td></td><td>10</td><td>-0.44</td><td>-0.92</td><td>0.612</td><td>1.000</td><td>1.000</td><td>28</td><td>tags=10%, list=0%, signal=10%</td></tr><tr><td class='lessen'>595</td><td>BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP</td><td></td><td>23</td><td>-0.36</td><td>-0.92</td><td>0.595</td><td>1.000</td><td>1.000</td><td>1214</td><td>tags=17%, list=11%, signal=19%</td></tr><tr><td class='lessen'>596</td><td>TANG_SENESCENCE_TP53_TARGETS_DN</td><td></td><td>46</td><td>-0.31</td><td>-0.92</td><td>0.583</td><td>1.000</td><td>1.000</td><td>1084</td><td>tags=24%, list=10%, signal=26%</td></tr><tr><td class='lessen'>597</td><td>RAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP</td><td></td><td>14</td><td>-0.40</td><td>-0.92</td><td>0.569</td><td>1.000</td><td>1.000</td><td>1528</td><td>tags=29%, list=14%, signal=33%</td></tr><tr><td class='lessen'>598</td><td>BOYLAN_MULTIPLE_MYELOMA_D_UP</td><td></td><td>70</td><td>-0.29</td><td>-0.92</td><td>0.616</td><td>1.000</td><td>1.000</td><td>1278</td><td>tags=13%, list=11%, signal=14%</td></tr><tr><td class='lessen'>599</td><td>MEISSNER_NPC_ICP_WITH_H3K4ME3</td><td></td><td>15</td><td>-0.39</td><td>-0.92</td><td>0.583</td><td>1.000</td><td>1.000</td><td>1444</td><td>tags=20%, list=13%, signal=23%</td></tr><tr><td class='lessen'>600</td><td>CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4</td><td></td><td>213</td><td>-0.25</td><td>-0.91</td><td>0.718</td><td>1.000</td><td>1.000</td><td>1406</td><td>tags=14%, list=13%, signal=16%</td></tr><tr><td class='lessen'>601</td><td>PEDRIOLI_MIR31_TARGETS_DN</td><td></td><td>282</td><td>-0.24</td><td>-0.91</td><td>0.744</td><td>1.000</td><td>1.000</td><td>1835</td><td>tags=20%, list=16%, signal=24%</td></tr><tr><td class='lessen'>602</td><td>PYEON_HPV_POSITIVE_TUMORS_DN</td><td></td><td>7</td><td>-0.46</td><td>-0.91</td><td>0.548</td><td>1.000</td><td>1.000</td><td>235</td><td>tags=14%, list=2%, signal=15%</td></tr><tr><td class='lessen'>603</td><td>LEE_LIVER_CANCER_CIPROFIBRATE_DN</td><td></td><td>51</td><td>-0.30</td><td>-0.91</td><td>0.626</td><td>1.000</td><td>1.000</td><td>2230</td><td>tags=39%, list=20%, signal=49%</td></tr><tr><td class='lessen'>604</td><td>KIM_WT1_TARGETS_8HR_UP</td><td></td><td>140</td><td>-0.26</td><td>-0.91</td><td>0.661</td><td>1.000</td><td>1.000</td><td>2292</td><td>tags=26%, list=21%, signal=32%</td></tr><tr><td class='lessen'>605</td><td>ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF</td><td></td><td>353</td><td>-0.24</td><td>-0.91</td><td>0.749</td><td>1.000</td><td>1.000</td><td>2559</td><td>tags=26%, list=23%, signal=33%</td></tr><tr><td class='lessen'>606</td><td>ABDELMOHSEN_ELAVL4_TARGETS</td><td></td><td>15</td><td>-0.39</td><td>-0.91</td><td>0.587</td><td>1.000</td><td>1.000</td><td>1685</td><td>tags=20%, list=15%, signal=24%</td></tr><tr><td class='lessen'>607</td><td>SEIDEN_ONCOGENESIS_BY_MET</td><td></td><td>71</td><td>-0.29</td><td>-0.91</td><td>0.629</td><td>1.000</td><td>1.000</td><td>2090</td><td>tags=24%, list=19%, signal=29%</td></tr><tr><td class='lessen'>608</td><td>FIRESTEIN_CTNNB1_PATHWAY</td><td></td><td>30</td><td>-0.34</td><td>-0.91</td><td>0.606</td><td>1.000</td><td>1.000</td><td>2499</td><td>tags=33%, list=22%, signal=43%</td></tr><tr><td class='lessen'>609</td><td>NAKAJIMA_EOSINOPHIL</td><td></td><td>21</td><td>-0.37</td><td>-0.91</td><td>0.592</td><td>1.000</td><td>1.000</td><td>523</td><td>tags=19%, list=5%, signal=20%</td></tr><tr><td class='lessen'>610</td><td>ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM</td><td></td><td>57</td><td>-0.30</td><td>-0.91</td><td>0.623</td><td>1.000</td><td>1.000</td><td>1482</td><td>tags=18%, list=13%, signal=20%</td></tr><tr><td class='lessen'>611</td><td>BROWNE_HCMV_INFECTION_16HR_UP</td><td></td><td>181</td><td>-0.25</td><td>-0.91</td><td>0.715</td><td>1.000</td><td>1.000</td><td>1955</td><td>tags=16%, list=18%, signal=19%</td></tr><tr><td class='lessen'>612</td><td>PENG_GLUTAMINE_DEPRIVATION_UP</td><td></td><td>34</td><td>-0.33</td><td>-0.91</td><td>0.589</td><td>1.000</td><td>1.000</td><td>1874</td><td>tags=24%, list=17%, signal=28%</td></tr><tr><td class='lessen'>613</td><td>DOUGLAS_BMI1_TARGETS_UP</td><td></td><td>433</td><td>-0.23</td><td>-0.91</td><td>0.821</td><td>1.000</td><td>1.000</td><td>1122</td><td>tags=10%, list=10%, signal=11%</td></tr><tr><td class='lessen'>614</td><td>JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN</td><td></td><td>49</td><td>-0.30</td><td>-0.91</td><td>0.617</td><td>1.000</td><td>1.000</td><td>1367</td><td>tags=14%, list=12%, signal=16%</td></tr><tr><td class='lessen'>615</td><td>POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP</td><td></td><td>45</td><td>-0.31</td><td>-0.91</td><td>0.650</td><td>1.000</td><td>1.000</td><td>1663</td><td>tags=20%, list=15%, signal=23%</td></tr><tr><td class='lessen'>616</td><td>KYNG_DNA_DAMAGE_BY_UV</td><td></td><td>55</td><td>-0.31</td><td>-0.91</td><td>0.641</td><td>1.000</td><td>1.000</td><td>1609</td><td>tags=15%, list=14%, signal=17%</td></tr><tr><td class='lessen'>617</td><td>GYORFFY_DOXORUBICIN_RESISTANCE</td><td></td><td>36</td><td>-0.33</td><td>-0.91</td><td>0.599</td><td>1.000</td><td>1.000</td><td>1318</td><td>tags=19%, list=12%, signal=22%</td></tr><tr><td class='lessen'>618</td><td>CHESLER_BRAIN_D6MIT150_QTL_CIS</td><td></td><td>6</td><td>-0.48</td><td>-0.91</td><td>0.594</td><td>1.000</td><td>1.000</td><td>2086</td><td>tags=67%, list=19%, signal=82%</td></tr><tr><td class='lessen'>619</td><td>PARENT_MTOR_SIGNALING_DN</td><td></td><td>30</td><td>-0.34</td><td>-0.91</td><td>0.581</td><td>1.000</td><td>1.000</td><td>1729</td><td>tags=20%, list=16%, signal=24%</td></tr><tr><td class='lessen'>620</td><td>GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11</td><td></td><td>47</td><td>-0.30</td><td>-0.91</td><td>0.629</td><td>1.000</td><td>1.000</td><td>2311</td><td>tags=28%, list=21%, signal=35%</td></tr><tr><td class='lessen'>621</td><td>GROSS_HYPOXIA_VIA_HIF1A_DN</td><td></td><td>89</td><td>-0.28</td><td>-0.91</td><td>0.665</td><td>1.000</td><td>1.000</td><td>1686</td><td>tags=24%, list=15%, signal=28%</td></tr><tr><td class='lessen'>622</td><td>LEE_LIVER_CANCER_MYC_TGFA_DN</td><td></td><td>52</td><td>-0.31</td><td>-0.91</td><td>0.615</td><td>1.000</td><td>1.000</td><td>2758</td><td>tags=35%, list=25%, signal=46%</td></tr><tr><td class='lessen'>623</td><td>MASSARWEH_TAMOXIFEN_RESISTANCE_UP</td><td></td><td>406</td><td>-0.23</td><td>-0.91</td><td>0.824</td><td>1.000</td><td>1.000</td><td>2509</td><td>tags=24%, list=23%, signal=30%</td></tr><tr><td class='lessen'>624</td><td>OLSSON_E2F3_TARGETS_UP</td><td></td><td>20</td><td>-0.38</td><td>-0.91</td><td>0.600</td><td>1.000</td><td>1.000</td><td>26</td><td>tags=5%, list=0%, signal=5%</td></tr><tr><td class='lessen'>625</td><td>CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP</td><td></td><td>59</td><td>-0.30</td><td>-0.90</td><td>0.622</td><td>1.000</td><td>1.000</td><td>1577</td><td>tags=15%, list=14%, signal=18%</td></tr><tr><td class='lessen'>626</td><td>WANG_RESPONSE_TO_PACLITAXEL_VIA_MAPK8_DN</td><td></td><td>5</td><td>-0.50</td><td>-0.90</td><td>0.584</td><td>1.000</td><td>1.000</td><td>3393</td><td>tags=40%, list=30%, signal=58%</td></tr><tr><td class='lessen'>627</td><td>ABE_VEGFA_TARGETS</td><td></td><td>15</td><td>-0.39</td><td>-0.90</td><td>0.595</td><td>1.000</td><td>1.000</td><td>418</td><td>tags=13%, list=4%, signal=14%</td></tr><tr><td class='lessen'>628</td><td>MCCLUNG_COCAINE_REWARD_5D</td><td></td><td>67</td><td>-0.29</td><td>-0.90</td><td>0.648</td><td>1.000</td><td>1.000</td><td>1648</td><td>tags=22%, list=15%, signal=26%</td></tr><tr><td class='lessen'>629</td><td>BROWNE_HCMV_INFECTION_48HR_DN</td><td></td><td>385</td><td>-0.23</td><td>-0.90</td><td>0.835</td><td>1.000</td><td>1.000</td><td>1304</td><td>tags=13%, list=12%, signal=14%</td></tr><tr><td class='lessen'>630</td><td>MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH</td><td></td><td>14</td><td>-0.41</td><td>-0.90</td><td>0.591</td><td>1.000</td><td>1.000</td><td>734</td><td>tags=14%, list=7%, signal=15%</td></tr><tr><td class='lessen'>631</td><td>STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP</td><td></td><td>148</td><td>-0.26</td><td>-0.90</td><td>0.714</td><td>1.000</td><td>1.000</td><td>1324</td><td>tags=14%, list=12%, signal=15%</td></tr><tr><td class='lessen'>632</td><td>GUILLAUMOND_KLF10_TARGETS_UP</td><td></td><td>41</td><td>-0.32</td><td>-0.90</td><td>0.620</td><td>1.000</td><td>1.000</td><td>1660</td><td>tags=22%, list=15%, signal=26%</td></tr><tr><td class='lessen'>633</td><td>NEWMAN_ERCC6_TARGETS_UP</td><td></td><td>16</td><td>-0.39</td><td>-0.90</td><td>0.594</td><td>1.000</td><td>1.000</td><td>224</td><td>tags=13%, list=2%, signal=13%</td></tr><tr><td class='lessen'>634</td><td>STREICHER_LSM1_TARGETS_DN</td><td></td><td>15</td><td>-0.41</td><td>-0.90</td><td>0.621</td><td>1.000</td><td>1.000</td><td>1721</td><td>tags=27%, list=15%, signal=32%</td></tr><tr><td class='lessen'>635</td><td>SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP</td><td></td><td>219</td><td>-0.25</td><td>-0.90</td><td>0.736</td><td>1.000</td><td>1.000</td><td>1550</td><td>tags=19%, list=14%, signal=21%</td></tr><tr><td class='lessen'>636</td><td>LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN</td><td></td><td>49</td><td>-0.31</td><td>-0.90</td><td>0.630</td><td>1.000</td><td>1.000</td><td>1676</td><td>tags=22%, list=15%, signal=26%</td></tr><tr><td class='lessen'>637</td><td>CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS</td><td></td><td>38</td><td>-0.32</td><td>-0.90</td><td>0.617</td><td>1.000</td><td>1.000</td><td>3267</td><td>tags=37%, list=29%, signal=52%</td></tr><tr><td class='lessen'>638</td><td>TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_DN</td><td></td><td>15</td><td>-0.39</td><td>-0.90</td><td>0.597</td><td>1.000</td><td>1.000</td><td>1888</td><td>tags=40%, list=17%, signal=48%</td></tr><tr><td class='lessen'>639</td><td>CARD_MIR302A_TARGETS</td><td></td><td>64</td><td>-0.29</td><td>-0.90</td><td>0.671</td><td>1.000</td><td>1.000</td><td>2010</td><td>tags=25%, list=18%, signal=30%</td></tr><tr><td class='lessen'>640</td><td>KYNG_DNA_DAMAGE_BY_4NQO_OR_GAMMA_RADIATION</td><td></td><td>13</td><td>-0.41</td><td>-0.90</td><td>0.603</td><td>1.000</td><td>1.000</td><td>516</td><td>tags=8%, list=5%, signal=8%</td></tr><tr><td class='lessen'>641</td><td>RUIZ_TNC_TARGETS_DN</td><td></td><td>119</td><td>-0.26</td><td>-0.90</td><td>0.696</td><td>1.000</td><td>1.000</td><td>876</td><td>tags=10%, list=8%, signal=11%</td></tr><tr><td class='lessen'>642</td><td>WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN</td><td></td><td>284</td><td>-0.24</td><td>-0.90</td><td>0.790</td><td>1.000</td><td>1.000</td><td>1368</td><td>tags=14%, list=12%, signal=16%</td></tr><tr><td class='lessen'>643</td><td>PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4</td><td></td><td>74</td><td>-0.28</td><td>-0.90</td><td>0.666</td><td>1.000</td><td>1.000</td><td>2344</td><td>tags=31%, list=21%, signal=39%</td></tr><tr><td class='lessen'>644</td><td>WU_ALZHEIMER_DISEASE_DN</td><td></td><td>15</td><td>-0.39</td><td>-0.90</td><td>0.633</td><td>1.000</td><td>1.000</td><td>75</td><td>tags=7%, list=1%, signal=7%</td></tr><tr><td class='lessen'>645</td><td>VERRECCHIA_RESPONSE_TO_TGFB1_C5</td><td></td><td>20</td><td>-0.37</td><td>-0.90</td><td>0.624</td><td>1.000</td><td>1.000</td><td>18</td><td>tags=5%, list=0%, signal=5%</td></tr><tr><td class='lessen'>646</td><td>MATZUK_SPERMATOGONIA</td><td></td><td>17</td><td>-0.38</td><td>-0.90</td><td>0.610</td><td>1.000</td><td>1.000</td><td>1306</td><td>tags=24%, list=12%, signal=27%</td></tr><tr><td class='lessen'>647</td><td>WAKASUGI_HAVE_ZNF143_BINDING_SITES</td><td></td><td>53</td><td>-0.30</td><td>-0.90</td><td>0.655</td><td>1.000</td><td>1.000</td><td>2741</td><td>tags=43%, list=25%, signal=57%</td></tr><tr><td class='lessen'>648</td><td>MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN</td><td></td><td>51</td><td>-0.30</td><td>-0.90</td><td>0.668</td><td>1.000</td><td>1.000</td><td>2056</td><td>tags=25%, list=18%, signal=31%</td></tr><tr><td class='lessen'>649</td><td>BROWNE_HCMV_INFECTION_24HR_UP</td><td></td><td>119</td><td>-0.27</td><td>-0.90</td><td>0.699</td><td>1.000</td><td>1.000</td><td>1122</td><td>tags=10%, list=10%, signal=11%</td></tr><tr><td class='lessen'>650</td><td>BROWNE_HCMV_INFECTION_20HR_UP</td><td></td><td>182</td><td>-0.25</td><td>-0.90</td><td>0.745</td><td>1.000</td><td>1.000</td><td>2868</td><td>tags=29%, list=26%, signal=38%</td></tr><tr><td class='lessen'>651</td><td>GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN</td><td></td><td>183</td><td>-0.25</td><td>-0.90</td><td>0.753</td><td>1.000</td><td>1.000</td><td>1165</td><td>tags=11%, list=10%, signal=13%</td></tr><tr><td class='lessen'>652</td><td>FARMER_BREAST_CANCER_CLUSTER_7</td><td></td><td>13</td><td>-0.40</td><td>-0.90</td><td>0.623</td><td>1.000</td><td>1.000</td><td>2281</td><td>tags=31%, list=20%, signal=39%</td></tr><tr><td class='lessen'>653</td><td>IWANAGA_CARCINOGENESIS_BY_KRAS_UP</td><td></td><td>116</td><td>-0.27</td><td>-0.90</td><td>0.721</td><td>1.000</td><td>1.000</td><td>960</td><td>tags=11%, list=9%, signal=12%</td></tr><tr><td class='lessen'>654</td><td>TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP</td><td></td><td>12</td><td>-0.41</td><td>-0.90</td><td>0.601</td><td>1.000</td><td>1.000</td><td>595</td><td>tags=17%, list=5%, signal=18%</td></tr><tr><td class='lessen'>655</td><td>KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN</td><td></td><td>19</td><td>-0.36</td><td>-0.90</td><td>0.612</td><td>1.000</td><td>1.000</td><td>2499</td><td>tags=42%, list=22%, signal=54%</td></tr><tr><td class='lessen'>656</td><td>SMIRNOV_RESPONSE_TO_IR_2HR_UP</td><td></td><td>42</td><td>-0.31</td><td>-0.89</td><td>0.658</td><td>1.000</td><td>1.000</td><td>1067</td><td>tags=19%, list=10%, signal=21%</td></tr><tr><td class='lessen'>657</td><td>NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_UP</td><td></td><td>14</td><td>-0.41</td><td>-0.89</td><td>0.630</td><td>1.000</td><td>1.000</td><td>852</td><td>tags=21%, list=8%, signal=23%</td></tr><tr><td class='lessen'>658</td><td>YAMAZAKI_TCEB3_TARGETS_DN</td><td></td><td>166</td><td>-0.25</td><td>-0.89</td><td>0.742</td><td>1.000</td><td>1.000</td><td>2286</td><td>tags=28%, list=21%, signal=35%</td></tr><tr><td class='lessen'>659</td><td>LE_NEURONAL_DIFFERENTIATION_UP</td><td></td><td>13</td><td>-0.41</td><td>-0.89</td><td>0.602</td><td>1.000</td><td>1.000</td><td>1963</td><td>tags=46%, list=18%, signal=56%</td></tr><tr><td class='lessen'>660</td><td>VIETOR_IFRD1_TARGETS</td><td></td><td>17</td><td>-0.38</td><td>-0.89</td><td>0.623</td><td>1.000</td><td>1.000</td><td>2424</td><td>tags=47%, list=22%, signal=60%</td></tr><tr><td class='lessen'>661</td><td>HSIAO_LIVER_SPECIFIC_GENES</td><td></td><td>191</td><td>-0.25</td><td>-0.89</td><td>0.736</td><td>1.000</td><td>1.000</td><td>2806</td><td>tags=29%, list=25%, signal=39%</td></tr><tr><td class='lessen'>662</td><td>SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_UP</td><td></td><td>5</td><td>-0.51</td><td>-0.89</td><td>0.624</td><td>1.000</td><td>1.000</td><td>941</td><td>tags=20%, list=8%, signal=22%</td></tr><tr><td class='lessen'>663</td><td>VANTVEER_BREAST_CANCER_METASTASIS_DN</td><td></td><td>91</td><td>-0.27</td><td>-0.89</td><td>0.710</td><td>1.000</td><td>1.000</td><td>1600</td><td>tags=21%, list=14%, signal=24%</td></tr><tr><td class='lessen'>664</td><td>MATZUK_PREOVULATORY_FOLLICLE</td><td></td><td>9</td><td>-0.45</td><td>-0.89</td><td>0.633</td><td>1.000</td><td>1.000</td><td>1248</td><td>tags=22%, list=11%, signal=25%</td></tr><tr><td class='lessen'>665</td><td>LEE_LIVER_CANCER_SURVIVAL_UP</td><td></td><td>131</td><td>-0.26</td><td>-0.89</td><td>0.736</td><td>1.000</td><td>1.000</td><td>1880</td><td>tags=22%, list=17%, signal=26%</td></tr><tr><td class='lessen'>666</td><td>TAVAZOIE_METASTASIS</td><td></td><td>64</td><td>-0.29</td><td>-0.89</td><td>0.669</td><td>1.000</td><td>1.000</td><td>1128</td><td>tags=17%, list=10%, signal=19%</td></tr><tr><td class='lessen'>667</td><td>MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN</td><td></td><td>430</td><td>-0.23</td><td>-0.89</td><td>0.846</td><td>1.000</td><td>1.000</td><td>3381</td><td>tags=34%, list=30%, signal=47%</td></tr><tr><td class='lessen'>668</td><td>CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP</td><td></td><td>45</td><td>-0.31</td><td>-0.89</td><td>0.652</td><td>1.000</td><td>1.000</td><td>1850</td><td>tags=27%, list=17%, signal=32%</td></tr><tr><td class='lessen'>669</td><td>LANDIS_ERBB2_BREAST_PRENEOPLASTIC_UP</td><td></td><td>17</td><td>-0.38</td><td>-0.89</td><td>0.615</td><td>1.000</td><td>1.000</td><td>4</td><td>tags=6%, list=0%, signal=6%</td></tr><tr><td class='lessen'>670</td><td>TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN</td><td></td><td>20</td><td>-0.37</td><td>-0.89</td><td>0.616</td><td>1.000</td><td>1.000</td><td>1074</td><td>tags=20%, list=10%, signal=22%</td></tr><tr><td class='lessen'>671</td><td>WANG_BARRETTS_ESOPHAGUS_DN</td><td></td><td>20</td><td>-0.37</td><td>-0.89</td><td>0.637</td><td>1.000</td><td>1.000</td><td>1864</td><td>tags=25%, list=17%, signal=30%</td></tr><tr><td class='lessen'>672</td><td>MARTINEZ_TP53_TARGETS_DN</td><td></td><td>430</td><td>-0.23</td><td>-0.89</td><td>0.888</td><td>1.000</td><td>1.000</td><td>1848</td><td>tags=19%, list=17%, signal=22%</td></tr><tr><td class='lessen'>673</td><td>SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP</td><td></td><td>16</td><td>-0.38</td><td>-0.89</td><td>0.617</td><td>1.000</td><td>1.000</td><td>2895</td><td>tags=38%, list=26%, signal=51%</td></tr><tr><td class='lessen'>674</td><td>RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN</td><td></td><td>72</td><td>-0.29</td><td>-0.89</td><td>0.669</td><td>1.000</td><td>1.000</td><td>1009</td><td>tags=11%, list=9%, signal=12%</td></tr><tr><td class='lessen'>675</td><td>VANTVEER_BREAST_CANCER_METASTASIS_UP</td><td></td><td>38</td><td>-0.32</td><td>-0.89</td><td>0.618</td><td>1.000</td><td>1.000</td><td>1390</td><td>tags=18%, list=12%, signal=21%</td></tr><tr><td class='lessen'>676</td><td>FURUKAWA_DUSP6_TARGETS_PCI35_DN</td><td></td><td>59</td><td>-0.29</td><td>-0.89</td><td>0.674</td><td>1.000</td><td>1.000</td><td>1231</td><td>tags=20%, list=11%, signal=23%</td></tr><tr><td class='lessen'>677</td><td>BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP</td><td></td><td>89</td><td>-0.27</td><td>-0.89</td><td>0.699</td><td>1.000</td><td>1.000</td><td>1344</td><td>tags=18%, list=12%, signal=20%</td></tr><tr><td class='lessen'>678</td><td>NAKAYAMA_FRA2_TARGETS</td><td></td><td>37</td><td>-0.32</td><td>-0.89</td><td>0.626</td><td>1.000</td><td>1.000</td><td>1358</td><td>tags=19%, list=12%, signal=21%</td></tr><tr><td class='lessen'>679</td><td>PARK_APL_PATHOGENESIS_UP</td><td></td><td>13</td><td>-0.40</td><td>-0.89</td><td>0.654</td><td>1.000</td><td>1.000</td><td>1335</td><td>tags=31%, list=12%, signal=35%</td></tr><tr><td class='lessen'>680</td><td>DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER</td><td></td><td>90</td><td>-0.27</td><td>-0.89</td><td>0.697</td><td>1.000</td><td>1.000</td><td>4219</td><td>tags=47%, list=38%, signal=75%</td></tr><tr><td class='lessen'>681</td><td>GOLUB_ALL_VS_AML_UP</td><td></td><td>23</td><td>-0.35</td><td>-0.89</td><td>0.633</td><td>1.000</td><td>1.000</td><td>36</td><td>tags=4%, list=0%, signal=4%</td></tr><tr><td class='lessen'>682</td><td>KAUFFMANN_DNA_REPAIR_GENES</td><td></td><td>202</td><td>-0.24</td><td>-0.88</td><td>0.778</td><td>1.000</td><td>1.000</td><td>1915</td><td>tags=25%, list=17%, signal=30%</td></tr><tr><td class='lessen'>683</td><td>MOOTHA_GLYCOLYSIS</td><td></td><td>19</td><td>-0.37</td><td>-0.88</td><td>0.627</td><td>1.000</td><td>1.000</td><td>2889</td><td>tags=37%, list=26%, signal=50%</td></tr><tr><td class='lessen'>684</td><td>BROWNE_HCMV_INFECTION_18HR_UP</td><td></td><td>144</td><td>-0.25</td><td>-0.88</td><td>0.748</td><td>1.000</td><td>1.000</td><td>3101</td><td>tags=35%, list=28%, signal=48%</td></tr><tr><td class='lessen'>685</td><td>DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP</td><td></td><td>25</td><td>-0.35</td><td>-0.88</td><td>0.646</td><td>1.000</td><td>1.000</td><td>1623</td><td>tags=28%, list=15%, signal=33%</td></tr><tr><td class='lessen'>686</td><td>GROSS_HYPOXIA_VIA_ELK3_ONLY_UP</td><td></td><td>30</td><td>-0.33</td><td>-0.88</td><td>0.686</td><td>1.000</td><td>1.000</td><td>1569</td><td>tags=23%, list=14%, signal=27%</td></tr><tr><td class='lessen'>687</td><td>RIZ_ERYTHROID_DIFFERENTIATION_CCNE1</td><td></td><td>34</td><td>-0.33</td><td>-0.88</td><td>0.613</td><td>1.000</td><td>1.000</td><td>3057</td><td>tags=53%, list=27%, signal=73%</td></tr><tr><td class='lessen'>688</td><td>SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5</td><td></td><td>43</td><td>-0.31</td><td>-0.88</td><td>0.674</td><td>1.000</td><td>1.000</td><td>1488</td><td>tags=16%, list=13%, signal=19%</td></tr><tr><td class='lessen'>689</td><td>GAVIN_FOXP3_TARGETS_CLUSTER_P7</td><td></td><td>73</td><td>-0.28</td><td>-0.88</td><td>0.709</td><td>1.000</td><td>1.000</td><td>2292</td><td>tags=30%, list=21%, signal=38%</td></tr><tr><td class='lessen'>690</td><td>BROWNE_HCMV_INFECTION_12HR_UP</td><td></td><td>80</td><td>-0.27</td><td>-0.88</td><td>0.723</td><td>1.000</td><td>1.000</td><td>2581</td><td>tags=25%, list=23%, signal=32%</td></tr><tr><td class='lessen'>691</td><td>KIM_GLIS2_TARGETS_DN</td><td></td><td>5</td><td>-0.50</td><td>-0.88</td><td>0.658</td><td>1.000</td><td>1.000</td><td>1074</td><td>tags=40%, list=10%, signal=44%</td></tr><tr><td class='lessen'>692</td><td>PUJANA_XPRSS_INT_NETWORK</td><td></td><td>145</td><td>-0.25</td><td>-0.88</td><td>0.763</td><td>1.000</td><td>1.000</td><td>3009</td><td>tags=38%, list=27%, signal=51%</td></tr><tr><td class='lessen'>693</td><td>KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION</td><td></td><td>77</td><td>-0.28</td><td>-0.88</td><td>0.700</td><td>1.000</td><td>1.000</td><td>698</td><td>tags=10%, list=6%, signal=11%</td></tr><tr><td class='lessen'>694</td><td>BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP</td><td></td><td>305</td><td>-0.23</td><td>-0.88</td><td>0.874</td><td>1.000</td><td>1.000</td><td>1882</td><td>tags=18%, list=17%, signal=21%</td></tr><tr><td class='lessen'>695</td><td>KIM_MYC_AMPLIFICATION_TARGETS_UP</td><td></td><td>149</td><td>-0.25</td><td>-0.88</td><td>0.771</td><td>1.000</td><td>1.000</td><td>2122</td><td>tags=23%, list=19%, signal=29%</td></tr><tr><td class='lessen'>696</td><td>MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP</td><td></td><td>199</td><td>-0.24</td><td>-0.88</td><td>0.819</td><td>1.000</td><td>1.000</td><td>2214</td><td>tags=24%, list=20%, signal=30%</td></tr><tr><td class='lessen'>697</td><td>TIAN_TNF_SIGNALING_VIA_NFKB</td><td></td><td>24</td><td>-0.35</td><td>-0.88</td><td>0.651</td><td>1.000</td><td>1.000</td><td>1420</td><td>tags=25%, list=13%, signal=29%</td></tr><tr><td class='lessen'>698</td><td>MIKKELSEN_MEF_LCP_WITH_H3K4ME3</td><td></td><td>102</td><td>-0.26</td><td>-0.88</td><td>0.728</td><td>1.000</td><td>1.000</td><td>952</td><td>tags=11%, list=9%, signal=12%</td></tr><tr><td class='lessen'>699</td><td>FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP</td><td></td><td>448</td><td>-0.22</td><td>-0.88</td><td>0.920</td><td>1.000</td><td>1.000</td><td>3406</td><td>tags=35%, list=31%, signal=49%</td></tr><tr><td class='lessen'>700</td><td>WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP</td><td></td><td>112</td><td>-0.26</td><td>-0.88</td><td>0.765</td><td>1.000</td><td>1.000</td><td>2050</td><td>tags=19%, list=18%, signal=23%</td></tr><tr><td class='lessen'>701</td><td>DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN</td><td></td><td>391</td><td>-0.23</td><td>-0.88</td><td>0.908</td><td>1.000</td><td>1.000</td><td>2123</td><td>tags=22%, list=19%, signal=27%</td></tr><tr><td class='lessen'>702</td><td>AMUNDSON_RESPONSE_TO_ARSENITE</td><td></td><td>171</td><td>-0.25</td><td>-0.88</td><td>0.806</td><td>1.000</td><td>1.000</td><td>2313</td><td>tags=23%, list=21%, signal=28%</td></tr><tr><td class='lessen'>703</td><td>SENESE_HDAC2_TARGETS_UP</td><td></td><td>91</td><td>-0.27</td><td>-0.87</td><td>0.728</td><td>1.000</td><td>1.000</td><td>1286</td><td>tags=11%, list=12%, signal=12%</td></tr><tr><td class='lessen'>704</td><td>MARTINEZ_RB1_AND_TP53_TARGETS_DN</td><td></td><td>431</td><td>-0.22</td><td>-0.87</td><td>0.916</td><td>1.000</td><td>1.000</td><td>1848</td><td>tags=19%, list=17%, signal=22%</td></tr><tr><td class='lessen'>705</td><td>FOURNIER_ACINAR_DEVELOPMENT_LATE_DN</td><td></td><td>20</td><td>-0.35</td><td>-0.87</td><td>0.673</td><td>1.000</td><td>1.000</td><td>175</td><td>tags=10%, list=2%, signal=10%</td></tr><tr><td class='lessen'>706</td><td>BECKER_TAMOXIFEN_RESISTANCE_DN</td><td></td><td>39</td><td>-0.30</td><td>-0.87</td><td>0.679</td><td>1.000</td><td>1.000</td><td>1753</td><td>tags=23%, list=16%, signal=27%</td></tr><tr><td class='lessen'>707</td><td>AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53</td><td></td><td>83</td><td>-0.27</td><td>-0.87</td><td>0.741</td><td>1.000</td><td>1.000</td><td>1827</td><td>tags=23%, list=16%, signal=27%</td></tr><tr><td class='lessen'>708</td><td>FORTSCHEGGER_PHF8_TARGETS_UP</td><td></td><td>199</td><td>-0.24</td><td>-0.87</td><td>0.844</td><td>1.000</td><td>1.000</td><td>2086</td><td>tags=21%, list=19%, signal=26%</td></tr><tr><td class='lessen'>709</td><td>LIAO_HAVE_SOX4_BINDING_SITES</td><td></td><td>37</td><td>-0.31</td><td>-0.87</td><td>0.677</td><td>1.000</td><td>1.000</td><td>1220</td><td>tags=11%, list=11%, signal=12%</td></tr><tr><td class='lessen'>710</td><td>MONTERO_THYROID_CANCER_POOR_SURVIVAL_UP</td><td></td><td>11</td><td>-0.41</td><td>-0.87</td><td>0.624</td><td>1.000</td><td>1.000</td><td>1225</td><td>tags=36%, list=11%, signal=41%</td></tr><tr><td class='lessen'>711</td><td>SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP</td><td></td><td>53</td><td>-0.29</td><td>-0.87</td><td>0.693</td><td>1.000</td><td>1.000</td><td>1440</td><td>tags=21%, list=13%, signal=24%</td></tr><tr><td class='lessen'>712</td><td>HINATA_NFKB_TARGETS_FIBROBLAST_UP</td><td></td><td>69</td><td>-0.28</td><td>-0.87</td><td>0.743</td><td>1.000</td><td>1.000</td><td>553</td><td>tags=7%, list=5%, signal=8%</td></tr><tr><td class='lessen'>713</td><td>TOMLINS_PROSTATE_CANCER_UP</td><td></td><td>34</td><td>-0.32</td><td>-0.87</td><td>0.683</td><td>1.000</td><td>1.000</td><td>2039</td><td>tags=21%, list=18%, signal=25%</td></tr><tr><td class='lessen'>714</td><td>WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP</td><td></td><td>19</td><td>-0.37</td><td>-0.87</td><td>0.632</td><td>1.000</td><td>1.000</td><td>1225</td><td>tags=21%, list=11%, signal=24%</td></tr><tr><td class='lessen'>715</td><td>FIRESTEIN_CTNNB1_PATHWAY_AND_PROLIFERATION</td><td></td><td>8</td><td>-0.44</td><td>-0.87</td><td>0.625</td><td>1.000</td><td>1.000</td><td>3866</td><td>tags=63%, list=35%, signal=96%</td></tr><tr><td class='lessen'>716</td><td>WILCOX_RESPONSE_TO_PROGESTERONE_DN</td><td></td><td>49</td><td>-0.29</td><td>-0.87</td><td>0.706</td><td>1.000</td><td>1.000</td><td>336</td><td>tags=6%, list=3%, signal=6%</td></tr><tr><td class='lessen'>717</td><td>SU_THYMUS</td><td></td><td>15</td><td>-0.38</td><td>-0.87</td><td>0.655</td><td>1.000</td><td>1.000</td><td>917</td><td>tags=20%, list=8%, signal=22%</td></tr><tr><td class='lessen'>718</td><td>HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP</td><td></td><td>19</td><td>-0.36</td><td>-0.87</td><td>0.666</td><td>1.000</td><td>1.000</td><td>739</td><td>tags=21%, list=7%, signal=23%</td></tr><tr><td class='lessen'>719</td><td>WANG_LMO4_TARGETS_DN</td><td></td><td>256</td><td>-0.23</td><td>-0.87</td><td>0.864</td><td>1.000</td><td>1.000</td><td>2369</td><td>tags=21%, list=21%, signal=26%</td></tr><tr><td class='lessen'>720</td><td>SHI_SPARC_TARGETS_UP</td><td></td><td>21</td><td>-0.35</td><td>-0.87</td><td>0.648</td><td>1.000</td><td>1.000</td><td>1405</td><td>tags=29%, list=13%, signal=33%</td></tr><tr><td class='lessen'>721</td><td>KOBAYASHI_RESPONSE_TO_ROMIDEPSIN</td><td></td><td>13</td><td>-0.39</td><td>-0.87</td><td>0.643</td><td>1.000</td><td>1.000</td><td>3765</td><td>tags=69%, list=34%, signal=104%</td></tr><tr><td class='lessen'>722</td><td>ALFANO_MYC_TARGETS</td><td></td><td>198</td><td>-0.24</td><td>-0.87</td><td>0.866</td><td>1.000</td><td>1.000</td><td>1623</td><td>tags=14%, list=15%, signal=16%</td></tr><tr><td class='lessen'>723</td><td>BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN</td><td></td><td>30</td><td>-0.32</td><td>-0.87</td><td>0.669</td><td>1.000</td><td>1.000</td><td>553</td><td>tags=10%, list=5%, signal=10%</td></tr><tr><td class='lessen'>724</td><td>VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP</td><td></td><td>55</td><td>-0.29</td><td>-0.86</td><td>0.701</td><td>1.000</td><td>1.000</td><td>1958</td><td>tags=15%, list=18%, signal=18%</td></tr><tr><td class='lessen'>725</td><td>BILD_E2F3_ONCOGENIC_SIGNATURE</td><td></td><td>177</td><td>-0.24</td><td>-0.86</td><td>0.819</td><td>1.000</td><td>1.000</td><td>2065</td><td>tags=24%, list=19%, signal=29%</td></tr><tr><td class='lessen'>726</td><td>LEE_RECENT_THYMIC_EMIGRANT</td><td></td><td>169</td><td>-0.24</td><td>-0.86</td><td>0.815</td><td>1.000</td><td>1.000</td><td>1556</td><td>tags=18%, list=14%, signal=20%</td></tr><tr><td class='lessen'>727</td><td>FINETTI_BREAST_CANCERS_KINOME_BLUE</td><td></td><td>14</td><td>-0.37</td><td>-0.86</td><td>0.663</td><td>1.000</td><td>1.000</td><td>1864</td><td>tags=29%, list=17%, signal=34%</td></tr><tr><td class='lessen'>728</td><td>VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN</td><td></td><td>109</td><td>-0.26</td><td>-0.86</td><td>0.789</td><td>1.000</td><td>1.000</td><td>553</td><td>tags=6%, list=5%, signal=7%</td></tr><tr><td class='lessen'>729</td><td>FIGUEROA_AML_METHYLATION_CLUSTER_1_UP</td><td></td><td>70</td><td>-0.28</td><td>-0.86</td><td>0.722</td><td>1.000</td><td>1.000</td><td>704</td><td>tags=9%, list=6%, signal=9%</td></tr><tr><td class='lessen'>730</td><td>MCCLUNG_DELTA_FOSB_TARGETS_2WK</td><td></td><td>30</td><td>-0.32</td><td>-0.86</td><td>0.681</td><td>1.000</td><td>1.000</td><td>1518</td><td>tags=23%, list=14%, signal=27%</td></tr><tr><td class='lessen'>731</td><td>BIDUS_METASTASIS_UP</td><td></td><td>160</td><td>-0.25</td><td>-0.86</td><td>0.811</td><td>1.000</td><td>1.000</td><td>2861</td><td>tags=29%, list=26%, signal=39%</td></tr><tr><td class='lessen'>732</td><td>BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN</td><td></td><td>30</td><td>-0.31</td><td>-0.86</td><td>0.676</td><td>1.000</td><td>1.000</td><td>1668</td><td>tags=27%, list=15%, signal=31%</td></tr><tr><td class='lessen'>733</td><td>YAMASHITA_LIVER_CANCER_STEM_CELL_DN</td><td></td><td>62</td><td>-0.28</td><td>-0.86</td><td>0.734</td><td>1.000</td><td>1.000</td><td>1866</td><td>tags=23%, list=17%, signal=27%</td></tr><tr><td class='lessen'>734</td><td>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP</td><td></td><td>45</td><td>-0.29</td><td>-0.86</td><td>0.690</td><td>1.000</td><td>1.000</td><td>851</td><td>tags=11%, list=8%, signal=12%</td></tr><tr><td class='lessen'>735</td><td>MATZUK_MALE_REPRODUCTION_SERTOLI</td><td></td><td>21</td><td>-0.34</td><td>-0.86</td><td>0.672</td><td>1.000</td><td>1.000</td><td>2543</td><td>tags=43%, list=23%, signal=55%</td></tr><tr><td class='lessen'>736</td><td>BURTON_ADIPOGENESIS_10</td><td></td><td>26</td><td>-0.33</td><td>-0.86</td><td>0.686</td><td>1.000</td><td>1.000</td><td>2532</td><td>tags=46%, list=23%, signal=60%</td></tr><tr><td class='lessen'>737</td><td>GU_PDEF_TARGETS_UP</td><td></td><td>67</td><td>-0.28</td><td>-0.86</td><td>0.734</td><td>1.000</td><td>1.000</td><td>1704</td><td>tags=19%, list=15%, signal=23%</td></tr><tr><td class='lessen'>738</td><td>PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7</td><td></td><td>291</td><td>-0.23</td><td>-0.86</td><td>0.888</td><td>1.000</td><td>1.000</td><td>2180</td><td>tags=22%, list=20%, signal=27%</td></tr><tr><td class='lessen'>739</td><td>MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN</td><td></td><td>158</td><td>-0.24</td><td>-0.86</td><td>0.812</td><td>1.000</td><td>1.000</td><td>1946</td><td>tags=23%, list=17%, signal=27%</td></tr><tr><td class='lessen'>740</td><td>BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP</td><td></td><td>41</td><td>-0.30</td><td>-0.86</td><td>0.678</td><td>1.000</td><td>1.000</td><td>809</td><td>tags=10%, list=7%, signal=10%</td></tr><tr><td class='lessen'>741</td><td>TERAMOTO_OPN_TARGETS_CLUSTER_7</td><td></td><td>16</td><td>-0.37</td><td>-0.86</td><td>0.644</td><td>1.000</td><td>1.000</td><td>2039</td><td>tags=38%, list=18%, signal=46%</td></tr><tr><td class='lessen'>742</td><td>VANTVEER_BREAST_CANCER_ESR1_UP</td><td></td><td>123</td><td>-0.25</td><td>-0.86</td><td>0.782</td><td>1.000</td><td>1.000</td><td>767</td><td>tags=10%, list=7%, signal=10%</td></tr><tr><td class='lessen'>743</td><td>WANG_ESOPHAGUS_CANCER_PROGRESSION_UP</td><td></td><td>6</td><td>-0.47</td><td>-0.86</td><td>0.651</td><td>1.000</td><td>1.000</td><td>293</td><td>tags=17%, list=3%, signal=17%</td></tr><tr><td class='lessen'>744</td><td>NADERI_BREAST_CANCER_PROGNOSIS_UP</td><td></td><td>33</td><td>-0.31</td><td>-0.86</td><td>0.689</td><td>1.000</td><td>1.000</td><td>633</td><td>tags=12%, list=6%, signal=13%</td></tr><tr><td class='lessen'>745</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0</td><td></td><td>61</td><td>-0.28</td><td>-0.86</td><td>0.752</td><td>1.000</td><td>1.000</td><td>1460</td><td>tags=16%, list=13%, signal=19%</td></tr><tr><td class='lessen'>746</td><td>HORIUCHI_WTAP_TARGETS_UP</td><td></td><td>226</td><td>-0.23</td><td>-0.86</td><td>0.883</td><td>1.000</td><td>1.000</td><td>1868</td><td>tags=18%, list=17%, signal=21%</td></tr><tr><td class='lessen'>747</td><td>BOYAULT_LIVER_CANCER_SUBCLASS_G23_DN</td><td></td><td>8</td><td>-0.44</td><td>-0.86</td><td>0.638</td><td>1.000</td><td>1.000</td><td>1272</td><td>tags=25%, list=11%, signal=28%</td></tr><tr><td class='lessen'>748</td><td>KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES</td><td></td><td>155</td><td>-0.25</td><td>-0.86</td><td>0.833</td><td>1.000</td><td>1.000</td><td>778</td><td>tags=8%, list=7%, signal=9%</td></tr><tr><td class='lessen'>749</td><td>MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS</td><td></td><td>10</td><td>-0.42</td><td>-0.86</td><td>0.690</td><td>1.000</td><td>1.000</td><td>1800</td><td>tags=30%, list=16%, signal=36%</td></tr><tr><td class='lessen'>750</td><td>KARAKAS_TGFB1_SIGNALING</td><td></td><td>14</td><td>-0.40</td><td>-0.86</td><td>0.664</td><td>1.000</td><td>1.000</td><td>654</td><td>tags=14%, list=6%, signal=15%</td></tr><tr><td class='lessen'>751</td><td>KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN</td><td></td><td>64</td><td>-0.28</td><td>-0.86</td><td>0.749</td><td>1.000</td><td>1.000</td><td>1885</td><td>tags=25%, list=17%, signal=30%</td></tr><tr><td class='lessen'>752</td><td>KOINUMA_COLON_CANCER_MSI_UP</td><td></td><td>12</td><td>-0.40</td><td>-0.86</td><td>0.646</td><td>1.000</td><td>1.000</td><td>175</td><td>tags=8%, list=2%, signal=8%</td></tr><tr><td class='lessen'>753</td><td>SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM</td><td></td><td>126</td><td>-0.25</td><td>-0.86</td><td>0.804</td><td>1.000</td><td>1.000</td><td>3546</td><td>tags=39%, list=32%, signal=56%</td></tr><tr><td class='lessen'>754</td><td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_7</td><td></td><td>6</td><td>-0.46</td><td>-0.86</td><td>0.642</td><td>1.000</td><td>1.000</td><td>1185</td><td>tags=33%, list=11%, signal=37%</td></tr><tr><td class='lessen'>755</td><td>BURTON_ADIPOGENESIS_12</td><td></td><td>20</td><td>-0.35</td><td>-0.86</td><td>0.650</td><td>1.000</td><td>1.000</td><td>3908</td><td>tags=55%, list=35%, signal=85%</td></tr><tr><td class='lessen'>756</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP</td><td></td><td>15</td><td>-0.37</td><td>-0.86</td><td>0.694</td><td>1.000</td><td>1.000</td><td>1298</td><td>tags=27%, list=12%, signal=30%</td></tr><tr><td class='lessen'>757</td><td>ZHENG_FOXP3_TARGETS_IN_THYMUS_DN</td><td></td><td>7</td><td>-0.45</td><td>-0.86</td><td>0.663</td><td>1.000</td><td>1.000</td><td>1397</td><td>tags=29%, list=13%, signal=33%</td></tr><tr><td class='lessen'>758</td><td>KAPOSI_LIVER_CANCER_MET_UP</td><td></td><td>17</td><td>-0.36</td><td>-0.86</td><td>0.691</td><td>1.000</td><td>1.000</td><td>485</td><td>tags=6%, list=4%, signal=6%</td></tr><tr><td class='lessen'>759</td><td>SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS</td><td></td><td>33</td><td>-0.31</td><td>-0.86</td><td>0.694</td><td>1.000</td><td>1.000</td><td>293</td><td>tags=6%, list=3%, signal=6%</td></tr><tr><td class='lessen'>760</td><td>VERHAAK_GLIOBLASTOMA_CLASSICAL</td><td></td><td>126</td><td>-0.25</td><td>-0.85</td><td>0.785</td><td>1.000</td><td>1.000</td><td>912</td><td>tags=10%, list=8%, signal=10%</td></tr><tr><td class='lessen'>761</td><td>PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_5</td><td></td><td>9</td><td>-0.42</td><td>-0.85</td><td>0.673</td><td>1.000</td><td>1.000</td><td>2286</td><td>tags=44%, list=21%, signal=56%</td></tr><tr><td class='lessen'>762</td><td>FRASOR_RESPONSE_TO_ESTRADIOL_UP</td><td></td><td>31</td><td>-0.31</td><td>-0.85</td><td>0.687</td><td>1.000</td><td>1.000</td><td>1034</td><td>tags=19%, list=9%, signal=21%</td></tr><tr><td class='lessen'>763</td><td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP</td><td></td><td>145</td><td>-0.25</td><td>-0.85</td><td>0.863</td><td>1.000</td><td>1.000</td><td>1415</td><td>tags=17%, list=13%, signal=19%</td></tr><tr><td class='lessen'>764</td><td>MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN</td><td></td><td>15</td><td>-0.38</td><td>-0.85</td><td>0.669</td><td>1.000</td><td>1.000</td><td>1102</td><td>tags=27%, list=10%, signal=30%</td></tr><tr><td class='lessen'>765</td><td>BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP</td><td></td><td>50</td><td>-0.29</td><td>-0.85</td><td>0.733</td><td>1.000</td><td>1.000</td><td>1405</td><td>tags=18%, list=13%, signal=21%</td></tr><tr><td class='lessen'>766</td><td>CAIRO_HEPATOBLASTOMA_DN</td><td></td><td>212</td><td>-0.23</td><td>-0.85</td><td>0.872</td><td>1.000</td><td>1.000</td><td>2360</td><td>tags=27%, list=21%, signal=34%</td></tr><tr><td class='lessen'>767</td><td>SASSON_FSH_RESPONSE</td><td></td><td>6</td><td>-0.45</td><td>-0.85</td><td>0.666</td><td>1.000</td><td>1.000</td><td>1526</td><td>tags=50%, list=14%, signal=58%</td></tr><tr><td class='lessen'>768</td><td>RASHI_NFKB1_TARGETS</td><td></td><td>18</td><td>-0.36</td><td>-0.85</td><td>0.688</td><td>1.000</td><td>1.000</td><td>2880</td><td>tags=39%, list=26%, signal=52%</td></tr><tr><td class='lessen'>769</td><td>MANTOVANI_NFKB_TARGETS_DN</td><td></td><td>6</td><td>-0.46</td><td>-0.85</td><td>0.667</td><td>1.000</td><td>1.000</td><td>1324</td><td>tags=50%, list=12%, signal=57%</td></tr><tr><td class='lessen'>770</td><td>ROESSLER_LIVER_CANCER_METASTASIS_DN</td><td></td><td>40</td><td>-0.30</td><td>-0.85</td><td>0.725</td><td>1.000</td><td>1.000</td><td>2407</td><td>tags=38%, list=22%, signal=48%</td></tr><tr><td class='lessen'>771</td><td>ROLEF_GLIS3_TARGETS</td><td></td><td>19</td><td>-0.35</td><td>-0.85</td><td>0.668</td><td>1.000</td><td>1.000</td><td>186</td><td>tags=11%, list=2%, signal=11%</td></tr><tr><td class='lessen'>772</td><td>GILMORE_CORE_NFKB_PATHWAY</td><td></td><td>14</td><td>-0.37</td><td>-0.85</td><td>0.687</td><td>1.000</td><td>1.000</td><td>1774</td><td>tags=29%, list=16%, signal=34%</td></tr><tr><td class='lessen'>773</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP</td><td></td><td>63</td><td>-0.27</td><td>-0.85</td><td>0.761</td><td>1.000</td><td>1.000</td><td>2426</td><td>tags=37%, list=22%, signal=46%</td></tr><tr><td class='lessen'>774</td><td>MA_MYELOID_DIFFERENTIATION_DN</td><td></td><td>39</td><td>-0.30</td><td>-0.85</td><td>0.721</td><td>1.000</td><td>1.000</td><td>2832</td><td>tags=33%, list=25%, signal=45%</td></tr><tr><td class='lessen'>775</td><td>PARK_HSC_VS_MULTIPOTENT_PROGENITORS_UP</td><td></td><td>15</td><td>-0.36</td><td>-0.85</td><td>0.679</td><td>1.000</td><td>1.000</td><td>1333</td><td>tags=20%, list=12%, signal=23%</td></tr><tr><td class='lessen'>776</td><td>NOJIMA_SFRP2_TARGETS_DN</td><td></td><td>22</td><td>-0.34</td><td>-0.85</td><td>0.690</td><td>1.000</td><td>1.000</td><td>1575</td><td>tags=23%, list=14%, signal=26%</td></tr><tr><td class='lessen'>777</td><td>KALMA_E2F1_TARGETS</td><td></td><td>11</td><td>-0.39</td><td>-0.85</td><td>0.676</td><td>1.000</td><td>1.000</td><td>1270</td><td>tags=27%, list=11%, signal=31%</td></tr><tr><td class='lessen'>778</td><td>IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN</td><td></td><td>82</td><td>-0.26</td><td>-0.84</td><td>0.792</td><td>1.000</td><td>1.000</td><td>1741</td><td>tags=22%, list=16%, signal=26%</td></tr><tr><td class='lessen'>779</td><td>DITTMER_PTHLH_TARGETS_DN</td><td></td><td>64</td><td>-0.27</td><td>-0.84</td><td>0.780</td><td>1.000</td><td>1.000</td><td>2806</td><td>tags=34%, list=25%, signal=46%</td></tr><tr><td class='lessen'>780</td><td>KHETCHOUMIAN_TRIM24_TARGETS_DN</td><td></td><td>8</td><td>-0.43</td><td>-0.84</td><td>0.712</td><td>1.000</td><td>1.000</td><td>851</td><td>tags=25%, list=8%, signal=27%</td></tr><tr><td class='lessen'>781</td><td>RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP</td><td></td><td>75</td><td>-0.27</td><td>-0.84</td><td>0.772</td><td>1.000</td><td>1.000</td><td>1838</td><td>tags=23%, list=17%, signal=27%</td></tr><tr><td class='lessen'>782</td><td>GRADE_COLON_VS_RECTAL_CANCER_DN</td><td></td><td>39</td><td>-0.30</td><td>-0.84</td><td>0.724</td><td>1.000</td><td>1.000</td><td>2091</td><td>tags=18%, list=19%, signal=22%</td></tr><tr><td class='lessen'>783</td><td>SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1B</td><td></td><td>12</td><td>-0.39</td><td>-0.84</td><td>0.694</td><td>1.000</td><td>1.000</td><td>1515</td><td>tags=17%, list=14%, signal=19%</td></tr><tr><td class='lessen'>784</td><td>GAJATE_RESPONSE_TO_TRABECTEDIN_UP</td><td></td><td>54</td><td>-0.28</td><td>-0.84</td><td>0.762</td><td>1.000</td><td>1.000</td><td>1604</td><td>tags=19%, list=14%, signal=22%</td></tr><tr><td class='lessen'>785</td><td>LEE_INTRATHYMIC_T_PROGENITOR</td><td></td><td>15</td><td>-0.37</td><td>-0.84</td><td>0.689</td><td>1.000</td><td>1.000</td><td>754</td><td>tags=13%, list=7%, signal=14%</td></tr><tr><td class='lessen'>786</td><td>GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_UP</td><td></td><td>7</td><td>-0.44</td><td>-0.84</td><td>0.656</td><td>1.000</td><td>1.000</td><td>2086</td><td>tags=43%, list=19%, signal=53%</td></tr><tr><td class='lessen'>787</td><td>ZHANG_TLX_TARGETS_36HR_DN</td><td></td><td>145</td><td>-0.24</td><td>-0.84</td><td>0.845</td><td>1.000</td><td>1.000</td><td>1068</td><td>tags=14%, list=10%, signal=16%</td></tr><tr><td class='lessen'>788</td><td>ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN</td><td></td><td>61</td><td>-0.28</td><td>-0.84</td><td>0.795</td><td>1.000</td><td>1.000</td><td>654</td><td>tags=10%, list=6%, signal=10%</td></tr><tr><td class='lessen'>789</td><td>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN</td><td></td><td>36</td><td>-0.30</td><td>-0.84</td><td>0.745</td><td>1.000</td><td>1.000</td><td>340</td><td>tags=8%, list=3%, signal=9%</td></tr><tr><td class='lessen'>790</td><td>DE_YY1_TARGETS_DN</td><td></td><td>82</td><td>-0.26</td><td>-0.84</td><td>0.831</td><td>1.000</td><td>1.000</td><td>3347</td><td>tags=44%, list=30%, signal=62%</td></tr><tr><td class='lessen'>791</td><td>BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP</td><td></td><td>89</td><td>-0.26</td><td>-0.84</td><td>0.783</td><td>1.000</td><td>1.000</td><td>3307</td><td>tags=39%, list=30%, signal=55%</td></tr><tr><td class='lessen'>792</td><td>SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6</td><td></td><td>31</td><td>-0.31</td><td>-0.84</td><td>0.735</td><td>1.000</td><td>1.000</td><td>1358</td><td>tags=19%, list=12%, signal=22%</td></tr><tr><td class='lessen'>793</td><td>HU_ANGIOGENESIS_DN</td><td></td><td>29</td><td>-0.32</td><td>-0.84</td><td>0.712</td><td>1.000</td><td>1.000</td><td>2404</td><td>tags=34%, list=22%, signal=44%</td></tr><tr><td class='lessen'>794</td><td>SEMBA_FHIT_TARGETS_UP</td><td></td><td>8</td><td>-0.43</td><td>-0.84</td><td>0.687</td><td>1.000</td><td>1.000</td><td>1264</td><td>tags=38%, list=11%, signal=42%</td></tr><tr><td class='lessen'>795</td><td>AMIT_EGF_RESPONSE_20_MCF10A</td><td></td><td>13</td><td>-0.39</td><td>-0.84</td><td>0.679</td><td>1.000</td><td>1.000</td><td>377</td><td>tags=8%, list=3%, signal=8%</td></tr><tr><td class='lessen'>796</td><td>LEE_LIVER_CANCER_ACOX1_DN</td><td></td><td>54</td><td>-0.28</td><td>-0.84</td><td>0.766</td><td>1.000</td><td>1.000</td><td>2896</td><td>tags=35%, list=26%, signal=47%</td></tr><tr><td class='lessen'>797</td><td>YEMELYANOV_GR_TARGETS_DN</td><td></td><td>10</td><td>-0.41</td><td>-0.84</td><td>0.695</td><td>1.000</td><td>1.000</td><td>1262</td><td>tags=20%, list=11%, signal=23%</td></tr><tr><td class='lessen'>798</td><td>MOHANKUMAR_TLX1_TARGETS_UP</td><td></td><td>324</td><td>-0.22</td><td>-0.84</td><td>0.946</td><td>1.000</td><td>1.000</td><td>2178</td><td>tags=18%, list=20%, signal=21%</td></tr><tr><td class='lessen'>799</td><td>SASAI_TARGETS_OF_CXCR6_AND_PTCH1_UP</td><td></td><td>6</td><td>-0.45</td><td>-0.84</td><td>0.673</td><td>1.000</td><td>1.000</td><td>465</td><td>tags=17%, list=4%, signal=17%</td></tr><tr><td class='lessen'>800</td><td>MEISSNER_NPC_HCP_WITH_H3K27ME3</td><td></td><td>26</td><td>-0.32</td><td>-0.84</td><td>0.721</td><td>1.000</td><td>1.000</td><td>363</td><td>tags=8%, list=3%, signal=8%</td></tr><tr><td class='lessen'>801</td><td>ENK_UV_RESPONSE_EPIDERMIS_DN</td><td></td><td>428</td><td>-0.21</td><td>-0.84</td><td>0.972</td><td>1.000</td><td>1.000</td><td>2149</td><td>tags=21%, list=19%, signal=25%</td></tr><tr><td class='lessen'>802</td><td>RIZ_ERYTHROID_DIFFERENTIATION_HEMGN</td><td></td><td>24</td><td>-0.32</td><td>-0.84</td><td>0.692</td><td>1.000</td><td>1.000</td><td>1397</td><td>tags=21%, list=13%, signal=24%</td></tr><tr><td class='lessen'>803</td><td>KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN</td><td></td><td>238</td><td>-0.23</td><td>-0.84</td><td>0.924</td><td>1.000</td><td>1.000</td><td>1851</td><td>tags=18%, list=17%, signal=21%</td></tr><tr><td class='lessen'>804</td><td>SENESE_HDAC1_TARGETS_UP</td><td></td><td>339</td><td>-0.22</td><td>-0.84</td><td>0.947</td><td>1.000</td><td>1.000</td><td>2148</td><td>tags=17%, list=19%, signal=21%</td></tr><tr><td class='lessen'>805</td><td>NIKOLSKY_BREAST_CANCER_7P15_AMPLICON</td><td></td><td>6</td><td>-0.44</td><td>-0.84</td><td>0.674</td><td>1.000</td><td>1.000</td><td>436</td><td>tags=17%, list=4%, signal=17%</td></tr><tr><td class='lessen'>806</td><td>PILON_KLF1_TARGETS_UP</td><td></td><td>404</td><td>-0.21</td><td>-0.84</td><td>0.980</td><td>1.000</td><td>1.000</td><td>2500</td><td>tags=25%, list=22%, signal=30%</td></tr><tr><td class='lessen'>807</td><td>WOO_LIVER_CANCER_RECURRENCE_UP</td><td></td><td>91</td><td>-0.26</td><td>-0.84</td><td>0.820</td><td>1.000</td><td>1.000</td><td>846</td><td>tags=10%, list=8%, signal=11%</td></tr><tr><td class='lessen'>808</td><td>MCGOWAN_RSP6_TARGETS_UP</td><td></td><td>14</td><td>-0.37</td><td>-0.84</td><td>0.697</td><td>1.000</td><td>1.000</td><td>463</td><td>tags=14%, list=4%, signal=15%</td></tr><tr><td class='lessen'>809</td><td>CHICAS_RB1_TARGETS_SENESCENT</td><td></td><td>429</td><td>-0.21</td><td>-0.84</td><td>0.973</td><td>1.000</td><td>1.000</td><td>1968</td><td>tags=21%, list=18%, signal=24%</td></tr><tr><td class='lessen'>810</td><td>NAGASHIMA_NRG1_SIGNALING_UP</td><td></td><td>142</td><td>-0.24</td><td>-0.84</td><td>0.846</td><td>1.000</td><td>1.000</td><td>1417</td><td>tags=20%, list=13%, signal=22%</td></tr><tr><td class='lessen'>811</td><td>PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN</td><td></td><td>114</td><td>-0.25</td><td>-0.84</td><td>0.827</td><td>1.000</td><td>1.000</td><td>2244</td><td>tags=24%, list=20%, signal=29%</td></tr><tr><td class='lessen'>812</td><td>XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP</td><td></td><td>11</td><td>-0.39</td><td>-0.84</td><td>0.686</td><td>1.000</td><td>1.000</td><td>23</td><td>tags=9%, list=0%, signal=9%</td></tr><tr><td class='lessen'>813</td><td>DORN_ADENOVIRUS_INFECTION_24HR_DN</td><td></td><td>37</td><td>-0.30</td><td>-0.84</td><td>0.728</td><td>1.000</td><td>1.000</td><td>1816</td><td>tags=27%, list=16%, signal=32%</td></tr><tr><td class='lessen'>814</td><td>WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN</td><td></td><td>148</td><td>-0.24</td><td>-0.84</td><td>0.872</td><td>1.000</td><td>1.000</td><td>797</td><td>tags=7%, list=7%, signal=7%</td></tr><tr><td class='lessen'>815</td><td>MARTIN_INTERACT_WITH_HDAC</td><td></td><td>40</td><td>-0.28</td><td>-0.83</td><td>0.762</td><td>1.000</td><td>1.000</td><td>3144</td><td>tags=40%, list=28%, signal=56%</td></tr><tr><td class='lessen'>816</td><td>REICHERT_G1S_REGULATORS_AS_PI3K_TARGETS</td><td></td><td>8</td><td>-0.43</td><td>-0.83</td><td>0.677</td><td>1.000</td><td>1.000</td><td>1140</td><td>tags=25%, list=10%, signal=28%</td></tr><tr><td class='lessen'>817</td><td>ZHU_SKIL_TARGETS_DN</td><td></td><td>8</td><td>-0.43</td><td>-0.83</td><td>0.659</td><td>1.000</td><td>1.000</td><td>1140</td><td>tags=25%, list=10%, signal=28%</td></tr><tr><td class='lessen'>818</td><td>VANOEVELEN_MYOGENESIS_SIN3A_TARGETS</td><td></td><td>166</td><td>-0.24</td><td>-0.83</td><td>0.904</td><td>1.000</td><td>1.000</td><td>1616</td><td>tags=13%, list=15%, signal=15%</td></tr><tr><td class='lessen'>819</td><td>VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_DN</td><td></td><td>12</td><td>-0.39</td><td>-0.83</td><td>0.716</td><td>1.000</td><td>1.000</td><td>2453</td><td>tags=42%, list=22%, signal=53%</td></tr><tr><td class='lessen'>820</td><td>NATSUME_RESPONSE_TO_INTERFERON_BETA_UP</td><td></td><td>57</td><td>-0.27</td><td>-0.83</td><td>0.774</td><td>1.000</td><td>1.000</td><td>1662</td><td>tags=19%, list=15%, signal=23%</td></tr><tr><td class='lessen'>821</td><td>SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP</td><td></td><td>16</td><td>-0.36</td><td>-0.83</td><td>0.668</td><td>1.000</td><td>1.000</td><td>111</td><td>tags=6%, list=1%, signal=6%</td></tr><tr><td class='lessen'>822</td><td>DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN</td><td></td><td>239</td><td>-0.22</td><td>-0.83</td><td>0.926</td><td>1.000</td><td>1.000</td><td>1661</td><td>tags=12%, list=15%, signal=14%</td></tr><tr><td class='lessen'>823</td><td>LIU_IL13_PRIMING_MODEL</td><td></td><td>11</td><td>-0.39</td><td>-0.83</td><td>0.667</td><td>1.000</td><td>1.000</td><td>1034</td><td>tags=27%, list=9%, signal=30%</td></tr><tr><td class='lessen'>824</td><td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_22</td><td></td><td>10</td><td>-0.40</td><td>-0.83</td><td>0.692</td><td>1.000</td><td>1.000</td><td>1848</td><td>tags=30%, list=17%, signal=36%</td></tr><tr><td class='lessen'>825</td><td>HOSHIDA_LIVER_CANCER_SUBCLASS_S2</td><td></td><td>103</td><td>-0.25</td><td>-0.83</td><td>0.847</td><td>1.000</td><td>1.000</td><td>1864</td><td>tags=17%, list=17%, signal=21%</td></tr><tr><td class='lessen'>826</td><td>DANG_MYC_TARGETS_UP</td><td></td><td>120</td><td>-0.24</td><td>-0.83</td><td>0.869</td><td>1.000</td><td>1.000</td><td>2054</td><td>tags=22%, list=18%, signal=26%</td></tr><tr><td class='lessen'>827</td><td>GENTILE_UV_RESPONSE_CLUSTER_D2</td><td></td><td>34</td><td>-0.30</td><td>-0.83</td><td>0.749</td><td>1.000</td><td>1.000</td><td>3574</td><td>tags=44%, list=32%, signal=65%</td></tr><tr><td class='lessen'>828</td><td>DURCHDEWALD_SKIN_CARCINOGENESIS_UP</td><td></td><td>61</td><td>-0.27</td><td>-0.83</td><td>0.758</td><td>1.000</td><td>1.000</td><td>1739</td><td>tags=20%, list=16%, signal=23%</td></tr><tr><td class='lessen'>829</td><td>LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN</td><td></td><td>36</td><td>-0.30</td><td>-0.83</td><td>0.720</td><td>1.000</td><td>1.000</td><td>1684</td><td>tags=22%, list=15%, signal=26%</td></tr><tr><td class='lessen'>830</td><td>NIELSEN_LEIOMYOSARCOMA_DN</td><td></td><td>13</td><td>-0.37</td><td>-0.83</td><td>0.682</td><td>1.000</td><td>1.000</td><td>2925</td><td>tags=31%, list=26%, signal=42%</td></tr><tr><td class='lessen'>831</td><td>BROWNE_HCMV_INFECTION_20HR_DN</td><td></td><td>86</td><td>-0.25</td><td>-0.83</td><td>0.837</td><td>1.000</td><td>1.000</td><td>2534</td><td>tags=34%, list=23%, signal=43%</td></tr><tr><td class='lessen'>832</td><td>DIRMEIER_LMP1_RESPONSE_EARLY</td><td></td><td>60</td><td>-0.27</td><td>-0.83</td><td>0.802</td><td>1.000</td><td>1.000</td><td>1339</td><td>tags=17%, list=12%, signal=19%</td></tr><tr><td class='lessen'>833</td><td>TSAI_RESPONSE_TO_IONIZING_RADIATION</td><td></td><td>124</td><td>-0.24</td><td>-0.83</td><td>0.836</td><td>1.000</td><td>1.000</td><td>2343</td><td>tags=26%, list=21%, signal=32%</td></tr><tr><td class='lessen'>834</td><td>CHICAS_RB1_TARGETS_LOW_SERUM</td><td></td><td>62</td><td>-0.27</td><td>-0.83</td><td>0.771</td><td>1.000</td><td>1.000</td><td>1140</td><td>tags=16%, list=10%, signal=18%</td></tr><tr><td class='lessen'>835</td><td>IKEDA_MIR133_TARGETS_DN</td><td></td><td>7</td><td>-0.43</td><td>-0.83</td><td>0.704</td><td>1.000</td><td>1.000</td><td>599</td><td>tags=14%, list=5%, signal=15%</td></tr><tr><td class='lessen'>836</td><td>BROWNE_HCMV_INFECTION_4HR_UP</td><td></td><td>43</td><td>-0.29</td><td>-0.83</td><td>0.769</td><td>1.000</td><td>1.000</td><td>1383</td><td>tags=19%, list=12%, signal=21%</td></tr><tr><td class='lessen'>837</td><td>MITSIADES_RESPONSE_TO_APLIDIN_DN</td><td></td><td>206</td><td>-0.22</td><td>-0.83</td><td>0.914</td><td>1.000</td><td>1.000</td><td>2643</td><td>tags=28%, list=24%, signal=36%</td></tr><tr><td class='lessen'>838</td><td>MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN</td><td></td><td>91</td><td>-0.25</td><td>-0.82</td><td>0.862</td><td>1.000</td><td>1.000</td><td>623</td><td>tags=8%, list=6%, signal=8%</td></tr><tr><td class='lessen'>839</td><td>COLINA_TARGETS_OF_4EBP1_AND_4EBP2</td><td></td><td>303</td><td>-0.22</td><td>-0.82</td><td>0.961</td><td>1.000</td><td>1.000</td><td>1405</td><td>tags=12%, list=13%, signal=13%</td></tr><tr><td class='lessen'>840</td><td>ZHENG_BOUND_BY_FOXP3</td><td></td><td>376</td><td>-0.21</td><td>-0.82</td><td>0.972</td><td>1.000</td><td>1.000</td><td>1175</td><td>tags=10%, list=11%, signal=11%</td></tr><tr><td class='lessen'>841</td><td>DER_IFN_BETA_RESPONSE_DN</td><td></td><td>7</td><td>-0.43</td><td>-0.82</td><td>0.697</td><td>1.000</td><td>1.000</td><td>2908</td><td>tags=43%, list=26%, signal=58%</td></tr><tr><td class='lessen'>842</td><td>HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN</td><td></td><td>13</td><td>-0.37</td><td>-0.82</td><td>0.714</td><td>1.000</td><td>1.000</td><td>930</td><td>tags=31%, list=8%, signal=34%</td></tr><tr><td class='lessen'>843</td><td>HUMMERICH_MALIGNANT_SKIN_TUMOR_UP</td><td></td><td>12</td><td>-0.38</td><td>-0.82</td><td>0.728</td><td>1.000</td><td>1.000</td><td>39</td><td>tags=8%, list=0%, signal=8%</td></tr><tr><td class='lessen'>844</td><td>LEIN_ASTROCYTE_MARKERS</td><td></td><td>33</td><td>-0.30</td><td>-0.82</td><td>0.769</td><td>1.000</td><td>1.000</td><td>197</td><td>tags=6%, list=2%, signal=6%</td></tr><tr><td class='lessen'>845</td><td>RIZ_ERYTHROID_DIFFERENTIATION_HBZ</td><td></td><td>28</td><td>-0.31</td><td>-0.82</td><td>0.726</td><td>1.000</td><td>1.000</td><td>2595</td><td>tags=36%, list=23%, signal=46%</td></tr><tr><td class='lessen'>846</td><td>DAZARD_RESPONSE_TO_UV_NHEK_DN</td><td></td><td>244</td><td>-0.22</td><td>-0.82</td><td>0.937</td><td>1.000</td><td>1.000</td><td>3588</td><td>tags=45%, list=32%, signal=64%</td></tr><tr><td class='lessen'>847</td><td>KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD</td><td></td><td>26</td><td>-0.31</td><td>-0.82</td><td>0.757</td><td>1.000</td><td>1.000</td><td>2502</td><td>tags=35%, list=22%, signal=45%</td></tr><tr><td class='lessen'>848</td><td>BERNARD_PPAPDC1B_TARGETS_UP</td><td></td><td>31</td><td>-0.30</td><td>-0.82</td><td>0.736</td><td>1.000</td><td>1.000</td><td>2464</td><td>tags=19%, list=22%, signal=25%</td></tr><tr><td class='lessen'>849</td><td>TAVOR_CEBPA_TARGETS_UP</td><td></td><td>40</td><td>-0.29</td><td>-0.82</td><td>0.761</td><td>1.000</td><td>1.000</td><td>1517</td><td>tags=23%, list=14%, signal=26%</td></tr><tr><td class='lessen'>850</td><td>GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN</td><td></td><td>30</td><td>-0.31</td><td>-0.82</td><td>0.746</td><td>1.000</td><td>1.000</td><td>2040</td><td>tags=23%, list=18%, signal=28%</td></tr><tr><td class='lessen'>851</td><td>NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP</td><td></td><td>212</td><td>-0.22</td><td>-0.82</td><td>0.936</td><td>1.000</td><td>1.000</td><td>1137</td><td>tags=9%, list=10%, signal=10%</td></tr><tr><td class='lessen'>852</td><td>BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER</td><td></td><td>22</td><td>-0.33</td><td>-0.82</td><td>0.736</td><td>1.000</td><td>1.000</td><td>1595</td><td>tags=18%, list=14%, signal=21%</td></tr><tr><td class='lessen'>853</td><td>RIZKI_TUMOR_INVASIVENESS_3D_UP</td><td></td><td>164</td><td>-0.23</td><td>-0.82</td><td>0.921</td><td>1.000</td><td>1.000</td><td>1509</td><td>tags=15%, list=14%, signal=17%</td></tr><tr><td class='lessen'>854</td><td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP</td><td></td><td>141</td><td>-0.23</td><td>-0.82</td><td>0.904</td><td>1.000</td><td>1.000</td><td>1101</td><td>tags=12%, list=10%, signal=13%</td></tr><tr><td class='lessen'>855</td><td>FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES</td><td></td><td>6</td><td>-0.44</td><td>-0.82</td><td>0.701</td><td>1.000</td><td>1.000</td><td>741</td><td>tags=17%, list=7%, signal=18%</td></tr><tr><td class='lessen'>856</td><td>NAGY_PCAF_COMPONENTS_HUMAN</td><td></td><td>6</td><td>-0.44</td><td>-0.82</td><td>0.672</td><td>1.000</td><td>1.000</td><td>725</td><td>tags=17%, list=7%, signal=18%</td></tr><tr><td class='lessen'>857</td><td>ENK_UV_RESPONSE_EPIDERMIS_UP</td><td></td><td>234</td><td>-0.22</td><td>-0.82</td><td>0.939</td><td>1.000</td><td>1.000</td><td>2118</td><td>tags=18%, list=19%, signal=22%</td></tr><tr><td class='lessen'>858</td><td>NAGY_TFTC_COMPONENTS_HUMAN</td><td></td><td>14</td><td>-0.36</td><td>-0.82</td><td>0.712</td><td>1.000</td><td>1.000</td><td>2742</td><td>tags=50%, list=25%, signal=66%</td></tr><tr><td class='lessen'>859</td><td>MARTINEZ_RB1_TARGETS_DN</td><td></td><td>400</td><td>-0.21</td><td>-0.82</td><td>0.965</td><td>1.000</td><td>1.000</td><td>1848</td><td>tags=19%, list=17%, signal=21%</td></tr><tr><td class='lessen'>860</td><td>MCCLUNG_CREB1_TARGETS_DN</td><td></td><td>41</td><td>-0.28</td><td>-0.82</td><td>0.794</td><td>1.000</td><td>1.000</td><td>2065</td><td>tags=22%, list=19%, signal=27%</td></tr><tr><td class='lessen'>861</td><td>HEIDENBLAD_AMPLICON_12P11_12_DN</td><td></td><td>15</td><td>-0.36</td><td>-0.82</td><td>0.692</td><td>1.000</td><td>1.000</td><td>2137</td><td>tags=33%, list=19%, signal=41%</td></tr><tr><td class='lessen'>862</td><td>CAFFAREL_RESPONSE_TO_THC_8HR_5_DN</td><td></td><td>9</td><td>-0.40</td><td>-0.82</td><td>0.700</td><td>1.000</td><td>1.000</td><td>2878</td><td>tags=44%, list=26%, signal=60%</td></tr><tr><td class='lessen'>863</td><td>CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1</td><td></td><td>369</td><td>-0.21</td><td>-0.82</td><td>0.992</td><td>1.000</td><td>1.000</td><td>1432</td><td>tags=13%, list=13%, signal=14%</td></tr><tr><td class='lessen'>864</td><td>ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN</td><td></td><td>46</td><td>-0.28</td><td>-0.82</td><td>0.817</td><td>1.000</td><td>1.000</td><td>2312</td><td>tags=28%, list=21%, signal=36%</td></tr><tr><td class='lessen'>865</td><td>TOMIDA_METASTASIS_DN</td><td></td><td>16</td><td>-0.35</td><td>-0.82</td><td>0.713</td><td>1.000</td><td>1.000</td><td>780</td><td>tags=13%, list=7%, signal=13%</td></tr><tr><td class='lessen'>866</td><td>HAN_SATB1_TARGETS_DN</td><td></td><td>328</td><td>-0.21</td><td>-0.82</td><td>0.973</td><td>1.000</td><td>1.000</td><td>878</td><td>tags=8%, list=8%, signal=8%</td></tr><tr><td class='lessen'>867</td><td>MARZEC_IL2_SIGNALING_DN</td><td></td><td>29</td><td>-0.30</td><td>-0.82</td><td>0.751</td><td>1.000</td><td>1.000</td><td>3577</td><td>tags=52%, list=32%, signal=76%</td></tr><tr><td class='lessen'>868</td><td>SENESE_HDAC3_TARGETS_UP</td><td></td><td>389</td><td>-0.21</td><td>-0.82</td><td>0.984</td><td>1.000</td><td>1.000</td><td>2215</td><td>tags=20%, list=20%, signal=24%</td></tr><tr><td class='lessen'>869</td><td>LIU_SOX4_TARGETS_DN</td><td></td><td>242</td><td>-0.22</td><td>-0.81</td><td>0.944</td><td>1.000</td><td>1.000</td><td>2844</td><td>tags=26%, list=26%, signal=34%</td></tr><tr><td class='lessen'>870</td><td>LINDSTEDT_DENDRITIC_CELL_MATURATION_B</td><td></td><td>49</td><td>-0.27</td><td>-0.81</td><td>0.792</td><td>1.000</td><td>1.000</td><td>1774</td><td>tags=22%, list=16%, signal=27%</td></tr><tr><td class='lessen'>871</td><td>GALIE_TUMOR_ANGIOGENESIS</td><td></td><td>8</td><td>-0.41</td><td>-0.81</td><td>0.711</td><td>1.000</td><td>1.000</td><td>16</td><td>tags=13%, list=0%, signal=13%</td></tr><tr><td class='lessen'>872</td><td>CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB</td><td></td><td>14</td><td>-0.37</td><td>-0.81</td><td>0.727</td><td>1.000</td><td>1.000</td><td>167</td><td>tags=7%, list=2%, signal=7%</td></tr><tr><td class='lessen'>873</td><td>KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP</td><td></td><td>13</td><td>-0.38</td><td>-0.81</td><td>0.736</td><td>1.000</td><td>1.000</td><td>874</td><td>tags=15%, list=8%, signal=17%</td></tr><tr><td class='lessen'>874</td><td>BENPORATH_ES_2</td><td></td><td>21</td><td>-0.32</td><td>-0.81</td><td>0.725</td><td>1.000</td><td>1.000</td><td>653</td><td>tags=14%, list=6%, signal=15%</td></tr><tr><td class='lessen'>875</td><td>GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN</td><td></td><td>231</td><td>-0.22</td><td>-0.81</td><td>0.951</td><td>1.000</td><td>1.000</td><td>2808</td><td>tags=26%, list=25%, signal=33%</td></tr><tr><td class='lessen'>876</td><td>HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS</td><td></td><td>62</td><td>-0.26</td><td>-0.81</td><td>0.825</td><td>1.000</td><td>1.000</td><td>797</td><td>tags=10%, list=7%, signal=10%</td></tr><tr><td class='lessen'>877</td><td>BONCI_TARGETS_OF_MIR15A_AND_MIR16_1</td><td></td><td>75</td><td>-0.25</td><td>-0.81</td><td>0.857</td><td>1.000</td><td>1.000</td><td>1235</td><td>tags=19%, list=11%, signal=21%</td></tr><tr><td class='lessen'>878</td><td>CASTELLANO_HRAS_TARGETS_DN</td><td></td><td>5</td><td>-0.47</td><td>-0.81</td><td>0.695</td><td>1.000</td><td>1.000</td><td>1496</td><td>tags=40%, list=13%, signal=46%</td></tr><tr><td class='lessen'>879</td><td>SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN</td><td></td><td>69</td><td>-0.26</td><td>-0.81</td><td>0.858</td><td>1.000</td><td>1.000</td><td>1880</td><td>tags=22%, list=17%, signal=26%</td></tr><tr><td class='lessen'>880</td><td>PATTERSON_DOCETAXEL_RESISTANCE</td><td></td><td>23</td><td>-0.32</td><td>-0.81</td><td>0.758</td><td>1.000</td><td>1.000</td><td>670</td><td>tags=9%, list=6%, signal=9%</td></tr><tr><td class='lessen'>881</td><td>PIEPOLI_LGI1_TARGETS_DN</td><td></td><td>7</td><td>-0.42</td><td>-0.81</td><td>0.711</td><td>1.000</td><td>1.000</td><td>50</td><td>tags=14%, list=0%, signal=14%</td></tr><tr><td class='lessen'>882</td><td>GENTILE_UV_RESPONSE_CLUSTER_D1</td><td></td><td>13</td><td>-0.36</td><td>-0.81</td><td>0.731</td><td>1.000</td><td>1.000</td><td>1501</td><td>tags=23%, list=13%, signal=27%</td></tr><tr><td class='lessen'>883</td><td>MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP</td><td></td><td>19</td><td>-0.33</td><td>-0.81</td><td>0.729</td><td>1.000</td><td>1.000</td><td>577</td><td>tags=21%, list=5%, signal=22%</td></tr><tr><td class='lessen'>884</td><td>OUYANG_PROSTATE_CANCER_PROGRESSION_DN</td><td></td><td>18</td><td>-0.33</td><td>-0.81</td><td>0.757</td><td>1.000</td><td>1.000</td><td>2460</td><td>tags=28%, list=22%, signal=36%</td></tr><tr><td class='lessen'>885</td><td>VARELA_ZMPSTE24_TARGETS_UP</td><td></td><td>33</td><td>-0.30</td><td>-0.81</td><td>0.780</td><td>1.000</td><td>1.000</td><td>1141</td><td>tags=21%, list=10%, signal=24%</td></tr><tr><td class='lessen'>886</td><td>AMUNDSON_DNA_DAMAGE_RESPONSE_TP53</td><td></td><td>14</td><td>-0.35</td><td>-0.81</td><td>0.746</td><td>1.000</td><td>1.000</td><td>1141</td><td>tags=21%, list=10%, signal=24%</td></tr><tr><td class='lessen'>887</td><td>GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP</td><td></td><td>120</td><td>-0.24</td><td>-0.81</td><td>0.890</td><td>1.000</td><td>1.000</td><td>2147</td><td>tags=23%, list=19%, signal=29%</td></tr><tr><td class='lessen'>888</td><td>TIEN_INTESTINE_PROBIOTICS_2HR_UP</td><td></td><td>24</td><td>-0.32</td><td>-0.81</td><td>0.773</td><td>1.000</td><td>1.000</td><td>2804</td><td>tags=33%, list=25%, signal=44%</td></tr><tr><td class='lessen'>889</td><td>KORKOLA_YOLK_SAC_TUMOR_UP</td><td></td><td>16</td><td>-0.34</td><td>-0.80</td><td>0.732</td><td>1.000</td><td>1.000</td><td>2112</td><td>tags=38%, list=19%, signal=46%</td></tr><tr><td class='lessen'>890</td><td>APPIERTO_RESPONSE_TO_FENRETINIDE_UP</td><td></td><td>32</td><td>-0.29</td><td>-0.80</td><td>0.779</td><td>1.000</td><td>1.000</td><td>841</td><td>tags=9%, list=8%, signal=10%</td></tr><tr><td class='lessen'>891</td><td>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_DN</td><td></td><td>11</td><td>-0.38</td><td>-0.80</td><td>0.730</td><td>1.000</td><td>1.000</td><td>97</td><td>tags=9%, list=1%, signal=9%</td></tr><tr><td class='lessen'>892</td><td>HILLION_HMGA1_TARGETS</td><td></td><td>72</td><td>-0.25</td><td>-0.80</td><td>0.856</td><td>1.000</td><td>1.000</td><td>2281</td><td>tags=25%, list=20%, signal=31%</td></tr><tr><td class='lessen'>893</td><td>SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN</td><td></td><td>39</td><td>-0.28</td><td>-0.80</td><td>0.807</td><td>1.000</td><td>1.000</td><td>3654</td><td>tags=56%, list=33%, signal=84%</td></tr><tr><td class='lessen'>894</td><td>KAAB_HEART_ATRIUM_VS_VENTRICLE_DN</td><td></td><td>213</td><td>-0.22</td><td>-0.80</td><td>0.961</td><td>1.000</td><td>1.000</td><td>2345</td><td>tags=23%, list=21%, signal=29%</td></tr><tr><td class='lessen'>895</td><td>BYSTROEM_CORRELATED_WITH_IL5_UP</td><td></td><td>44</td><td>-0.28</td><td>-0.80</td><td>0.806</td><td>1.000</td><td>1.000</td><td>794</td><td>tags=9%, list=7%, signal=10%</td></tr><tr><td class='lessen'>896</td><td>BROWNE_HCMV_INFECTION_24HR_DN</td><td></td><td>120</td><td>-0.23</td><td>-0.80</td><td>0.915</td><td>1.000</td><td>1.000</td><td>1618</td><td>tags=17%, list=15%, signal=19%</td></tr><tr><td class='lessen'>897</td><td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_27</td><td></td><td>9</td><td>-0.40</td><td>-0.80</td><td>0.712</td><td>1.000</td><td>1.000</td><td>313</td><td>tags=11%, list=3%, signal=11%</td></tr><tr><td class='lessen'>898</td><td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_DN</td><td></td><td>6</td><td>-0.43</td><td>-0.80</td><td>0.689</td><td>1.000</td><td>1.000</td><td>2293</td><td>tags=50%, list=21%, signal=63%</td></tr><tr><td class='lessen'>899</td><td>CHEOK_RESPONSE_TO_HD_MTX_DN</td><td></td><td>21</td><td>-0.32</td><td>-0.80</td><td>0.737</td><td>1.000</td><td>1.000</td><td>1878</td><td>tags=24%, list=17%, signal=29%</td></tr><tr><td class='lessen'>900</td><td>LIN_NPAS4_TARGETS_UP</td><td></td><td>117</td><td>-0.24</td><td>-0.80</td><td>0.900</td><td>1.000</td><td>1.000</td><td>2062</td><td>tags=22%, list=19%, signal=27%</td></tr><tr><td class='lessen'>901</td><td>ONDER_CDH1_TARGETS_3_UP</td><td></td><td>16</td><td>-0.35</td><td>-0.80</td><td>0.746</td><td>1.000</td><td>1.000</td><td>1390</td><td>tags=38%, list=12%, signal=43%</td></tr><tr><td class='lessen'>902</td><td>LEE_LIVER_CANCER_MYC_DN</td><td></td><td>49</td><td>-0.27</td><td>-0.80</td><td>0.841</td><td>1.000</td><td>1.000</td><td>1973</td><td>tags=27%, list=18%, signal=32%</td></tr><tr><td class='lessen'>903</td><td>NAKAMURA_ADIPOGENESIS_EARLY_UP</td><td></td><td>45</td><td>-0.28</td><td>-0.80</td><td>0.854</td><td>1.000</td><td>1.000</td><td>1704</td><td>tags=24%, list=15%, signal=29%</td></tr><tr><td class='lessen'>904</td><td>XU_GH1_EXOGENOUS_TARGETS_DN</td><td></td><td>76</td><td>-0.25</td><td>-0.80</td><td>0.860</td><td>1.000</td><td>1.000</td><td>1800</td><td>tags=20%, list=16%, signal=23%</td></tr><tr><td class='lessen'>905</td><td>YOSHIMURA_MAPK8_TARGETS_DN</td><td></td><td>305</td><td>-0.21</td><td>-0.79</td><td>0.984</td><td>1.000</td><td>1.000</td><td>1770</td><td>tags=14%, list=16%, signal=16%</td></tr><tr><td class='lessen'>906</td><td>GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP</td><td></td><td>11</td><td>-0.37</td><td>-0.79</td><td>0.733</td><td>1.000</td><td>1.000</td><td>1620</td><td>tags=27%, list=15%, signal=32%</td></tr><tr><td class='lessen'>907</td><td>WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT</td><td></td><td>48</td><td>-0.27</td><td>-0.79</td><td>0.830</td><td>1.000</td><td>1.000</td><td>2975</td><td>tags=40%, list=27%, signal=54%</td></tr><tr><td class='lessen'>908</td><td>ELVIDGE_HYPOXIA_UP</td><td></td><td>135</td><td>-0.23</td><td>-0.79</td><td>0.904</td><td>1.000</td><td>1.000</td><td>1630</td><td>tags=18%, list=15%, signal=21%</td></tr><tr><td class='lessen'>909</td><td>INAMURA_LUNG_CANCER_SCC_UP</td><td></td><td>10</td><td>-0.38</td><td>-0.79</td><td>0.739</td><td>1.000</td><td>1.000</td><td>680</td><td>tags=20%, list=6%, signal=21%</td></tr><tr><td class='lessen'>910</td><td>COLDREN_GEFITINIB_RESISTANCE_UP</td><td></td><td>62</td><td>-0.26</td><td>-0.79</td><td>0.869</td><td>1.000</td><td>1.000</td><td>2824</td><td>tags=29%, list=25%, signal=39%</td></tr><tr><td class='lessen'>911</td><td>WARTERS_IR_RESPONSE_5GY</td><td></td><td>34</td><td>-0.29</td><td>-0.79</td><td>0.826</td><td>1.000</td><td>1.000</td><td>1141</td><td>tags=18%, list=10%, signal=20%</td></tr><tr><td class='lessen'>912</td><td>WANG_RECURRENT_LIVER_CANCER_UP</td><td></td><td>18</td><td>-0.33</td><td>-0.79</td><td>0.786</td><td>1.000</td><td>1.000</td><td>2884</td><td>tags=33%, list=26%, signal=45%</td></tr><tr><td class='lessen'>913</td><td>LY_AGING_MIDDLE_UP</td><td></td><td>9</td><td>-0.38</td><td>-0.79</td><td>0.746</td><td>1.000</td><td>1.000</td><td>381</td><td>tags=11%, list=3%, signal=11%</td></tr><tr><td class='lessen'>914</td><td>HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN</td><td></td><td>99</td><td>-0.24</td><td>-0.79</td><td>0.904</td><td>1.000</td><td>1.000</td><td>2910</td><td>tags=28%, list=26%, signal=38%</td></tr><tr><td class='lessen'>915</td><td>AIGNER_ZEB1_TARGETS</td><td></td><td>27</td><td>-0.30</td><td>-0.79</td><td>0.800</td><td>1.000</td><td>1.000</td><td>1489</td><td>tags=15%, list=13%, signal=17%</td></tr><tr><td class='lessen'>916</td><td>ZHAN_MULTIPLE_MYELOMA_LB_UP</td><td></td><td>30</td><td>-0.30</td><td>-0.79</td><td>0.815</td><td>1.000</td><td>1.000</td><td>641</td><td>tags=10%, list=6%, signal=11%</td></tr><tr><td class='lessen'>917</td><td>BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING</td><td></td><td>399</td><td>-0.20</td><td>-0.79</td><td>0.994</td><td>1.000</td><td>1.000</td><td>2366</td><td>tags=22%, list=21%, signal=27%</td></tr><tr><td class='lessen'>918</td><td>ABDULRAHMAN_KIDNEY_CANCER_VHL_DN</td><td></td><td>13</td><td>-0.35</td><td>-0.79</td><td>0.745</td><td>1.000</td><td>1.000</td><td>1150</td><td>tags=31%, list=10%, signal=34%</td></tr><tr><td class='lessen'>919</td><td>JAEGER_METASTASIS_UP</td><td></td><td>34</td><td>-0.29</td><td>-0.79</td><td>0.794</td><td>1.000</td><td>1.000</td><td>1532</td><td>tags=24%, list=14%, signal=27%</td></tr><tr><td class='lessen'>920</td><td>YIH_RESPONSE_TO_ARSENITE_C1</td><td></td><td>22</td><td>-0.31</td><td>-0.79</td><td>0.796</td><td>1.000</td><td>1.000</td><td>1264</td><td>tags=23%, list=11%, signal=26%</td></tr><tr><td class='lessen'>921</td><td>NIKOLSKY_BREAST_CANCER_17P11_AMPLICON</td><td></td><td>6</td><td>-0.43</td><td>-0.79</td><td>0.723</td><td>1.000</td><td>1.000</td><td>423</td><td>tags=17%, list=4%, signal=17%</td></tr><tr><td class='lessen'>922</td><td>WEBER_METHYLATED_IN_COLON_CANCER</td><td></td><td>11</td><td>-0.36</td><td>-0.79</td><td>0.739</td><td>1.000</td><td>1.000</td><td>2262</td><td>tags=55%, list=20%, signal=68%</td></tr><tr><td class='lessen'>923</td><td>VERNELL_RETINOBLASTOMA_PATHWAY_UP</td><td></td><td>61</td><td>-0.26</td><td>-0.79</td><td>0.887</td><td>1.000</td><td>1.000</td><td>1052</td><td>tags=15%, list=9%, signal=16%</td></tr><tr><td class='lessen'>924</td><td>HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP</td><td></td><td>22</td><td>-0.31</td><td>-0.78</td><td>0.787</td><td>1.000</td><td>1.000</td><td>326</td><td>tags=9%, list=3%, signal=9%</td></tr><tr><td class='lessen'>925</td><td>WHITFIELD_CELL_CYCLE_G1_S</td><td></td><td>102</td><td>-0.23</td><td>-0.78</td><td>0.928</td><td>1.000</td><td>1.000</td><td>2314</td><td>tags=32%, list=21%, signal=40%</td></tr><tr><td class='lessen'>926</td><td>HENDRICKS_SMARCA4_TARGETS_DN</td><td></td><td>37</td><td>-0.28</td><td>-0.78</td><td>0.817</td><td>1.000</td><td>1.000</td><td>1557</td><td>tags=22%, list=14%, signal=25%</td></tr><tr><td class='lessen'>927</td><td>JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN</td><td></td><td>14</td><td>-0.34</td><td>-0.78</td><td>0.753</td><td>1.000</td><td>1.000</td><td>1963</td><td>tags=21%, list=18%, signal=26%</td></tr><tr><td class='lessen'>928</td><td>ZHANG_RESPONSE_TO_CANTHARIDIN_DN</td><td></td><td>59</td><td>-0.25</td><td>-0.78</td><td>0.868</td><td>1.000</td><td>1.000</td><td>2398</td><td>tags=31%, list=22%, signal=39%</td></tr><tr><td class='lessen'>929</td><td>BURTON_ADIPOGENESIS_PEAK_AT_2HR</td><td></td><td>46</td><td>-0.26</td><td>-0.78</td><td>0.866</td><td>1.000</td><td>1.000</td><td>1397</td><td>tags=22%, list=13%, signal=25%</td></tr><tr><td class='lessen'>930</td><td>YU_MYC_TARGETS_UP</td><td></td><td>34</td><td>-0.28</td><td>-0.78</td><td>0.807</td><td>1.000</td><td>1.000</td><td>1348</td><td>tags=21%, list=12%, signal=23%</td></tr><tr><td class='lessen'>931</td><td>MEISSNER_BRAIN_ICP_WITH_H3K4ME3</td><td></td><td>19</td><td>-0.32</td><td>-0.78</td><td>0.764</td><td>1.000</td><td>1.000</td><td>1444</td><td>tags=16%, list=13%, signal=18%</td></tr><tr><td class='lessen'>932</td><td>LUI_TARGETS_OF_PAX8_PPARG_FUSION</td><td></td><td>27</td><td>-0.29</td><td>-0.78</td><td>0.799</td><td>1.000</td><td>1.000</td><td>3221</td><td>tags=48%, list=29%, signal=68%</td></tr><tr><td class='lessen'>933</td><td>BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN</td><td></td><td>36</td><td>-0.28</td><td>-0.78</td><td>0.819</td><td>1.000</td><td>1.000</td><td>1036</td><td>tags=8%, list=9%, signal=9%</td></tr><tr><td class='lessen'>934</td><td>NAGASHIMA_NRG1_SIGNALING_DN</td><td></td><td>38</td><td>-0.28</td><td>-0.78</td><td>0.821</td><td>1.000</td><td>1.000</td><td>2500</td><td>tags=39%, list=22%, signal=51%</td></tr><tr><td class='lessen'>935</td><td>JIANG_TIP30_TARGETS_UP</td><td></td><td>38</td><td>-0.28</td><td>-0.77</td><td>0.834</td><td>1.000</td><td>1.000</td><td>872</td><td>tags=13%, list=8%, signal=14%</td></tr><tr><td class='lessen'>936</td><td>GAZIN_EPIGENETIC_SILENCING_BY_KRAS</td><td></td><td>22</td><td>-0.31</td><td>-0.77</td><td>0.793</td><td>1.000</td><td>1.000</td><td>674</td><td>tags=9%, list=6%, signal=10%</td></tr><tr><td class='lessen'>937</td><td>ZHENG_FOXP3_TARGETS_UP</td><td></td><td>21</td><td>-0.31</td><td>-0.77</td><td>0.813</td><td>1.000</td><td>1.000</td><td>1240</td><td>tags=19%, list=11%, signal=21%</td></tr><tr><td class='lessen'>938</td><td>KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP</td><td></td><td>48</td><td>-0.26</td><td>-0.77</td><td>0.857</td><td>1.000</td><td>1.000</td><td>2017</td><td>tags=23%, list=18%, signal=28%</td></tr><tr><td class='lessen'>939</td><td>EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN</td><td></td><td>30</td><td>-0.29</td><td>-0.77</td><td>0.809</td><td>1.000</td><td>1.000</td><td>2262</td><td>tags=27%, list=20%, signal=33%</td></tr><tr><td class='lessen'>940</td><td>WHITFIELD_CELL_CYCLE_G2_M</td><td></td><td>171</td><td>-0.21</td><td>-0.77</td><td>0.972</td><td>1.000</td><td>1.000</td><td>1128</td><td>tags=12%, list=10%, signal=13%</td></tr><tr><td class='lessen'>941</td><td>RAO_BOUND_BY_SALL4</td><td></td><td>155</td><td>-0.22</td><td>-0.77</td><td>0.961</td><td>1.000</td><td>1.000</td><td>1930</td><td>tags=19%, list=17%, signal=22%</td></tr><tr><td class='lessen'>942</td><td>IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN</td><td></td><td>21</td><td>-0.31</td><td>-0.77</td><td>0.805</td><td>1.000</td><td>1.000</td><td>2687</td><td>tags=33%, list=24%, signal=44%</td></tr><tr><td class='lessen'>943</td><td>MEISSNER_ES_ICP_WITH_H3K4ME3</td><td></td><td>19</td><td>-0.31</td><td>-0.77</td><td>0.793</td><td>1.000</td><td>1.000</td><td>1444</td><td>tags=16%, list=13%, signal=18%</td></tr><tr><td class='lessen'>944</td><td>WEINMANN_ADAPTATION_TO_HYPOXIA_UP</td><td></td><td>24</td><td>-0.31</td><td>-0.77</td><td>0.796</td><td>1.000</td><td>1.000</td><td>423</td><td>tags=8%, list=4%, signal=9%</td></tr><tr><td class='lessen'>945</td><td>WANG_METASTASIS_OF_BREAST_CANCER</td><td></td><td>8</td><td>-0.39</td><td>-0.77</td><td>0.764</td><td>1.000</td><td>1.000</td><td>2614</td><td>tags=63%, list=23%, signal=82%</td></tr><tr><td class='lessen'>946</td><td>VALK_AML_CLUSTER_3</td><td></td><td>27</td><td>-0.30</td><td>-0.77</td><td>0.797</td><td>1.000</td><td>1.000</td><td>97</td><td>tags=4%, list=1%, signal=4%</td></tr><tr><td class='lessen'>947</td><td>LANDIS_ERBB2_BREAST_TUMORS_324_DN</td><td></td><td>137</td><td>-0.22</td><td>-0.77</td><td>0.955</td><td>1.000</td><td>1.000</td><td>1831</td><td>tags=17%, list=16%, signal=20%</td></tr><tr><td class='lessen'>948</td><td>SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN</td><td></td><td>23</td><td>-0.30</td><td>-0.77</td><td>0.836</td><td>1.000</td><td>1.000</td><td>7</td><td>tags=4%, list=0%, signal=4%</td></tr><tr><td class='lessen'>949</td><td>GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN</td><td></td><td>7</td><td>-0.39</td><td>-0.77</td><td>0.709</td><td>1.000</td><td>1.000</td><td>1397</td><td>tags=43%, list=13%, signal=49%</td></tr><tr><td class='lessen'>950</td><td>IRITANI_MAD1_TARGETS_DN</td><td></td><td>38</td><td>-0.27</td><td>-0.77</td><td>0.865</td><td>1.000</td><td>1.000</td><td>2643</td><td>tags=32%, list=24%, signal=41%</td></tr><tr><td class='lessen'>951</td><td>BOCHKIS_FOXA2_TARGETS</td><td></td><td>337</td><td>-0.20</td><td>-0.77</td><td>0.996</td><td>1.000</td><td>1.000</td><td>2467</td><td>tags=23%, list=22%, signal=29%</td></tr><tr><td class='lessen'>952</td><td>SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER</td><td></td><td>31</td><td>-0.28</td><td>-0.77</td><td>0.840</td><td>1.000</td><td>1.000</td><td>344</td><td>tags=10%, list=3%, signal=10%</td></tr><tr><td class='lessen'>953</td><td>ZHU_CMV_24_HR_DN</td><td></td><td>77</td><td>-0.24</td><td>-0.77</td><td>0.917</td><td>1.000</td><td>1.000</td><td>2180</td><td>tags=26%, list=20%, signal=32%</td></tr><tr><td class='lessen'>954</td><td>IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP</td><td></td><td>129</td><td>-0.22</td><td>-0.76</td><td>0.956</td><td>1.000</td><td>1.000</td><td>2977</td><td>tags=36%, list=27%, signal=48%</td></tr><tr><td class='lessen'>955</td><td>LI_WILMS_TUMOR_ANAPLASTIC_UP</td><td></td><td>15</td><td>-0.33</td><td>-0.76</td><td>0.789</td><td>1.000</td><td>1.000</td><td>1053</td><td>tags=20%, list=9%, signal=22%</td></tr><tr><td class='lessen'>956</td><td>LEE_METASTASIS_AND_RNA_PROCESSING_UP</td><td></td><td>15</td><td>-0.33</td><td>-0.76</td><td>0.785</td><td>1.000</td><td>1.000</td><td>2610</td><td>tags=40%, list=23%, signal=52%</td></tr><tr><td class='lessen'>957</td><td>POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN</td><td></td><td>42</td><td>-0.27</td><td>-0.76</td><td>0.882</td><td>1.000</td><td>1.000</td><td>2112</td><td>tags=33%, list=19%, signal=41%</td></tr><tr><td class='lessen'>958</td><td>WENG_POR_TARGETS_GLOBAL_UP</td><td></td><td>15</td><td>-0.33</td><td>-0.76</td><td>0.797</td><td>1.000</td><td>1.000</td><td>1585</td><td>tags=20%, list=14%, signal=23%</td></tr><tr><td class='lessen'>959</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP</td><td></td><td>29</td><td>-0.28</td><td>-0.76</td><td>0.844</td><td>1.000</td><td>1.000</td><td>2599</td><td>tags=38%, list=23%, signal=49%</td></tr><tr><td class='lessen'>960</td><td>ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN</td><td></td><td>32</td><td>-0.28</td><td>-0.76</td><td>0.830</td><td>1.000</td><td>1.000</td><td>938</td><td>tags=16%, list=8%, signal=17%</td></tr><tr><td class='lessen'>961</td><td>LY_AGING_OLD_UP</td><td></td><td>6</td><td>-0.41</td><td>-0.76</td><td>0.739</td><td>1.000</td><td>1.000</td><td>381</td><td>tags=17%, list=3%, signal=17%</td></tr><tr><td class='lessen'>962</td><td>BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2</td><td></td><td>56</td><td>-0.25</td><td>-0.76</td><td>0.875</td><td>1.000</td><td>1.000</td><td>3025</td><td>tags=32%, list=27%, signal=44%</td></tr><tr><td class='lessen'>963</td><td>HSIAO_HOUSEKEEPING_GENES</td><td></td><td>350</td><td>-0.20</td><td>-0.76</td><td>0.996</td><td>1.000</td><td>1.000</td><td>2124</td><td>tags=18%, list=19%, signal=22%</td></tr><tr><td class='lessen'>964</td><td>LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP</td><td></td><td>162</td><td>-0.21</td><td>-0.76</td><td>0.982</td><td>1.000</td><td>1.000</td><td>1918</td><td>tags=17%, list=17%, signal=21%</td></tr><tr><td class='lessen'>965</td><td>WANG_ADIPOGENIC_GENES_REPRESSED_BY_SIRT1</td><td></td><td>23</td><td>-0.30</td><td>-0.76</td><td>0.819</td><td>1.000</td><td>1.000</td><td>575</td><td>tags=9%, list=5%, signal=9%</td></tr><tr><td class='lessen'>966</td><td>SWEET_KRAS_TARGETS_DN</td><td></td><td>49</td><td>-0.26</td><td>-0.76</td><td>0.894</td><td>1.000</td><td>1.000</td><td>1096</td><td>tags=14%, list=10%, signal=16%</td></tr><tr><td class='lessen'>967</td><td>PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_3</td><td></td><td>12</td><td>-0.35</td><td>-0.76</td><td>0.764</td><td>1.000</td><td>1.000</td><td>3193</td><td>tags=58%, list=29%, signal=82%</td></tr><tr><td class='lessen'>968</td><td>TRAYNOR_RETT_SYNDROM_DN</td><td></td><td>13</td><td>-0.34</td><td>-0.76</td><td>0.789</td><td>1.000</td><td>1.000</td><td>891</td><td>tags=15%, list=8%, signal=17%</td></tr><tr><td class='lessen'>969</td><td>WEI_MIR34A_TARGETS</td><td></td><td>119</td><td>-0.22</td><td>-0.76</td><td>0.947</td><td>1.000</td><td>1.000</td><td>2771</td><td>tags=24%, list=25%, signal=31%</td></tr><tr><td class='lessen'>970</td><td>MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_UP</td><td></td><td>17</td><td>-0.32</td><td>-0.76</td><td>0.796</td><td>1.000</td><td>1.000</td><td>1773</td><td>tags=29%, list=16%, signal=35%</td></tr><tr><td class='lessen'>971</td><td>SMID_BREAST_CANCER_LUMINAL_A_DN</td><td></td><td>14</td><td>-0.34</td><td>-0.76</td><td>0.806</td><td>1.000</td><td>1.000</td><td>633</td><td>tags=14%, list=6%, signal=15%</td></tr><tr><td class='lessen'>972</td><td>BROWNE_HCMV_INFECTION_8HR_DN</td><td></td><td>32</td><td>-0.28</td><td>-0.76</td><td>0.860</td><td>1.000</td><td>1.000</td><td>289</td><td>tags=6%, list=3%, signal=6%</td></tr><tr><td class='lessen'>973</td><td>BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING</td><td></td><td>171</td><td>-0.21</td><td>-0.76</td><td>0.979</td><td>1.000</td><td>1.000</td><td>2008</td><td>tags=20%, list=18%, signal=24%</td></tr><tr><td class='lessen'>974</td><td>HILLION_HMGA1B_TARGETS</td><td></td><td>80</td><td>-0.24</td><td>-0.76</td><td>0.940</td><td>1.000</td><td>1.000</td><td>1643</td><td>tags=20%, list=15%, signal=23%</td></tr><tr><td class='lessen'>975</td><td>LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q</td><td></td><td>90</td><td>-0.23</td><td>-0.76</td><td>0.952</td><td>1.000</td><td>1.000</td><td>1900</td><td>tags=14%, list=17%, signal=17%</td></tr><tr><td class='lessen'>976</td><td>DOUGLAS_BMI1_TARGETS_DN</td><td></td><td>233</td><td>-0.21</td><td>-0.76</td><td>1.000</td><td>1.000</td><td>1.000</td><td>2433</td><td>tags=21%, list=22%, signal=26%</td></tr><tr><td class='lessen'>977</td><td>RIZ_ERYTHROID_DIFFERENTIATION</td><td></td><td>67</td><td>-0.24</td><td>-0.75</td><td>0.926</td><td>1.000</td><td>1.000</td><td>2813</td><td>tags=36%, list=25%, signal=48%</td></tr><tr><td class='lessen'>978</td><td>SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4</td><td></td><td>211</td><td>-0.21</td><td>-0.75</td><td>0.994</td><td>1.000</td><td>1.000</td><td>2723</td><td>tags=32%, list=24%, signal=41%</td></tr><tr><td class='lessen'>979</td><td>RICKMAN_METASTASIS_UP</td><td></td><td>230</td><td>-0.21</td><td>-0.75</td><td>1.000</td><td>1.000</td><td>1.000</td><td>1834</td><td>tags=15%, list=16%, signal=17%</td></tr><tr><td class='lessen'>980</td><td>TCGA_GLIOBLASTOMA_COPY_NUMBER_DN</td><td></td><td>25</td><td>-0.29</td><td>-0.75</td><td>0.828</td><td>1.000</td><td>1.000</td><td>3848</td><td>tags=60%, list=35%, signal=91%</td></tr><tr><td class='lessen'>981</td><td>BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP</td><td></td><td>22</td><td>-0.30</td><td>-0.75</td><td>0.816</td><td>1.000</td><td>1.000</td><td>2016</td><td>tags=27%, list=18%, signal=33%</td></tr><tr><td class='lessen'>982</td><td>VALK_AML_CLUSTER_1</td><td></td><td>23</td><td>-0.30</td><td>-0.75</td><td>0.805</td><td>1.000</td><td>1.000</td><td>1397</td><td>tags=17%, list=13%, signal=20%</td></tr><tr><td class='lessen'>983</td><td>BOUDOUKHA_BOUND_BY_IGF2BP2</td><td></td><td>85</td><td>-0.23</td><td>-0.75</td><td>0.929</td><td>1.000</td><td>1.000</td><td>1753</td><td>tags=14%, list=16%, signal=17%</td></tr><tr><td class='lessen'>984</td><td>CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN</td><td></td><td>260</td><td>-0.20</td><td>-0.75</td><td>0.998</td><td>1.000</td><td>1.000</td><td>2902</td><td>tags=32%, list=26%, signal=42%</td></tr><tr><td class='lessen'>985</td><td>KANG_FLUOROURACIL_RESISTANCE_DN</td><td></td><td>14</td><td>-0.33</td><td>-0.75</td><td>0.808</td><td>1.000</td><td>1.000</td><td>930</td><td>tags=14%, list=8%, signal=16%</td></tr><tr><td class='lessen'>986</td><td>LY_AGING_PREMATURE_DN</td><td></td><td>25</td><td>-0.29</td><td>-0.75</td><td>0.845</td><td>1.000</td><td>1.000</td><td>2159</td><td>tags=40%, list=19%, signal=50%</td></tr><tr><td class='lessen'>987</td><td>PETROVA_PROX1_TARGETS_UP</td><td></td><td>24</td><td>-0.30</td><td>-0.75</td><td>0.813</td><td>1.000</td><td>1.000</td><td>1140</td><td>tags=17%, list=10%, signal=19%</td></tr><tr><td class='lessen'>988</td><td>LINSLEY_MIR16_TARGETS</td><td></td><td>169</td><td>-0.21</td><td>-0.75</td><td>0.990</td><td>1.000</td><td>1.000</td><td>1812</td><td>tags=14%, list=16%, signal=16%</td></tr><tr><td class='lessen'>989</td><td>MEDINA_SMARCA4_TARGETS</td><td></td><td>36</td><td>-0.27</td><td>-0.75</td><td>0.865</td><td>1.000</td><td>1.000</td><td>2339</td><td>tags=28%, list=21%, signal=35%</td></tr><tr><td class='lessen'>990</td><td>ROME_INSULIN_TARGETS_IN_MUSCLE_UP</td><td></td><td>338</td><td>-0.19</td><td>-0.75</td><td>0.998</td><td>1.000</td><td>1.000</td><td>2301</td><td>tags=18%, list=21%, signal=22%</td></tr><tr><td class='lessen'>991</td><td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN</td><td></td><td>27</td><td>-0.28</td><td>-0.75</td><td>0.843</td><td>1.000</td><td>1.000</td><td>2429</td><td>tags=33%, list=22%, signal=43%</td></tr><tr><td class='lessen'>992</td><td>OSMAN_BLADDER_CANCER_DN</td><td></td><td>284</td><td>-0.20</td><td>-0.75</td><td>0.996</td><td>1.000</td><td>1.000</td><td>1804</td><td>tags=15%, list=16%, signal=18%</td></tr><tr><td class='lessen'>993</td><td>BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN</td><td></td><td>25</td><td>-0.29</td><td>-0.75</td><td>0.847</td><td>1.000</td><td>1.000</td><td>1685</td><td>tags=20%, list=15%, signal=24%</td></tr><tr><td class='lessen'>994</td><td>CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY</td><td></td><td>18</td><td>-0.31</td><td>-0.75</td><td>0.846</td><td>1.000</td><td>1.000</td><td>33</td><td>tags=6%, list=0%, signal=6%</td></tr><tr><td class='lessen'>995</td><td>SHIN_B_CELL_LYMPHOMA_CLUSTER_5</td><td></td><td>10</td><td>-0.36</td><td>-0.74</td><td>0.788</td><td>1.000</td><td>1.000</td><td>1984</td><td>tags=40%, list=18%, signal=49%</td></tr><tr><td class='lessen'>996</td><td>CAMPS_COLON_CANCER_COPY_NUMBER_UP</td><td></td><td>55</td><td>-0.25</td><td>-0.74</td><td>0.900</td><td>1.000</td><td>1.000</td><td>2985</td><td>tags=36%, list=27%, signal=49%</td></tr><tr><td class='lessen'>997</td><td>ZHU_CMV_ALL_UP</td><td></td><td>97</td><td>-0.22</td><td>-0.74</td><td>0.960</td><td>1.000</td><td>1.000</td><td>2453</td><td>tags=22%, list=22%, signal=28%</td></tr><tr><td class='lessen'>998</td><td>KYNG_ENVIRONMENTAL_STRESS_RESPONSE_DN</td><td></td><td>15</td><td>-0.32</td><td>-0.74</td><td>0.824</td><td>1.000</td><td>1.000</td><td>4329</td><td>tags=60%, list=39%, signal=98%</td></tr><tr><td class='lessen'>999</td><td>LINDGREN_BLADDER_CANCER_CLUSTER_1_UP</td><td></td><td>87</td><td>-0.23</td><td>-0.74</td><td>0.953</td><td>1.000</td><td>1.000</td><td>1954</td><td>tags=17%, list=18%, signal=21%</td></tr><tr><td class='lessen'>1000</td><td>BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN</td><td></td><td>23</td><td>-0.30</td><td>-0.74</td><td>0.856</td><td>1.000</td><td>1.000</td><td>2598</td><td>tags=30%, list=23%, signal=40%</td></tr><tr><td class='lessen'>1001</td><td>WANG_RESPONSE_TO_FORSKOLIN_UP</td><td></td><td>18</td><td>-0.31</td><td>-0.74</td><td>0.814</td><td>1.000</td><td>1.000</td><td>277</td><td>tags=6%, list=2%, signal=6%</td></tr><tr><td class='lessen'>1002</td><td>VANTVEER_BREAST_CANCER_BRCA1_UP</td><td></td><td>27</td><td>-0.28</td><td>-0.74</td><td>0.853</td><td>1.000</td><td>1.000</td><td>56</td><td>tags=4%, list=1%, signal=4%</td></tr><tr><td class='lessen'>1003</td><td>SWEET_KRAS_TARGETS_UP</td><td></td><td>71</td><td>-0.24</td><td>-0.74</td><td>0.945</td><td>1.000</td><td>1.000</td><td>608</td><td>tags=6%, list=5%, signal=6%</td></tr><tr><td class='lessen'>1004</td><td>RAY_ALZHEIMERS_DISEASE</td><td></td><td>7</td><td>-0.39</td><td>-0.74</td><td>0.781</td><td>1.000</td><td>1.000</td><td>1339</td><td>tags=43%, list=12%, signal=49%</td></tr><tr><td class='lessen'>1005</td><td>HASLINGER_B_CLL_WITH_13Q14_DELETION</td><td></td><td>17</td><td>-0.32</td><td>-0.74</td><td>0.807</td><td>1.000</td><td>1.000</td><td>1134</td><td>tags=24%, list=10%, signal=26%</td></tr><tr><td class='lessen'>1006</td><td>ALONSO_METASTASIS_NEURAL_UP</td><td></td><td>16</td><td>-0.32</td><td>-0.74</td><td>0.810</td><td>1.000</td><td>1.000</td><td>473</td><td>tags=6%, list=4%, signal=7%</td></tr><tr><td class='lessen'>1007</td><td>VANTVEER_BREAST_CANCER_BRCA1_DN</td><td></td><td>28</td><td>-0.28</td><td>-0.74</td><td>0.863</td><td>1.000</td><td>1.000</td><td>1137</td><td>tags=14%, list=10%, signal=16%</td></tr><tr><td class='lessen'>1008</td><td>ONDER_CDH1_TARGETS_3_DN</td><td></td><td>25</td><td>-0.29</td><td>-0.74</td><td>0.840</td><td>1.000</td><td>1.000</td><td>814</td><td>tags=16%, list=7%, signal=17%</td></tr><tr><td class='lessen'>1009</td><td>MATZUK_FERTILIZATION</td><td></td><td>5</td><td>-0.41</td><td>-0.74</td><td>0.774</td><td>1.000</td><td>1.000</td><td>3064</td><td>tags=40%, list=28%, signal=55%</td></tr><tr><td class='lessen'>1010</td><td>NAGY_STAGA_COMPONENTS_HUMAN</td><td></td><td>10</td><td>-0.36</td><td>-0.74</td><td>0.809</td><td>1.000</td><td>1.000</td><td>2742</td><td>tags=40%, list=25%, signal=53%</td></tr><tr><td class='lessen'>1011</td><td>CAFFAREL_RESPONSE_TO_THC_8HR_5_UP</td><td></td><td>11</td><td>-0.35</td><td>-0.74</td><td>0.816</td><td>1.000</td><td>1.000</td><td>2180</td><td>tags=36%, list=20%, signal=45%</td></tr><tr><td class='lessen'>1012</td><td>RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN</td><td></td><td>131</td><td>-0.21</td><td>-0.74</td><td>0.976</td><td>1.000</td><td>1.000</td><td>1657</td><td>tags=17%, list=15%, signal=19%</td></tr><tr><td class='lessen'>1013</td><td>MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN</td><td></td><td>219</td><td>-0.20</td><td>-0.73</td><td>0.998</td><td>1.000</td><td>1.000</td><td>2938</td><td>tags=25%, list=26%, signal=33%</td></tr><tr><td class='lessen'>1014</td><td>LI_CISPLATIN_RESISTANCE_DN</td><td></td><td>21</td><td>-0.30</td><td>-0.73</td><td>0.867</td><td>1.000</td><td>1.000</td><td>708</td><td>tags=14%, list=6%, signal=15%</td></tr><tr><td class='lessen'>1015</td><td>CHUANG_OXIDATIVE_STRESS_RESPONSE_UP</td><td></td><td>23</td><td>-0.28</td><td>-0.73</td><td>0.877</td><td>1.000</td><td>1.000</td><td>741</td><td>tags=13%, list=7%, signal=14%</td></tr><tr><td class='lessen'>1016</td><td>DARWICHE_PAPILLOMA_RISK_HIGH_VS_LOW_DN</td><td></td><td>24</td><td>-0.29</td><td>-0.73</td><td>0.842</td><td>1.000</td><td>1.000</td><td>1161</td><td>tags=17%, list=10%, signal=19%</td></tr><tr><td class='lessen'>1017</td><td>VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN</td><td></td><td>33</td><td>-0.27</td><td>-0.73</td><td>0.877</td><td>1.000</td><td>1.000</td><td>3590</td><td>tags=36%, list=32%, signal=54%</td></tr><tr><td class='lessen'>1018</td><td>TOMIDA_METASTASIS_UP</td><td></td><td>18</td><td>-0.30</td><td>-0.73</td><td>0.841</td><td>1.000</td><td>1.000</td><td>553</td><td>tags=11%, list=5%, signal=12%</td></tr><tr><td class='lessen'>1019</td><td>OXFORD_RALA_OR_RALB_TARGETS_DN</td><td></td><td>17</td><td>-0.31</td><td>-0.73</td><td>0.831</td><td>1.000</td><td>1.000</td><td>845</td><td>tags=12%, list=8%, signal=13%</td></tr><tr><td class='lessen'>1020</td><td>KAMMINGA_EZH2_TARGETS</td><td></td><td>40</td><td>-0.26</td><td>-0.73</td><td>0.901</td><td>1.000</td><td>1.000</td><td>1052</td><td>tags=18%, list=9%, signal=19%</td></tr><tr><td class='lessen'>1021</td><td>YANG_BREAST_CANCER_ESR1_UP</td><td></td><td>28</td><td>-0.28</td><td>-0.73</td><td>0.872</td><td>1.000</td><td>1.000</td><td>1880</td><td>tags=29%, list=17%, signal=34%</td></tr><tr><td class='lessen'>1022</td><td>LANDIS_ERBB2_BREAST_TUMORS_65_DN</td><td></td><td>34</td><td>-0.26</td><td>-0.73</td><td>0.897</td><td>1.000</td><td>1.000</td><td>1625</td><td>tags=18%, list=15%, signal=21%</td></tr><tr><td class='lessen'>1023</td><td>WENG_POR_DOSAGE</td><td></td><td>16</td><td>-0.31</td><td>-0.73</td><td>0.853</td><td>1.000</td><td>1.000</td><td>2336</td><td>tags=38%, list=21%, signal=47%</td></tr><tr><td class='lessen'>1024</td><td>BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN</td><td></td><td>142</td><td>-0.21</td><td>-0.73</td><td>0.984</td><td>1.000</td><td>1.000</td><td>1805</td><td>tags=18%, list=16%, signal=21%</td></tr><tr><td class='lessen'>1025</td><td>ZHU_CMV_ALL_DN</td><td></td><td>107</td><td>-0.21</td><td>-0.73</td><td>0.983</td><td>1.000</td><td>1.000</td><td>2969</td><td>tags=33%, list=27%, signal=44%</td></tr><tr><td class='lessen'>1026</td><td>DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP</td><td></td><td>57</td><td>-0.24</td><td>-0.73</td><td>0.930</td><td>1.000</td><td>1.000</td><td>1901</td><td>tags=23%, list=17%, signal=27%</td></tr><tr><td class='lessen'>1027</td><td>JACKSON_DNMT1_TARGETS_UP</td><td></td><td>72</td><td>-0.23</td><td>-0.73</td><td>0.955</td><td>1.000</td><td>1.000</td><td>1247</td><td>tags=14%, list=11%, signal=16%</td></tr><tr><td class='lessen'>1028</td><td>FAELT_B_CLL_WITH_VH3_21_DN</td><td></td><td>42</td><td>-0.25</td><td>-0.73</td><td>0.899</td><td>1.000</td><td>1.000</td><td>681</td><td>tags=10%, list=6%, signal=10%</td></tr><tr><td class='lessen'>1029</td><td>DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP</td><td></td><td>193</td><td>-0.20</td><td>-0.73</td><td>0.998</td><td>1.000</td><td>1.000</td><td>1899</td><td>tags=17%, list=17%, signal=20%</td></tr><tr><td class='lessen'>1030</td><td>FIGUEROA_AML_METHYLATION_CLUSTER_6_DN</td><td></td><td>18</td><td>-0.30</td><td>-0.73</td><td>0.854</td><td>1.000</td><td>1.000</td><td>669</td><td>tags=11%, list=6%, signal=12%</td></tr><tr><td class='lessen'>1031</td><td>RODRIGUES_NTN1_TARGETS_UP</td><td></td><td>12</td><td>-0.33</td><td>-0.72</td><td>0.823</td><td>1.000</td><td>1.000</td><td>799</td><td>tags=17%, list=7%, signal=18%</td></tr><tr><td class='lessen'>1032</td><td>SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM</td><td></td><td>32</td><td>-0.27</td><td>-0.72</td><td>0.886</td><td>1.000</td><td>1.000</td><td>1816</td><td>tags=22%, list=16%, signal=26%</td></tr><tr><td class='lessen'>1033</td><td>IWANAGA_CARCINOGENESIS_BY_KRAS_DN</td><td></td><td>88</td><td>-0.22</td><td>-0.72</td><td>0.972</td><td>1.000</td><td>1.000</td><td>1759</td><td>tags=19%, list=16%, signal=23%</td></tr><tr><td class='lessen'>1034</td><td>CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN</td><td></td><td>18</td><td>-0.30</td><td>-0.72</td><td>0.868</td><td>1.000</td><td>1.000</td><td>1763</td><td>tags=33%, list=16%, signal=40%</td></tr><tr><td class='lessen'>1035</td><td>LUI_THYROID_CANCER_CLUSTER_3</td><td></td><td>23</td><td>-0.29</td><td>-0.72</td><td>0.875</td><td>1.000</td><td>1.000</td><td>3221</td><td>tags=48%, list=29%, signal=67%</td></tr><tr><td class='lessen'>1036</td><td>NOUZOVA_TRETINOIN_AND_H4_ACETYLATION</td><td></td><td>97</td><td>-0.22</td><td>-0.72</td><td>0.963</td><td>1.000</td><td>1.000</td><td>2042</td><td>tags=20%, list=18%, signal=24%</td></tr><tr><td class='lessen'>1037</td><td>WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER</td><td></td><td>45</td><td>-0.25</td><td>-0.72</td><td>0.922</td><td>1.000</td><td>1.000</td><td>1518</td><td>tags=18%, list=14%, signal=21%</td></tr><tr><td class='lessen'>1038</td><td>HOEBEKE_LYMPHOID_STEM_CELL_DN</td><td></td><td>74</td><td>-0.23</td><td>-0.72</td><td>0.941</td><td>1.000</td><td>1.000</td><td>1976</td><td>tags=20%, list=18%, signal=24%</td></tr><tr><td class='lessen'>1039</td><td>DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_DN</td><td></td><td>8</td><td>-0.36</td><td>-0.72</td><td>0.794</td><td>1.000</td><td>1.000</td><td>575</td><td>tags=13%, list=5%, signal=13%</td></tr><tr><td class='lessen'>1040</td><td>UDAYAKUMAR_MED1_TARGETS_DN</td><td></td><td>194</td><td>-0.20</td><td>-0.72</td><td>1.000</td><td>1.000</td><td>1.000</td><td>2938</td><td>tags=28%, list=26%, signal=38%</td></tr><tr><td class='lessen'>1041</td><td>ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP</td><td></td><td>68</td><td>-0.23</td><td>-0.72</td><td>0.949</td><td>1.000</td><td>1.000</td><td>1556</td><td>tags=15%, list=14%, signal=17%</td></tr><tr><td class='lessen'>1042</td><td>HASEGAWA_TUMORIGENESIS_BY_RET_C634R</td><td></td><td>6</td><td>-0.39</td><td>-0.72</td><td>0.786</td><td>1.000</td><td>1.000</td><td>553</td><td>tags=17%, list=5%, signal=18%</td></tr><tr><td class='lessen'>1043</td><td>STANHILL_HRAS_TRANSFROMATION_UP</td><td></td><td>8</td><td>-0.37</td><td>-0.72</td><td>0.798</td><td>1.000</td><td>1.000</td><td>2292</td><td>tags=50%, list=21%, signal=63%</td></tr><tr><td class='lessen'>1044</td><td>BILD_SRC_ONCOGENIC_SIGNATURE</td><td></td><td>50</td><td>-0.24</td><td>-0.72</td><td>0.915</td><td>1.000</td><td>1.000</td><td>3097</td><td>tags=38%, list=28%, signal=52%</td></tr><tr><td class='lessen'>1045</td><td>RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN</td><td></td><td>315</td><td>-0.19</td><td>-0.72</td><td>1.000</td><td>1.000</td><td>1.000</td><td>1823</td><td>tags=17%, list=16%, signal=20%</td></tr><tr><td class='lessen'>1046</td><td>RAMALHO_STEMNESS_UP</td><td></td><td>172</td><td>-0.20</td><td>-0.71</td><td>0.996</td><td>1.000</td><td>1.000</td><td>3291</td><td>tags=30%, list=30%, signal=42%</td></tr><tr><td class='lessen'>1047</td><td>SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_DN</td><td></td><td>5</td><td>-0.40</td><td>-0.71</td><td>0.785</td><td>1.000</td><td>1.000</td><td>1902</td><td>tags=60%, list=17%, signal=72%</td></tr><tr><td class='lessen'>1048</td><td>WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP</td><td></td><td>17</td><td>-0.30</td><td>-0.71</td><td>0.884</td><td>1.000</td><td>1.000</td><td>2586</td><td>tags=41%, list=23%, signal=54%</td></tr><tr><td class='lessen'>1049</td><td>BEIER_GLIOMA_STEM_CELL_DN</td><td></td><td>43</td><td>-0.25</td><td>-0.71</td><td>0.916</td><td>1.000</td><td>1.000</td><td>1044</td><td>tags=12%, list=9%, signal=13%</td></tr><tr><td class='lessen'>1050</td><td>LEE_LIVER_CANCER_MYC_UP</td><td></td><td>51</td><td>-0.24</td><td>-0.71</td><td>0.928</td><td>1.000</td><td>1.000</td><td>2286</td><td>tags=25%, list=21%, signal=32%</td></tr><tr><td class='lessen'>1051</td><td>PUJANA_BREAST_CANCER_LIT_INT_NETWORK</td><td></td><td>92</td><td>-0.21</td><td>-0.71</td><td>0.967</td><td>1.000</td><td>1.000</td><td>2391</td><td>tags=26%, list=21%, signal=33%</td></tr><tr><td class='lessen'>1052</td><td>TAKAYAMA_BOUND_BY_AR</td><td></td><td>7</td><td>-0.36</td><td>-0.71</td><td>0.760</td><td>1.000</td><td>1.000</td><td>2936</td><td>tags=57%, list=26%, signal=78%</td></tr><tr><td class='lessen'>1053</td><td>BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP</td><td></td><td>23</td><td>-0.28</td><td>-0.71</td><td>0.872</td><td>1.000</td><td>1.000</td><td>2129</td><td>tags=30%, list=19%, signal=38%</td></tr><tr><td class='lessen'>1054</td><td>GOLDRATH_IMMUNE_MEMORY</td><td></td><td>57</td><td>-0.23</td><td>-0.71</td><td>0.964</td><td>1.000</td><td>1.000</td><td>1916</td><td>tags=28%, list=17%, signal=34%</td></tr><tr><td class='lessen'>1055</td><td>CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_UP</td><td></td><td>8</td><td>-0.34</td><td>-0.71</td><td>0.783</td><td>1.000</td><td>1.000</td><td>2468</td><td>tags=25%, list=22%, signal=32%</td></tr><tr><td class='lessen'>1056</td><td>BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN</td><td></td><td>39</td><td>-0.25</td><td>-0.71</td><td>0.915</td><td>1.000</td><td>1.000</td><td>1799</td><td>tags=21%, list=16%, signal=24%</td></tr><tr><td class='lessen'>1057</td><td>GENTILE_UV_RESPONSE_CLUSTER_D5</td><td></td><td>28</td><td>-0.27</td><td>-0.71</td><td>0.897</td><td>1.000</td><td>1.000</td><td>2015</td><td>tags=21%, list=18%, signal=26%</td></tr><tr><td class='lessen'>1058</td><td>RIZ_ERYTHROID_DIFFERENTIATION_12HR</td><td></td><td>38</td><td>-0.25</td><td>-0.70</td><td>0.935</td><td>1.000</td><td>1.000</td><td>1599</td><td>tags=24%, list=14%, signal=28%</td></tr><tr><td class='lessen'>1059</td><td>FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP</td><td></td><td>55</td><td>-0.23</td><td>-0.70</td><td>0.948</td><td>1.000</td><td>1.000</td><td>1934</td><td>tags=20%, list=17%, signal=24%</td></tr><tr><td class='lessen'>1060</td><td>RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP</td><td></td><td>24</td><td>-0.28</td><td>-0.70</td><td>0.879</td><td>1.000</td><td>1.000</td><td>1084</td><td>tags=13%, list=10%, signal=14%</td></tr><tr><td class='lessen'>1061</td><td>INAMURA_LUNG_CANCER_SCC_DN</td><td></td><td>11</td><td>-0.32</td><td>-0.70</td><td>0.808</td><td>1.000</td><td>1.000</td><td>77</td><td>tags=9%, list=1%, signal=9%</td></tr><tr><td class='lessen'>1062</td><td>CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_DN</td><td></td><td>13</td><td>-0.32</td><td>-0.70</td><td>0.851</td><td>1.000</td><td>1.000</td><td>1737</td><td>tags=23%, list=16%, signal=27%</td></tr><tr><td class='lessen'>1063</td><td>ZWANG_EGF_INTERVAL_UP</td><td></td><td>45</td><td>-0.24</td><td>-0.70</td><td>0.940</td><td>1.000</td><td>1.000</td><td>2296</td><td>tags=29%, list=21%, signal=36%</td></tr><tr><td class='lessen'>1064</td><td>LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP</td><td></td><td>61</td><td>-0.23</td><td>-0.70</td><td>0.961</td><td>1.000</td><td>1.000</td><td>1049</td><td>tags=10%, list=9%, signal=11%</td></tr><tr><td class='lessen'>1065</td><td>WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_DN</td><td></td><td>5</td><td>-0.40</td><td>-0.70</td><td>0.799</td><td>1.000</td><td>1.000</td><td>516</td><td>tags=20%, list=5%, signal=21%</td></tr><tr><td class='lessen'>1066</td><td>WU_ALZHEIMER_DISEASE_UP</td><td></td><td>11</td><td>-0.33</td><td>-0.70</td><td>0.838</td><td>1.000</td><td>1.000</td><td>878</td><td>tags=18%, list=8%, signal=20%</td></tr><tr><td class='lessen'>1067</td><td>OHGUCHI_LIVER_HNF4A_TARGETS_DN</td><td></td><td>118</td><td>-0.20</td><td>-0.70</td><td>0.986</td><td>1.000</td><td>1.000</td><td>3297</td><td>tags=35%, list=30%, signal=49%</td></tr><tr><td class='lessen'>1068</td><td>JIANG_AGING_CEREBRAL_CORTEX_UP</td><td></td><td>31</td><td>-0.26</td><td>-0.70</td><td>0.913</td><td>1.000</td><td>1.000</td><td>2505</td><td>tags=35%, list=23%, signal=46%</td></tr><tr><td class='lessen'>1069</td><td>GENTILE_UV_HIGH_DOSE_DN</td><td></td><td>249</td><td>-0.19</td><td>-0.70</td><td>1.000</td><td>1.000</td><td>1.000</td><td>3091</td><td>tags=29%, list=28%, signal=39%</td></tr><tr><td class='lessen'>1070</td><td>NADLER_OBESITY_DN</td><td></td><td>44</td><td>-0.24</td><td>-0.69</td><td>0.934</td><td>1.000</td><td>1.000</td><td>2112</td><td>tags=23%, list=19%, signal=28%</td></tr><tr><td class='lessen'>1071</td><td>WARTERS_RESPONSE_TO_IR_SKIN</td><td></td><td>51</td><td>-0.23</td><td>-0.69</td><td>0.945</td><td>1.000</td><td>1.000</td><td>2136</td><td>tags=25%, list=19%, signal=31%</td></tr><tr><td class='lessen'>1072</td><td>SCHRAMM_INHBA_TARGETS_DN</td><td></td><td>23</td><td>-0.27</td><td>-0.69</td><td>0.884</td><td>1.000</td><td>1.000</td><td>2962</td><td>tags=35%, list=27%, signal=47%</td></tr><tr><td class='lessen'>1073</td><td>CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN</td><td></td><td>40</td><td>-0.24</td><td>-0.69</td><td>0.941</td><td>1.000</td><td>1.000</td><td>2016</td><td>tags=25%, list=18%, signal=30%</td></tr><tr><td class='lessen'>1074</td><td>YAMASHITA_LIVER_CANCER_STEM_CELL_UP</td><td></td><td>44</td><td>-0.24</td><td>-0.69</td><td>0.951</td><td>1.000</td><td>1.000</td><td>2844</td><td>tags=34%, list=26%, signal=46%</td></tr><tr><td class='lessen'>1075</td><td>MCDOWELL_ACUTE_LUNG_INJURY_UP</td><td></td><td>40</td><td>-0.25</td><td>-0.69</td><td>0.934</td><td>1.000</td><td>1.000</td><td>1995</td><td>tags=25%, list=18%, signal=30%</td></tr><tr><td class='lessen'>1076</td><td>GUO_TARGETS_OF_IRS1_AND_IRS2</td><td></td><td>84</td><td>-0.21</td><td>-0.69</td><td>0.968</td><td>1.000</td><td>1.000</td><td>2950</td><td>tags=30%, list=26%, signal=40%</td></tr><tr><td class='lessen'>1077</td><td>RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN</td><td></td><td>40</td><td>-0.25</td><td>-0.69</td><td>0.929</td><td>1.000</td><td>1.000</td><td>2118</td><td>tags=28%, list=19%, signal=34%</td></tr><tr><td class='lessen'>1078</td><td>WENG_POR_TARGETS_LIVER_DN</td><td></td><td>18</td><td>-0.29</td><td>-0.69</td><td>0.861</td><td>1.000</td><td>1.000</td><td>3170</td><td>tags=44%, list=28%, signal=62%</td></tr><tr><td class='lessen'>1079</td><td>RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP</td><td></td><td>493</td><td>-0.18</td><td>-0.69</td><td>1.000</td><td>1.000</td><td>1.000</td><td>2689</td><td>tags=24%, list=24%, signal=30%</td></tr><tr><td class='lessen'>1080</td><td>LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_UP</td><td></td><td>11</td><td>-0.32</td><td>-0.69</td><td>0.856</td><td>1.000</td><td>1.000</td><td>259</td><td>tags=9%, list=2%, signal=9%</td></tr><tr><td class='lessen'>1081</td><td>HEIDENBLAD_AMPLICON_8Q24_UP</td><td></td><td>28</td><td>-0.26</td><td>-0.69</td><td>0.908</td><td>1.000</td><td>1.000</td><td>1027</td><td>tags=7%, list=9%, signal=8%</td></tr><tr><td class='lessen'>1082</td><td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23</td><td></td><td>17</td><td>-0.29</td><td>-0.69</td><td>0.881</td><td>1.000</td><td>1.000</td><td>1993</td><td>tags=29%, list=18%, signal=36%</td></tr><tr><td class='lessen'>1083</td><td>PHONG_TNF_RESPONSE_VIA_P38_COMPLETE</td><td></td><td>180</td><td>-0.19</td><td>-0.69</td><td>0.998</td><td>1.000</td><td>1.000</td><td>2952</td><td>tags=30%, list=27%, signal=40%</td></tr><tr><td class='lessen'>1084</td><td>SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN</td><td></td><td>38</td><td>-0.25</td><td>-0.69</td><td>0.938</td><td>1.000</td><td>1.000</td><td>2142</td><td>tags=21%, list=19%, signal=26%</td></tr><tr><td class='lessen'>1085</td><td>SCHUHMACHER_MYC_TARGETS_UP</td><td></td><td>69</td><td>-0.22</td><td>-0.69</td><td>0.970</td><td>1.000</td><td>1.000</td><td>1471</td><td>tags=10%, list=13%, signal=12%</td></tr><tr><td class='lessen'>1086</td><td>LASTOWSKA_COAMPLIFIED_WITH_MYCN</td><td></td><td>30</td><td>-0.26</td><td>-0.69</td><td>0.911</td><td>1.000</td><td>1.000</td><td>2577</td><td>tags=27%, list=23%, signal=35%</td></tr><tr><td class='lessen'>1087</td><td>HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_DN</td><td></td><td>14</td><td>-0.31</td><td>-0.69</td><td>0.871</td><td>1.000</td><td>1.000</td><td>1626</td><td>tags=21%, list=15%, signal=25%</td></tr><tr><td class='lessen'>1088</td><td>POS_HISTAMINE_RESPONSE_NETWORK</td><td></td><td>28</td><td>-0.26</td><td>-0.68</td><td>0.935</td><td>1.000</td><td>1.000</td><td>1617</td><td>tags=18%, list=15%, signal=21%</td></tr><tr><td class='lessen'>1089</td><td>WALLACE_PROSTATE_CANCER_RACE_DN</td><td></td><td>55</td><td>-0.23</td><td>-0.68</td><td>0.957</td><td>1.000</td><td>1.000</td><td>961</td><td>tags=9%, list=9%, signal=10%</td></tr><tr><td class='lessen'>1090</td><td>CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP</td><td></td><td>19</td><td>-0.28</td><td>-0.68</td><td>0.917</td><td>1.000</td><td>1.000</td><td>2889</td><td>tags=42%, list=26%, signal=57%</td></tr><tr><td class='lessen'>1091</td><td>LU_EZH2_TARGETS_DN</td><td></td><td>278</td><td>-0.18</td><td>-0.68</td><td>0.998</td><td>1.000</td><td>1.000</td><td>2019</td><td>tags=17%, list=18%, signal=20%</td></tr><tr><td class='lessen'>1092</td><td>WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN</td><td></td><td>17</td><td>-0.29</td><td>-0.68</td><td>0.893</td><td>1.000</td><td>1.000</td><td>1632</td><td>tags=24%, list=15%, signal=28%</td></tr><tr><td class='lessen'>1093</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP</td><td></td><td>21</td><td>-0.28</td><td>-0.68</td><td>0.909</td><td>1.000</td><td>1.000</td><td>3392</td><td>tags=43%, list=30%, signal=62%</td></tr><tr><td class='lessen'>1094</td><td>CHANGOLKAR_H2AFY_TARGETS_UP</td><td></td><td>38</td><td>-0.25</td><td>-0.68</td><td>0.932</td><td>1.000</td><td>1.000</td><td>2771</td><td>tags=29%, list=25%, signal=38%</td></tr><tr><td class='lessen'>1095</td><td>TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_DN</td><td></td><td>6</td><td>-0.36</td><td>-0.68</td><td>0.819</td><td>1.000</td><td>1.000</td><td>2734</td><td>tags=67%, list=25%, signal=88%</td></tr><tr><td class='lessen'>1096</td><td>ZHAN_MULTIPLE_MYELOMA_CD1_DN</td><td></td><td>34</td><td>-0.25</td><td>-0.68</td><td>0.941</td><td>1.000</td><td>1.000</td><td>58</td><td>tags=3%, list=1%, signal=3%</td></tr><tr><td class='lessen'>1097</td><td>CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5</td><td></td><td>344</td><td>-0.18</td><td>-0.67</td><td>1.000</td><td>1.000</td><td>1.000</td><td>2715</td><td>tags=24%, list=24%, signal=31%</td></tr><tr><td class='lessen'>1098</td><td>SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN</td><td></td><td>23</td><td>-0.26</td><td>-0.67</td><td>0.927</td><td>1.000</td><td>1.000</td><td>990</td><td>tags=13%, list=9%, signal=14%</td></tr><tr><td class='lessen'>1099</td><td>ROSS_AML_OF_FAB_M7_TYPE</td><td></td><td>62</td><td>-0.22</td><td>-0.67</td><td>0.976</td><td>1.000</td><td>1.000</td><td>1120</td><td>tags=10%, list=10%, signal=11%</td></tr><tr><td class='lessen'>1100</td><td>DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP</td><td></td><td>21</td><td>-0.26</td><td>-0.67</td><td>0.916</td><td>1.000</td><td>1.000</td><td>1953</td><td>tags=24%, list=18%, signal=29%</td></tr><tr><td class='lessen'>1101</td><td>LOPEZ_TRANSLATION_VIA_FN1_SIGNALING</td><td></td><td>34</td><td>-0.24</td><td>-0.67</td><td>0.956</td><td>1.000</td><td>1.000</td><td>2398</td><td>tags=21%, list=22%, signal=26%</td></tr><tr><td class='lessen'>1102</td><td>CLAUS_PGR_POSITIVE_MENINGIOMA_UP</td><td></td><td>5</td><td>-0.37</td><td>-0.67</td><td>0.837</td><td>1.000</td><td>1.000</td><td>3938</td><td>tags=80%, list=35%, signal=124%</td></tr><tr><td class='lessen'>1103</td><td>GENTILE_UV_RESPONSE_CLUSTER_D6</td><td></td><td>25</td><td>-0.26</td><td>-0.67</td><td>0.936</td><td>1.000</td><td>1.000</td><td>3041</td><td>tags=40%, list=27%, signal=55%</td></tr><tr><td class='lessen'>1104</td><td>MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_DN</td><td></td><td>9</td><td>-0.32</td><td>-0.67</td><td>0.837</td><td>1.000</td><td>1.000</td><td>3337</td><td>tags=44%, list=30%, signal=63%</td></tr><tr><td class='lessen'>1105</td><td>HONMA_DOCETAXEL_RESISTANCE</td><td></td><td>28</td><td>-0.25</td><td>-0.67</td><td>0.912</td><td>1.000</td><td>1.000</td><td>1925</td><td>tags=21%, list=17%, signal=26%</td></tr><tr><td class='lessen'>1106</td><td>LIM_MAMMARY_STEM_CELL_DN</td><td></td><td>352</td><td>-0.17</td><td>-0.67</td><td>1.000</td><td>1.000</td><td>1.000</td><td>2258</td><td>tags=19%, list=20%, signal=23%</td></tr><tr><td class='lessen'>1107</td><td>SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN</td><td></td><td>16</td><td>-0.29</td><td>-0.67</td><td>0.896</td><td>1.000</td><td>1.000</td><td>366</td><td>tags=6%, list=3%, signal=6%</td></tr><tr><td class='lessen'>1108</td><td>SHIN_B_CELL_LYMPHOMA_CLUSTER_7</td><td></td><td>27</td><td>-0.26</td><td>-0.67</td><td>0.934</td><td>1.000</td><td>1.000</td><td>2645</td><td>tags=33%, list=24%, signal=44%</td></tr><tr><td class='lessen'>1109</td><td>NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN</td><td></td><td>12</td><td>-0.30</td><td>-0.67</td><td>0.881</td><td>1.000</td><td>1.000</td><td>1339</td><td>tags=25%, list=12%, signal=28%</td></tr><tr><td class='lessen'>1110</td><td>WANG_CLIM2_TARGETS_DN</td><td></td><td>135</td><td>-0.19</td><td>-0.66</td><td>1.000</td><td>1.000</td><td>1.000</td><td>2804</td><td>tags=24%, list=25%, signal=32%</td></tr><tr><td class='lessen'>1111</td><td>ZHOU_TNF_SIGNALING_4HR</td><td></td><td>46</td><td>-0.23</td><td>-0.66</td><td>0.958</td><td>1.000</td><td>1.000</td><td>3020</td><td>tags=33%, list=27%, signal=45%</td></tr><tr><td class='lessen'>1112</td><td>MODY_HIPPOCAMPUS_POSTNATAL</td><td></td><td>52</td><td>-0.22</td><td>-0.66</td><td>0.958</td><td>1.000</td><td>1.000</td><td>2204</td><td>tags=21%, list=20%, signal=26%</td></tr><tr><td class='lessen'>1113</td><td>IKEDA_MIR30_TARGETS_UP</td><td></td><td>106</td><td>-0.20</td><td>-0.66</td><td>0.993</td><td>1.000</td><td>1.000</td><td>3484</td><td>tags=43%, list=31%, signal=63%</td></tr><tr><td class='lessen'>1114</td><td>PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_DN</td><td></td><td>6</td><td>-0.36</td><td>-0.66</td><td>0.841</td><td>1.000</td><td>1.000</td><td>2924</td><td>tags=50%, list=26%, signal=68%</td></tr><tr><td class='lessen'>1115</td><td>ZHU_CMV_8_HR_DN</td><td></td><td>43</td><td>-0.23</td><td>-0.66</td><td>0.965</td><td>1.000</td><td>1.000</td><td>3418</td><td>tags=40%, list=31%, signal=57%</td></tr><tr><td class='lessen'>1116</td><td>VARELA_ZMPSTE24_TARGETS_DN</td><td></td><td>30</td><td>-0.25</td><td>-0.66</td><td>0.957</td><td>1.000</td><td>1.000</td><td>2109</td><td>tags=23%, list=19%, signal=29%</td></tr><tr><td class='lessen'>1117</td><td>HE_PTEN_TARGETS_UP</td><td></td><td>15</td><td>-0.29</td><td>-0.66</td><td>0.900</td><td>1.000</td><td>1.000</td><td>481</td><td>tags=7%, list=4%, signal=7%</td></tr><tr><td class='lessen'>1118</td><td>TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP</td><td></td><td>46</td><td>-0.23</td><td>-0.66</td><td>0.954</td><td>1.000</td><td>1.000</td><td>2119</td><td>tags=26%, list=19%, signal=32%</td></tr><tr><td class='lessen'>1119</td><td>GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP</td><td></td><td>83</td><td>-0.21</td><td>-0.66</td><td>0.994</td><td>1.000</td><td>1.000</td><td>1653</td><td>tags=17%, list=15%, signal=20%</td></tr><tr><td class='lessen'>1120</td><td>AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP</td><td></td><td>229</td><td>-0.18</td><td>-0.66</td><td>1.000</td><td>1.000</td><td>1.000</td><td>1898</td><td>tags=17%, list=17%, signal=20%</td></tr><tr><td class='lessen'>1121</td><td>KORKOLA_CHORIOCARCINOMA_UP</td><td></td><td>5</td><td>-0.37</td><td>-0.66</td><td>0.845</td><td>1.000</td><td>1.000</td><td>575</td><td>tags=20%, list=5%, signal=21%</td></tr><tr><td class='lessen'>1122</td><td>KARLSSON_TGFB1_TARGETS_DN</td><td></td><td>175</td><td>-0.18</td><td>-0.66</td><td>1.000</td><td>1.000</td><td>1.000</td><td>2220</td><td>tags=19%, list=20%, signal=24%</td></tr><tr><td class='lessen'>1123</td><td>GAL_LEUKEMIC_STEM_CELL_UP</td><td></td><td>100</td><td>-0.19</td><td>-0.66</td><td>0.986</td><td>1.000</td><td>1.000</td><td>2238</td><td>tags=22%, list=20%, signal=27%</td></tr><tr><td class='lessen'>1124</td><td>BROWNE_HCMV_INFECTION_12HR_DN</td><td></td><td>70</td><td>-0.21</td><td>-0.66</td><td>0.988</td><td>1.000</td><td>1.000</td><td>2977</td><td>tags=39%, list=27%, signal=52%</td></tr><tr><td class='lessen'>1125</td><td>RADAEVA_RESPONSE_TO_IFNA1_DN</td><td></td><td>6</td><td>-0.35</td><td>-0.65</td><td>0.847</td><td>1.000</td><td>1.000</td><td>1217</td><td>tags=33%, list=11%, signal=37%</td></tr><tr><td class='lessen'>1126</td><td>YANAGIHARA_ESX1_TARGETS</td><td></td><td>26</td><td>-0.25</td><td>-0.65</td><td>0.931</td><td>1.000</td><td>1.000</td><td>2534</td><td>tags=35%, list=23%, signal=45%</td></tr><tr><td class='lessen'>1127</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15</td><td></td><td>29</td><td>-0.25</td><td>-0.65</td><td>0.939</td><td>1.000</td><td>1.000</td><td>1470</td><td>tags=17%, list=13%, signal=20%</td></tr><tr><td class='lessen'>1128</td><td>AMIT_EGF_RESPONSE_240_MCF10A</td><td></td><td>16</td><td>-0.28</td><td>-0.65</td><td>0.899</td><td>1.000</td><td>1.000</td><td>2293</td><td>tags=25%, list=21%, signal=31%</td></tr><tr><td class='lessen'>1129</td><td>KIM_HYPOXIA</td><td></td><td>20</td><td>-0.26</td><td>-0.65</td><td>0.926</td><td>1.000</td><td>1.000</td><td>2922</td><td>tags=40%, list=26%, signal=54%</td></tr><tr><td class='lessen'>1130</td><td>GU_PDEF_TARGETS_DN</td><td></td><td>22</td><td>-0.26</td><td>-0.65</td><td>0.934</td><td>1.000</td><td>1.000</td><td>132</td><td>tags=5%, list=1%, signal=5%</td></tr><tr><td class='lessen'>1131</td><td>DELASERNA_MYOD_TARGETS_DN</td><td></td><td>50</td><td>-0.22</td><td>-0.64</td><td>0.961</td><td>1.000</td><td>1.000</td><td>1286</td><td>tags=10%, list=12%, signal=11%</td></tr><tr><td class='lessen'>1132</td><td>PLASARI_TGFB1_TARGETS_1HR_DN</td><td></td><td>6</td><td>-0.34</td><td>-0.64</td><td>0.858</td><td>1.000</td><td>1.000</td><td>3322</td><td>tags=50%, list=30%, signal=71%</td></tr><tr><td class='lessen'>1133</td><td>PRAMOONJAGO_SOX4_TARGETS_UP</td><td></td><td>44</td><td>-0.22</td><td>-0.64</td><td>0.973</td><td>1.000</td><td>1.000</td><td>2426</td><td>tags=27%, list=22%, signal=35%</td></tr><tr><td class='lessen'>1134</td><td>MCBRYAN_PUBERTAL_BREAST_4_5WK_DN</td><td></td><td>159</td><td>-0.18</td><td>-0.64</td><td>1.000</td><td>1.000</td><td>1.000</td><td>1351</td><td>tags=10%, list=12%, signal=11%</td></tr><tr><td class='lessen'>1135</td><td>WAESCH_ANAPHASE_PROMOTING_COMPLEX</td><td></td><td>12</td><td>-0.29</td><td>-0.64</td><td>0.905</td><td>1.000</td><td>1.000</td><td>1752</td><td>tags=25%, list=16%, signal=30%</td></tr><tr><td class='lessen'>1136</td><td>FAELT_B_CLL_WITH_VH3_21_UP</td><td></td><td>38</td><td>-0.23</td><td>-0.64</td><td>0.961</td><td>1.000</td><td>1.000</td><td>1947</td><td>tags=18%, list=17%, signal=22%</td></tr><tr><td class='lessen'>1137</td><td>TSUDA_ALVEOLAR_SOFT_PART_SARCOMA</td><td></td><td>10</td><td>-0.30</td><td>-0.64</td><td>0.903</td><td>1.000</td><td>1.000</td><td>2936</td><td>tags=50%, list=26%, signal=68%</td></tr><tr><td class='lessen'>1138</td><td>HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_DN</td><td></td><td>12</td><td>-0.30</td><td>-0.64</td><td>0.901</td><td>1.000</td><td>1.000</td><td>2065</td><td>tags=25%, list=19%, signal=31%</td></tr><tr><td class='lessen'>1139</td><td>SESTO_RESPONSE_TO_UV_C0</td><td></td><td>95</td><td>-0.20</td><td>-0.64</td><td>0.992</td><td>1.000</td><td>1.000</td><td>2404</td><td>tags=20%, list=22%, signal=25%</td></tr><tr><td class='lessen'>1140</td><td>CHOI_ATL_STAGE_PREDICTOR</td><td></td><td>31</td><td>-0.24</td><td>-0.64</td><td>0.957</td><td>1.000</td><td>1.000</td><td>2653</td><td>tags=29%, list=24%, signal=38%</td></tr><tr><td class='lessen'>1141</td><td>RUAN_RESPONSE_TO_TNF_DN</td><td></td><td>79</td><td>-0.20</td><td>-0.64</td><td>0.990</td><td>1.000</td><td>1.000</td><td>2516</td><td>tags=29%, list=23%, signal=37%</td></tr><tr><td class='lessen'>1142</td><td>XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR</td><td></td><td>16</td><td>-0.27</td><td>-0.64</td><td>0.946</td><td>1.000</td><td>1.000</td><td>1926</td><td>tags=31%, list=17%, signal=38%</td></tr><tr><td class='lessen'>1143</td><td>LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_DN</td><td></td><td>6</td><td>-0.35</td><td>-0.64</td><td>0.857</td><td>1.000</td><td>1.000</td><td>2436</td><td>tags=33%, list=22%, signal=43%</td></tr><tr><td class='lessen'>1144</td><td>GAVIN_FOXP3_TARGETS_CLUSTER_T7</td><td></td><td>81</td><td>-0.20</td><td>-0.63</td><td>0.990</td><td>1.000</td><td>1.000</td><td>2760</td><td>tags=33%, list=25%, signal=44%</td></tr><tr><td class='lessen'>1145</td><td>VERRECCHIA_RESPONSE_TO_TGFB1_C3</td><td></td><td>13</td><td>-0.28</td><td>-0.63</td><td>0.924</td><td>1.000</td><td>1.000</td><td>7967</td><td>tags=100%, list=72%, signal=351%</td></tr><tr><td class='lessen'>1146</td><td>FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP</td><td></td><td>130</td><td>-0.18</td><td>-0.63</td><td>1.000</td><td>1.000</td><td>1.000</td><td>2196</td><td>tags=18%, list=20%, signal=22%</td></tr><tr><td class='lessen'>1147</td><td>MA_PITUITARY_FETAL_VS_ADULT_UP</td><td></td><td>21</td><td>-0.26</td><td>-0.63</td><td>0.924</td><td>1.000</td><td>1.000</td><td>1672</td><td>tags=19%, list=15%, signal=22%</td></tr><tr><td class='lessen'>1148</td><td>NICK_RESPONSE_TO_PROC_TREATMENT_DN</td><td></td><td>20</td><td>-0.26</td><td>-0.63</td><td>0.953</td><td>1.000</td><td>1.000</td><td>1324</td><td>tags=20%, list=12%, signal=23%</td></tr><tr><td class='lessen'>1149</td><td>GERHOLD_RESPONSE_TO_TZD_DN</td><td></td><td>12</td><td>-0.29</td><td>-0.63</td><td>0.893</td><td>1.000</td><td>1.000</td><td>2281</td><td>tags=33%, list=20%, signal=42%</td></tr><tr><td class='lessen'>1150</td><td>BUSA_SAM68_TARGETS_DN</td><td></td><td>5</td><td>-0.35</td><td>-0.63</td><td>0.854</td><td>1.000</td><td>1.000</td><td>935</td><td>tags=20%, list=8%, signal=22%</td></tr><tr><td class='lessen'>1151</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP</td><td></td><td>92</td><td>-0.19</td><td>-0.63</td><td>1.000</td><td>1.000</td><td>1.000</td><td>2520</td><td>tags=27%, list=23%, signal=35%</td></tr><tr><td class='lessen'>1152</td><td>HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_UP</td><td></td><td>15</td><td>-0.27</td><td>-0.63</td><td>0.921</td><td>1.000</td><td>1.000</td><td>2796</td><td>tags=47%, list=25%, signal=62%</td></tr><tr><td class='lessen'>1153</td><td>FARMER_BREAST_CANCER_CLUSTER_5</td><td></td><td>18</td><td>-0.26</td><td>-0.63</td><td>0.926</td><td>1.000</td><td>1.000</td><td>1518</td><td>tags=17%, list=14%, signal=19%</td></tr><tr><td class='lessen'>1154</td><td>TURJANSKI_MAPK11_TARGETS</td><td></td><td>5</td><td>-0.36</td><td>-0.63</td><td>0.869</td><td>1.000</td><td>1.000</td><td>1034</td><td>tags=20%, list=9%, signal=22%</td></tr><tr><td class='lessen'>1155</td><td>PHONG_TNF_TARGETS_DN</td><td></td><td>6</td><td>-0.34</td><td>-0.63</td><td>0.883</td><td>1.000</td><td>1.000</td><td>3354</td><td>tags=67%, list=30%, signal=95%</td></tr><tr><td class='lessen'>1156</td><td>IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM</td><td></td><td>24</td><td>-0.25</td><td>-0.63</td><td>0.933</td><td>1.000</td><td>1.000</td><td>3043</td><td>tags=42%, list=27%, signal=57%</td></tr><tr><td class='lessen'>1157</td><td>MARTINEZ_RESPONSE_TO_TRABECTEDIN</td><td></td><td>44</td><td>-0.21</td><td>-0.63</td><td>0.982</td><td>1.000</td><td>1.000</td><td>2594</td><td>tags=32%, list=23%, signal=41%</td></tr><tr><td class='lessen'>1158</td><td>ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP</td><td></td><td>25</td><td>-0.24</td><td>-0.63</td><td>0.934</td><td>1.000</td><td>1.000</td><td>2581</td><td>tags=32%, list=23%, signal=42%</td></tr><tr><td class='lessen'>1159</td><td>JIANG_VHL_TARGETS</td><td></td><td>105</td><td>-0.19</td><td>-0.63</td><td>0.996</td><td>1.000</td><td>1.000</td><td>2714</td><td>tags=24%, list=24%, signal=31%</td></tr><tr><td class='lessen'>1160</td><td>SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL</td><td></td><td>59</td><td>-0.20</td><td>-0.63</td><td>0.986</td><td>1.000</td><td>1.000</td><td>1816</td><td>tags=15%, list=16%, signal=18%</td></tr><tr><td class='lessen'>1161</td><td>MURAKAMI_UV_RESPONSE_1HR_DN</td><td></td><td>7</td><td>-0.32</td><td>-0.63</td><td>0.888</td><td>1.000</td><td>1.000</td><td>516</td><td>tags=14%, list=5%, signal=15%</td></tr><tr><td class='lessen'>1162</td><td>GUILLAUMOND_KLF10_TARGETS_DN</td><td></td><td>24</td><td>-0.24</td><td>-0.62</td><td>0.960</td><td>1.000</td><td>1.000</td><td>1904</td><td>tags=29%, list=17%, signal=35%</td></tr><tr><td class='lessen'>1163</td><td>SANA_TNF_SIGNALING_DN</td><td></td><td>74</td><td>-0.20</td><td>-0.62</td><td>0.986</td><td>1.000</td><td>1.000</td><td>1299</td><td>tags=14%, list=12%, signal=15%</td></tr><tr><td class='lessen'>1164</td><td>UEDA_PERIFERAL_CLOCK</td><td></td><td>137</td><td>-0.18</td><td>-0.62</td><td>1.000</td><td>1.000</td><td>1.000</td><td>2998</td><td>tags=31%, list=27%, signal=41%</td></tr><tr><td class='lessen'>1165</td><td>DAZARD_UV_RESPONSE_CLUSTER_G3</td><td></td><td>11</td><td>-0.29</td><td>-0.62</td><td>0.915</td><td>1.000</td><td>1.000</td><td>1515</td><td>tags=27%, list=14%, signal=32%</td></tr><tr><td class='lessen'>1166</td><td>WANG_TUMOR_INVASIVENESS_UP</td><td></td><td>311</td><td>-0.16</td><td>-0.62</td><td>1.000</td><td>1.000</td><td>1.000</td><td>1861</td><td>tags=13%, list=17%, signal=15%</td></tr><tr><td class='lessen'>1167</td><td>SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE</td><td></td><td>90</td><td>-0.19</td><td>-0.61</td><td>0.994</td><td>1.000</td><td>1.000</td><td>1754</td><td>tags=12%, list=16%, signal=14%</td></tr><tr><td class='lessen'>1168</td><td>AKL_HTLV1_INFECTION_DN</td><td></td><td>52</td><td>-0.20</td><td>-0.61</td><td>0.987</td><td>1.000</td><td>1.000</td><td>2511</td><td>tags=25%, list=23%, signal=32%</td></tr><tr><td class='lessen'>1169</td><td>SUZUKI_CTCFL_TARGETS_UP</td><td></td><td>7</td><td>-0.32</td><td>-0.61</td><td>0.889</td><td>1.000</td><td>1.000</td><td>7609</td><td>tags=100%, list=68%, signal=316%</td></tr><tr><td class='lessen'>1170</td><td>ONDER_CDH1_TARGETS_1_DN</td><td></td><td>115</td><td>-0.18</td><td>-0.61</td><td>0.998</td><td>1.000</td><td>1.000</td><td>2384</td><td>tags=20%, list=21%, signal=25%</td></tr><tr><td class='lessen'>1171</td><td>FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_UP</td><td></td><td>10</td><td>-0.29</td><td>-0.61</td><td>0.921</td><td>1.000</td><td>1.000</td><td>798</td><td>tags=20%, list=7%, signal=22%</td></tr><tr><td class='lessen'>1172</td><td>WIKMAN_ASBESTOS_LUNG_CANCER_UP</td><td></td><td>13</td><td>-0.28</td><td>-0.61</td><td>0.921</td><td>1.000</td><td>1.000</td><td>8063</td><td>tags=100%, list=72%, signal=362%</td></tr><tr><td class='lessen'>1173</td><td>WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP</td><td></td><td>11</td><td>-0.29</td><td>-0.61</td><td>0.915</td><td>1.000</td><td>1.000</td><td>2623</td><td>tags=36%, list=24%, signal=48%</td></tr><tr><td class='lessen'>1174</td><td>IGARASHI_ATF4_TARGETS_DN</td><td></td><td>72</td><td>-0.19</td><td>-0.61</td><td>0.994</td><td>1.000</td><td>1.000</td><td>2556</td><td>tags=25%, list=23%, signal=32%</td></tr><tr><td class='lessen'>1175</td><td>FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN</td><td></td><td>20</td><td>-0.25</td><td>-0.60</td><td>0.946</td><td>1.000</td><td>1.000</td><td>1421</td><td>tags=20%, list=13%, signal=23%</td></tr><tr><td class='lessen'>1176</td><td>BRACHAT_RESPONSE_TO_METHOTREXATE_DN</td><td></td><td>22</td><td>-0.24</td><td>-0.60</td><td>0.945</td><td>1.000</td><td>1.000</td><td>2286</td><td>tags=32%, list=21%, signal=40%</td></tr><tr><td class='lessen'>1177</td><td>FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN</td><td></td><td>39</td><td>-0.21</td><td>-0.60</td><td>0.976</td><td>1.000</td><td>1.000</td><td>1325</td><td>tags=13%, list=12%, signal=15%</td></tr><tr><td class='lessen'>1178</td><td>BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_DN</td><td></td><td>8</td><td>-0.31</td><td>-0.60</td><td>0.889</td><td>1.000</td><td>1.000</td><td>1889</td><td>tags=25%, list=17%, signal=30%</td></tr><tr><td class='lessen'>1179</td><td>SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN</td><td></td><td>406</td><td>-0.15</td><td>-0.60</td><td>1.000</td><td>1.000</td><td>1.000</td><td>2995</td><td>tags=26%, list=27%, signal=34%</td></tr><tr><td class='lessen'>1180</td><td>TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_DN</td><td></td><td>16</td><td>-0.25</td><td>-0.60</td><td>0.945</td><td>1.000</td><td>1.000</td><td>2016</td><td>tags=19%, list=18%, signal=23%</td></tr><tr><td class='lessen'>1181</td><td>VERRECCHIA_RESPONSE_TO_TGFB1_C6</td><td></td><td>5</td><td>-0.33</td><td>-0.60</td><td>0.880</td><td>1.000</td><td>1.000</td><td>7441</td><td>tags=100%, list=67%, signal=301%</td></tr><tr><td class='lessen'>1182</td><td>GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION</td><td></td><td>12</td><td>-0.27</td><td>-0.59</td><td>0.934</td><td>1.000</td><td>1.000</td><td>8087</td><td>tags=100%, list=73%, signal=365%</td></tr><tr><td class='lessen'>1183</td><td>HORTON_SREBF_TARGETS</td><td></td><td>23</td><td>-0.23</td><td>-0.59</td><td>0.973</td><td>1.000</td><td>1.000</td><td>3999</td><td>tags=48%, list=36%, signal=74%</td></tr><tr><td class='lessen'>1184</td><td>IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM</td><td></td><td>22</td><td>-0.24</td><td>-0.59</td><td>0.960</td><td>1.000</td><td>1.000</td><td>2225</td><td>tags=23%, list=20%, signal=28%</td></tr><tr><td class='lessen'>1185</td><td>CASORELLI_APL_SECONDARY_VS_DE_NOVO_DN</td><td></td><td>9</td><td>-0.29</td><td>-0.59</td><td>0.906</td><td>1.000</td><td>1.000</td><td>1775</td><td>tags=33%, list=16%, signal=40%</td></tr><tr><td class='lessen'>1186</td><td>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP</td><td></td><td>13</td><td>-0.27</td><td>-0.59</td><td>0.962</td><td>1.000</td><td>1.000</td><td>851</td><td>tags=15%, list=8%, signal=17%</td></tr><tr><td class='lessen'>1187</td><td>FUNG_IL2_SIGNALING_1</td><td></td><td>8</td><td>-0.29</td><td>-0.59</td><td>0.898</td><td>1.000</td><td>1.000</td><td>741</td><td>tags=13%, list=7%, signal=13%</td></tr><tr><td class='lessen'>1188</td><td>HOSHIDA_LIVER_CANCER_SURVIVAL_DN</td><td></td><td>89</td><td>-0.19</td><td>-0.59</td><td>1.000</td><td>1.000</td><td>1.000</td><td>2289</td><td>tags=21%, list=21%, signal=27%</td></tr><tr><td class='lessen'>1189</td><td>WONG_IFNA2_RESISTANCE_DN</td><td></td><td>24</td><td>-0.23</td><td>-0.59</td><td>0.970</td><td>1.000</td><td>1.000</td><td>1567</td><td>tags=17%, list=14%, signal=19%</td></tr><tr><td class='lessen'>1190</td><td>DAZARD_RESPONSE_TO_UV_SCC_DN</td><td></td><td>98</td><td>-0.18</td><td>-0.59</td><td>1.000</td><td>1.000</td><td>1.000</td><td>2714</td><td>tags=24%, list=24%, signal=32%</td></tr><tr><td class='lessen'>1191</td><td>SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_DN</td><td></td><td>7</td><td>-0.31</td><td>-0.59</td><td>0.917</td><td>1.000</td><td>1.000</td><td>554</td><td>tags=14%, list=5%, signal=15%</td></tr><tr><td class='lessen'>1192</td><td>BILD_CTNNB1_ONCOGENIC_SIGNATURE</td><td></td><td>57</td><td>-0.19</td><td>-0.59</td><td>0.994</td><td>1.000</td><td>1.000</td><td>3074</td><td>tags=39%, list=28%, signal=53%</td></tr><tr><td class='lessen'>1193</td><td>OZEN_MIR125B1_TARGETS</td><td></td><td>21</td><td>-0.24</td><td>-0.58</td><td>0.979</td><td>1.000</td><td>1.000</td><td>3653</td><td>tags=52%, list=33%, signal=78%</td></tr><tr><td class='lessen'>1194</td><td>HU_ANGIOGENESIS_UP</td><td></td><td>19</td><td>-0.24</td><td>-0.58</td><td>0.969</td><td>1.000</td><td>1.000</td><td>2288</td><td>tags=26%, list=21%, signal=33%</td></tr><tr><td class='lessen'>1195</td><td>PARENT_MTOR_SIGNALING_UP</td><td></td><td>443</td><td>-0.15</td><td>-0.58</td><td>1.000</td><td>1.000</td><td>1.000</td><td>2659</td><td>tags=23%, list=24%, signal=29%</td></tr><tr><td class='lessen'>1196</td><td>WU_HBX_TARGETS_1_DN</td><td></td><td>20</td><td>-0.24</td><td>-0.58</td><td>0.963</td><td>1.000</td><td>1.000</td><td>564</td><td>tags=5%, list=5%, signal=5%</td></tr><tr><td class='lessen'>1197</td><td>IWANAGA_E2F1_TARGETS_NOT_INDUCED_BY_SERUM</td><td></td><td>5</td><td>-0.33</td><td>-0.58</td><td>0.909</td><td>1.000</td><td>1.000</td><td>3112</td><td>tags=60%, list=28%, signal=83%</td></tr><tr><td class='lessen'>1198</td><td>DAUER_STAT3_TARGETS_UP</td><td></td><td>42</td><td>-0.20</td><td>-0.57</td><td>0.990</td><td>1.000</td><td>1.000</td><td>1247</td><td>tags=14%, list=11%, signal=16%</td></tr><tr><td class='lessen'>1199</td><td>OHASHI_AURKA_TARGETS</td><td></td><td>5</td><td>-0.32</td><td>-0.57</td><td>0.911</td><td>1.000</td><td>1.000</td><td>2409</td><td>tags=40%, list=22%, signal=51%</td></tr><tr><td class='lessen'>1200</td><td>MMS_MOUSE_LYMPH_HIGH_4HRS_UP</td><td></td><td>31</td><td>-0.21</td><td>-0.56</td><td>0.992</td><td>1.000</td><td>1.000</td><td>4194</td><td>tags=52%, list=38%, signal=83%</td></tr><tr><td class='lessen'>1201</td><td>DORSAM_HOXA9_TARGETS_DN</td><td></td><td>30</td><td>-0.21</td><td>-0.56</td><td>0.977</td><td>1.000</td><td>1.000</td><td>1776</td><td>tags=20%, list=16%, signal=24%</td></tr><tr><td class='lessen'>1202</td><td>KIM_ALL_DISORDERS_DURATION_CORR_UP</td><td></td><td>5</td><td>-0.32</td><td>-0.56</td><td>0.925</td><td>1.000</td><td>1.000</td><td>3971</td><td>tags=60%, list=36%, signal=93%</td></tr><tr><td class='lessen'>1203</td><td>TAKADA_GASTRIC_CANCER_COPY_NUMBER_UP</td><td></td><td>7</td><td>-0.29</td><td>-0.56</td><td>0.925</td><td>1.000</td><td>1.000</td><td>633</td><td>tags=14%, list=6%, signal=15%</td></tr><tr><td class='lessen'>1204</td><td>SASAKI_TARGETS_OF_TP73_AND_TP63</td><td></td><td>6</td><td>-0.31</td><td>-0.56</td><td>0.904</td><td>1.000</td><td>1.000</td><td>7723</td><td>tags=100%, list=69%, signal=326%</td></tr><tr><td class='lessen'>1205</td><td>MARCHINI_TRABECTEDIN_RESISTANCE_DN</td><td></td><td>43</td><td>-0.20</td><td>-0.56</td><td>0.992</td><td>1.000</td><td>1.000</td><td>3148</td><td>tags=28%, list=28%, signal=39%</td></tr><tr><td class='lessen'>1206</td><td>DAZARD_UV_RESPONSE_CLUSTER_G5</td><td></td><td>7</td><td>-0.29</td><td>-0.56</td><td>0.922</td><td>1.000</td><td>1.000</td><td>2477</td><td>tags=43%, list=22%, signal=55%</td></tr><tr><td class='lessen'>1207</td><td>RAHMAN_TP53_TARGETS_PHOSPHORYLATED</td><td></td><td>18</td><td>-0.23</td><td>-0.56</td><td>0.965</td><td>1.000</td><td>1.000</td><td>2417</td><td>tags=22%, list=22%, signal=28%</td></tr><tr><td class='lessen'>1208</td><td>BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN</td><td></td><td>40</td><td>-0.20</td><td>-0.55</td><td>0.990</td><td>1.000</td><td>1.000</td><td>3471</td><td>tags=38%, list=31%, signal=54%</td></tr><tr><td class='lessen'>1209</td><td>CHUANG_OXIDATIVE_STRESS_RESPONSE_DN</td><td></td><td>10</td><td>-0.27</td><td>-0.55</td><td>0.930</td><td>1.000</td><td>1.000</td><td>2686</td><td>tags=40%, list=24%, signal=53%</td></tr><tr><td class='lessen'>1210</td><td>NEBEN_AML_WITH_FLT3_OR_NRAS_UP</td><td></td><td>6</td><td>-0.30</td><td>-0.55</td><td>0.944</td><td>1.000</td><td>1.000</td><td>2296</td><td>tags=33%, list=21%, signal=42%</td></tr><tr><td class='lessen'>1211</td><td>HEDVAT_ELF4_TARGETS_UP</td><td></td><td>7</td><td>-0.29</td><td>-0.55</td><td>0.928</td><td>1.000</td><td>1.000</td><td>3267</td><td>tags=43%, list=29%, signal=61%</td></tr><tr><td class='lessen'>1212</td><td>NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON</td><td></td><td>41</td><td>-0.20</td><td>-0.55</td><td>0.992</td><td>1.000</td><td>1.000</td><td>1901</td><td>tags=15%, list=17%, signal=18%</td></tr><tr><td class='lessen'>1213</td><td>WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2</td><td></td><td>30</td><td>-0.20</td><td>-0.55</td><td>0.984</td><td>1.000</td><td>1.000</td><td>1165</td><td>tags=10%, list=10%, signal=11%</td></tr><tr><td class='lessen'>1214</td><td>SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_UP</td><td></td><td>8</td><td>-0.28</td><td>-0.55</td><td>0.941</td><td>1.000</td><td>1.000</td><td>3124</td><td>tags=50%, list=28%, signal=69%</td></tr><tr><td class='lessen'>1215</td><td>LIN_MELANOMA_COPY_NUMBER_UP</td><td></td><td>51</td><td>-0.18</td><td>-0.54</td><td>0.998</td><td>1.000</td><td>1.000</td><td>3517</td><td>tags=39%, list=32%, signal=57%</td></tr><tr><td class='lessen'>1216</td><td>YANG_MUC2_TARGETS_DUODENUM_6MO_DN</td><td></td><td>14</td><td>-0.24</td><td>-0.54</td><td>0.969</td><td>1.000</td><td>1.000</td><td>2633</td><td>tags=36%, list=24%, signal=47%</td></tr><tr><td class='lessen'>1217</td><td>KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN</td><td></td><td>37</td><td>-0.19</td><td>-0.54</td><td>0.992</td><td>1.000</td><td>1.000</td><td>1037</td><td>tags=11%, list=9%, signal=12%</td></tr><tr><td class='lessen'>1218</td><td>BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS</td><td></td><td>5</td><td>-0.31</td><td>-0.54</td><td>0.932</td><td>1.000</td><td>1.000</td><td>7723</td><td>tags=100%, list=69%, signal=326%</td></tr><tr><td class='lessen'>1219</td><td>GUTIERREZ_MULTIPLE_MYELOMA_DN</td><td></td><td>30</td><td>-0.20</td><td>-0.54</td><td>0.988</td><td>1.000</td><td>1.000</td><td>2246</td><td>tags=23%, list=20%, signal=29%</td></tr><tr><td class='lessen'>1220</td><td>WANG_TARGETS_OF_MLL_CBP_FUSION_DN</td><td></td><td>38</td><td>-0.19</td><td>-0.54</td><td>0.994</td><td>1.000</td><td>1.000</td><td>970</td><td>tags=11%, list=9%, signal=11%</td></tr><tr><td class='lessen'>1221</td><td>COURTOIS_SENESCENCE_TRIGGERS</td><td></td><td>6</td><td>-0.28</td><td>-0.53</td><td>0.928</td><td>1.000</td><td>1.000</td><td>3781</td><td>tags=50%, list=34%, signal=76%</td></tr><tr><td class='lessen'>1222</td><td>CLIMENT_BREAST_CANCER_COPY_NUMBER_DN</td><td></td><td>7</td><td>-0.27</td><td>-0.53</td><td>0.951</td><td>1.000</td><td>1.000</td><td>2047</td><td>tags=29%, list=18%, signal=35%</td></tr><tr><td class='lessen'>1223</td><td>MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP</td><td></td><td>63</td><td>-0.17</td><td>-0.53</td><td>1.000</td><td>1.000</td><td>1.000</td><td>2547</td><td>tags=24%, list=23%, signal=31%</td></tr><tr><td class='lessen'>1224</td><td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_8</td><td></td><td>11</td><td>-0.25</td><td>-0.53</td><td>0.960</td><td>1.000</td><td>1.000</td><td>3598</td><td>tags=45%, list=32%, signal=67%</td></tr><tr><td class='lessen'>1225</td><td>PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN</td><td></td><td>15</td><td>-0.23</td><td>-0.53</td><td>0.975</td><td>1.000</td><td>1.000</td><td>2231</td><td>tags=20%, list=20%, signal=25%</td></tr><tr><td class='lessen'>1226</td><td>ZHAN_MULTIPLE_MYELOMA_MS_DN</td><td></td><td>30</td><td>-0.20</td><td>-0.52</td><td>0.988</td><td>1.000</td><td>1.000</td><td>2751</td><td>tags=30%, list=25%, signal=40%</td></tr><tr><td class='lessen'>1227</td><td>OXFORD_RALA_AND_RALB_TARGETS_DN</td><td></td><td>9</td><td>-0.26</td><td>-0.52</td><td>0.942</td><td>1.000</td><td>1.000</td><td>8288</td><td>tags=100%, list=74%, signal=391%</td></tr><tr><td class='lessen'>1228</td><td>VALK_AML_WITH_EVI1</td><td></td><td>16</td><td>-0.22</td><td>-0.52</td><td>0.972</td><td>1.000</td><td>1.000</td><td>523</td><td>tags=6%, list=5%, signal=7%</td></tr><tr><td class='lessen'>1229</td><td>NELSON_RESPONSE_TO_ANDROGEN_UP</td><td></td><td>73</td><td>-0.16</td><td>-0.52</td><td>1.000</td><td>1.000</td><td>1.000</td><td>2640</td><td>tags=26%, list=24%, signal=34%</td></tr><tr><td class='lessen'>1230</td><td>MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN</td><td></td><td>16</td><td>-0.22</td><td>-0.52</td><td>0.973</td><td>1.000</td><td>1.000</td><td>2253</td><td>tags=19%, list=20%, signal=23%</td></tr><tr><td class='lessen'>1231</td><td>STEGMEIER_PRE-MITOTIC_CELL_CYCLE_REGULATORS</td><td></td><td>10</td><td>-0.25</td><td>-0.52</td><td>0.955</td><td>1.000</td><td>1.000</td><td>1568</td><td>tags=20%, list=14%, signal=23%</td></tr><tr><td class='lessen'>1232</td><td>CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN</td><td></td><td>27</td><td>-0.20</td><td>-0.51</td><td>0.998</td><td>1.000</td><td>1.000</td><td>8941</td><td>tags=100%, list=80%, signal=507%</td></tr><tr><td class='lessen'>1233</td><td>BAE_BRCA1_TARGETS_DN</td><td></td><td>28</td><td>-0.19</td><td>-0.51</td><td>0.990</td><td>1.000</td><td>1.000</td><td>3551</td><td>tags=39%, list=32%, signal=58%</td></tr><tr><td class='lessen'>1234</td><td>VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP</td><td></td><td>11</td><td>-0.23</td><td>-0.50</td><td>0.979</td><td>1.000</td><td>1.000</td><td>2653</td><td>tags=27%, list=24%, signal=36%</td></tr><tr><td class='lessen'>1235</td><td>ZEMBUTSU_SENSITIVITY_TO_METHOTREXATE</td><td></td><td>13</td><td>-0.23</td><td>-0.50</td><td>0.973</td><td>1.000</td><td>1.000</td><td>633</td><td>tags=8%, list=6%, signal=8%</td></tr><tr><td class='lessen'>1236</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_DN</td><td></td><td>8</td><td>-0.24</td><td>-0.50</td><td>0.941</td><td>1.000</td><td>1.000</td><td>951</td><td>tags=13%, list=9%, signal=14%</td></tr><tr><td class='lessen'>1237</td><td>BRUNEAU_SEPTATION_VENTRICULAR</td><td></td><td>8</td><td>-0.25</td><td>-0.50</td><td>0.963</td><td>1.000</td><td>1.000</td><td>8324</td><td>tags=100%, list=75%, signal=396%</td></tr><tr><td class='lessen'>1238</td><td>YIH_RESPONSE_TO_ARSENITE_C2</td><td></td><td>15</td><td>-0.22</td><td>-0.50</td><td>0.977</td><td>1.000</td><td>1.000</td><td>4087</td><td>tags=60%, list=37%, signal=95%</td></tr><tr><td class='lessen'>1239</td><td>DING_LUNG_CANCER_BY_MUTATION_RATE</td><td></td><td>17</td><td>-0.21</td><td>-0.50</td><td>0.982</td><td>1.000</td><td>1.000</td><td>3319</td><td>tags=35%, list=30%, signal=50%</td></tr><tr><td class='lessen'>1240</td><td>RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_UP</td><td></td><td>5</td><td>-0.27</td><td>-0.49</td><td>0.960</td><td>1.000</td><td>1.000</td><td>8138</td><td>tags=100%, list=73%, signal=372%</td></tr><tr><td class='lessen'>1241</td><td>WANG_RESPONSE_TO_FORSKOLIN_DN</td><td></td><td>8</td><td>-0.24</td><td>-0.48</td><td>0.971</td><td>1.000</td><td>1.000</td><td>8447</td><td>tags=100%, list=76%, signal=414%</td></tr><tr><td class='lessen'>1242</td><td>KAUFFMANN_MELANOMA_RELAPSE_DN</td><td></td><td>5</td><td>-0.27</td><td>-0.48</td><td>0.965</td><td>1.000</td><td>1.000</td><td>2565</td><td>tags=40%, list=23%, signal=52%</td></tr><tr><td class='lessen'>1243</td><td>GENTILE_UV_RESPONSE_CLUSTER_D7</td><td></td><td>33</td><td>-0.18</td><td>-0.48</td><td>1.000</td><td>1.000</td><td>1.000</td><td>9170</td><td>tags=100%, list=82%, signal=565%</td></tr><tr><td class='lessen'>1244</td><td>WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK</td><td></td><td>114</td><td>-0.14</td><td>-0.47</td><td>1.000</td><td>1.000</td><td>1.000</td><td>3342</td><td>tags=30%, list=30%, signal=42%</td></tr><tr><td class='lessen'>1245</td><td>STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP</td><td></td><td>100</td><td>-0.14</td><td>-0.47</td><td>1.000</td><td>1.000</td><td>1.000</td><td>3638</td><td>tags=41%, list=33%, signal=60%</td></tr><tr><td class='lessen'>1246</td><td>KIM_RESPONSE_TO_TSA_AND_DECITABINE_DN</td><td></td><td>10</td><td>-0.23</td><td>-0.47</td><td>0.974</td><td>1.000</td><td>1.000</td><td>2246</td><td>tags=30%, list=20%, signal=38%</td></tr><tr><td class='lessen'>1247</td><td>ZERBINI_RESPONSE_TO_SULINDAC_UP</td><td></td><td>5</td><td>-0.26</td><td>-0.46</td><td>0.986</td><td>1.000</td><td>1.000</td><td>1298</td><td>tags=20%, list=12%, signal=23%</td></tr><tr><td class='lessen'>1248</td><td>IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_DN</td><td></td><td>10</td><td>-0.22</td><td>-0.46</td><td>0.973</td><td>1.000</td><td>1.000</td><td>850</td><td>tags=10%, list=8%, signal=11%</td></tr><tr><td class='lessen'>1249</td><td>PASTURAL_RIZ1_TARGETS_UP</td><td></td><td>6</td><td>-0.25</td><td>-0.46</td><td>0.973</td><td>1.000</td><td>1.000</td><td>3460</td><td>tags=50%, list=31%, signal=73%</td></tr><tr><td class='lessen'>1250</td><td>UDAYAKUMAR_MED1_TARGETS_UP</td><td></td><td>113</td><td>-0.14</td><td>-0.46</td><td>1.000</td><td>1.000</td><td>1.000</td><td>1843</td><td>tags=13%, list=17%, signal=16%</td></tr><tr><td class='lessen'>1251</td><td>SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN</td><td></td><td>12</td><td>-0.21</td><td>-0.45</td><td>0.991</td><td>1.000</td><td>1.000</td><td>3850</td><td>tags=50%, list=35%, signal=76%</td></tr><tr><td class='lessen'>1252</td><td>SESTO_RESPONSE_TO_UV_C4</td><td></td><td>14</td><td>-0.20</td><td>-0.44</td><td>0.990</td><td>1.000</td><td>1.000</td><td>3183</td><td>tags=36%, list=29%, signal=50%</td></tr><tr><td class='lessen'>1253</td><td>TERAO_AOX4_TARGETS_SKIN_UP</td><td></td><td>33</td><td>-0.16</td><td>-0.44</td><td>1.000</td><td>1.000</td><td>1.000</td><td>3440</td><td>tags=33%, list=31%, signal=48%</td></tr><tr><td class='lessen'>1254</td><td>RASHI_RESPONSE_TO_IONIZING_RADIATION_3</td><td></td><td>40</td><td>-0.16</td><td>-0.44</td><td>1.000</td><td>1.000</td><td>1.000</td><td>4141</td><td>tags=50%, list=37%, signal=79%</td></tr><tr><td class='lessen'>1255</td><td>SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_DN</td><td></td><td>16</td><td>-0.19</td><td>-0.44</td><td>0.988</td><td>1.000</td><td>1.000</td><td>3353</td><td>tags=44%, list=30%, signal=63%</td></tr><tr><td class='lessen'>1256</td><td>KANG_CISPLATIN_RESISTANCE_DN</td><td></td><td>5</td><td>-0.24</td><td>-0.43</td><td>0.994</td><td>1.000</td><td>1.000</td><td>8473</td><td>tags=100%, list=76%, signal=418%</td></tr><tr><td class='lessen'>1257</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_DN</td><td></td><td>8</td><td>-0.21</td><td>-0.42</td><td>0.996</td><td>1.000</td><td>1.000</td><td>8812</td><td>tags=100%, list=79%, signal=479%</td></tr><tr><td class='lessen'>1258</td><td>GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_DN</td><td></td><td>5</td><td>-0.23</td><td>-0.41</td><td>0.992</td><td>1.000</td><td>1.000</td><td>8554</td><td>tags=100%, list=77%, signal=431%</td></tr><tr><td class='lessen'>1259</td><td>JUBAN_TARGETS_OF_SPI1_AND_FLI1_UP</td><td></td><td>91</td><td>-0.12</td><td>-0.41</td><td>1.000</td><td>1.000</td><td>1.000</td><td>3242</td><td>tags=30%, list=29%, signal=42%</td></tr><tr><td class='lessen'>1260</td><td>DASU_IL6_SIGNALING_SCAR_DN</td><td></td><td>13</td><td>-0.19</td><td>-0.41</td><td>1.000</td><td>1.000</td><td>1.000</td><td>2941</td><td>tags=38%, list=26%, signal=52%</td></tr><tr><td class='lessen'>1261</td><td>CAFFAREL_RESPONSE_TO_THC_24HR_3_UP</td><td></td><td>6</td><td>-0.21</td><td>-0.40</td><td>0.991</td><td>1.000</td><td>1.000</td><td>4271</td><td>tags=67%, list=38%, signal=108%</td></tr><tr><td class='lessen'>1262</td><td>WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR</td><td></td><td>25</td><td>-0.15</td><td>-0.38</td><td>0.998</td><td>1.000</td><td>1.000</td><td>2678</td><td>tags=20%, list=24%, signal=26%</td></tr><tr><td class='lessen'>1263</td><td>OXFORD_RALB_TARGETS_UP</td><td></td><td>7</td><td>-0.19</td><td>-0.37</td><td>0.998</td><td>1.000</td><td>1.000</td><td>8993</td><td>tags=100%, list=81%, signal=520%</td></tr><tr><td class='lessen'>1264</td><td>PETRETTO_HEART_MASS_QTL_CIS_UP</td><td></td><td>20</td><td>-0.15</td><td>-0.37</td><td>0.998</td><td>1.000</td><td>1.000</td><td>724</td><td>tags=5%, list=7%, signal=5%</td></tr><tr><td class='lessen'>1265</td><td>BARRIER_COLON_CANCER_RECURRENCE_DN</td><td></td><td>15</td><td>-0.15</td><td>-0.35</td><td>0.998</td><td>1.000</td><td>1.000</td><td>1948</td><td>tags=13%, list=17%, signal=16%</td></tr><caption class='table'>Table: Gene sets enriched in phenotype <b>na<b>&nbsp<a href='gsea_report_for_na_neg_1441901072646.xls'>[plain text format]</a></caption></table></div><br></body></html>